Professor John Snowden

BSc, MBChB, MD, FRCP (London), FRCP (Edin), FRCPath, DTM&H

School of Medicine and Population Health

Professor of Haematology

Honorary Consultant Haematologist, Sheffield Teaching Hospitals NHS Foundation Trust

Professor John Snowden
Professor John Snowden
Profile picture of Professor John Snowden
john.snowden@sheffield.ac.uk
+44 114 215 9026
+44 114 271 3357 (Clinical Secretary)
EU38, The Medical School

Full contact details

Professor John Snowden
School of Medicine and Population Health
EU38
The Medical School
Beech Hill Road
Sheffield
S10 2RX
Profile

For enquiries, please contact  SMPH-West-Operational@sheffield.ac.uk

I trained as an undergraduate at the University of Leeds, and as a postgraduate in the UK, Australia and New Zealand. I was an NHS Consultant Haematologist and Director of the Blood and Marrow Transplantation & Cellular Therapy Programme in Sheffield Teaching Hospitals NHS Foundation Trust, UK, from 2002 until my appointment as Professor of Haematology at the University of Sheffield in February 2025.

Nationally, I have held several key leadership roles in Blood and Marrow Transplantation (BMT) and Haemato-oncology, including Clinical Lead for various NICE Guidelines and Chair of the NHS England Clinical Reference Group for BMT (2016-20). From 2017-20, I was Chair of the Intercollegiate Committee on Haematology (ICH) to the Royal College of Physicians and Royal College of Pathologists. I was President of the British Society of Blood and Marrow Transplantation & Cellular Therapy (BSBMTCT) for 2021-22 and continued within the Board of Trustees as Past President (2023-24). In 2022, I was elected to the Board of Trustees of the British Society for Haematology (BSH).

Internationally, I have a long association with the European Society for Blood and Marrow Transplantation (EBMT) and the international accreditation organisation for transplant programmes, ‘JACIE’, including JACIE Medical Director (2012-16) and Chair of the JACIE Committee (2015-20). I have served as a member of the EBMT Board and Scientific Council, initially as Autoimmune Diseases Working Party Chair (2016-20) and as Secretary to EBMT from 2020-24.

Academically, I have contributed to the fields of BMT, haematology-oncology and autoimmunity with authorship of over 400 publications (Google Scholar h-index 77, with over 21,000 citations), along with clinical trials, grant awards, educational meetings, teaching, supervision, examination, journal editorship and scientific peer review. I have been awarded honorary professorships by the University of Sheffield and University College London (UCL).

Other recent appointments

  • Consultant Haematologist & Director of Blood and Marrow Transplantation (BMT) and Cellular Therapy Programme, Sheffield Teaching Hospitals NHS Foundation Trust, 2002-25.
  • Honorary Professor, Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, UK, 2013-25.
  • Honorary Clinical Professor, Department of Haematology, The Cancer Institute, UCL, 2016-25.
  • Secretary to the European Society for Blood and Marrow Transplantation (EBMT), 2020-24.
  • President of British Society of Blood and Marrow Transplantation & Cellular Therapy (BSBMTCT), 2021-22.
  • Chair of the Intercollegiate Committee on Haematology (ICH) to the RCP (London) and RCPath, 2017-20.
  • Co-Lead Clinician for Haematology-Oncology in the NHS England Genomic Laboratory Hub (GLH) for North-East & Yorkshire (NEY) region, 2019-25.
  • British Society for Haematology (BSH), Elected Member of Board of Trustees, 2022-25.
Qualifications
  • BSc Pathology, First Class Honours, University of Leeds, 1987.
    • Willis Prize in Pathology, University of Leeds 1987.
  • MBChB Medicine, University of Leeds, 1989.
    • Paul Fitton Prize in Anaesthesia, Association of Anaesthetists, UK 1988.
    • Pullen Prize in Obstetrics and Gynaecology, University of Leeds 1989.
    • William MacAdam Prize in Medicine, University of Leeds 1989.
  • Membership of the Royal College of Physicians, MRCP (UK), 1992.
  • Membership of the Royal College of Pathologists, MRCPath, 1999.
  • Doctor of Medicine, MD, University of Leeds, 1999.
  • Specialist Certification in Haematology, 1999.
  • Fellowship of the Royal College of Physicians of London, FRCP (Lond), 2004.
  • Fellowship of the Royal College of Pathologists, FRCPath, 2007.
  • Fellowship of the Royal College of Physicians of Edinburgh, FRCP (Edin), 2019.
  • Diploma in Tropical Medicine & Hygiene, DTM&H, awarded by RCP London 2021.
Research interests

In conjunction with NHS roles, my principal academic areas of interest are:

  • Blood and marrow stem cell transplantation in cancer and non-malignant disorders.
  • Physical and psychological late effects in survivors of cancer treatment and BMT.
  • Multiple myeloma, from cell biology to supportive care and survivorship research.
  • Leukaemia and other haematological cancers.
  • Service development, ‘quality’, accreditation, benchmarking and health economics in haemato-oncology and BMT.

My academic activity is reflected by:

  • Full publication of over 400 medical & scientific articles, with Google Scholar citation h-index of 77 and over 21,000 total citations.
  • Over £10 million in grant awards as co-applicant or chief/principal investigator.
  • Organising numerous national and international conferences.
  • Regular invitations to speak and chair sessions at numerous national & international meetings.
  • Extensive scientific peer review for respected general and specialist journals.
  • Collaborations with other national and international Haemato-oncology and BMT Programmes.
  • Principal Investigator/Chief Investigator roles in multicentre National Institute for Health Research (NIHR), National Cancer Research Institute (NCRI), investigator-led and industry-sponsored clinical research trials.
  • Delivering undergraduate/postgraduate teaching, supervision, training, and examination in Sheffield Teaching Hospitals, The University of Sheffield and Sheffield Hallam University.
  • External examiner for PhD examinations in other Universities (Birmingham, Newcastle, Oxford). 
Publications

Show: Featured publications All publications

Journal articles

  • Muraro PA, Mariottini A, Greco R, Burman J, Iacobaeus E, Inglese M, Snowden JA, Alexander T, Amato MP, Bø L , Boffa G et al (2025) . Nature Reviews Neurology, 21(3), 140-158.
  • Mayor NP, Szydlo RM, Sheikh Y, Lee J, Pearce RM, Farrow C, Agapiou M, Rao K, Orchard K, Olavarria E , Marsh SGE et al (2024) . The Lancet Haematology, 11(12), E916-E926.
  • Lindsay JO, Hind D, Swaby E, Berntsson H, Bradburn M, Bannur U, Byrne J, Clarke C, Desoysa L, Dickins B , Din S et al (2024) . The Lancet Gastroenterology and Hepatology.
  • Barnes E, Goodyear CS, Willicombe M, Gaskell C, Siebert S, I de Silva T, Murray SM, Rea D, Snowden JA, Carroll M , Pirrie S et al (2023) . Nature Medicine, 29(7), 1760-1774.
  • Rejeski K, Subklewe M, Aljurf M, Bachy E, Balduzzi AC, Barba P, Bruno B, Benjamin R, Carrabba MG, Chabannon C , Ciceri F et al (2023) . Blood Journal.
  • Saccardi R, Putter H, Eikema D-J, Busto MP, McGrath E, Middelkoop B, Adams G, Atlija M, Ayuk FA, Baldomero H , Beguin Y et al (2023) . Bone Marrow Transplantation.
  • Clark A, Thomas S, Hamblin A, Talley P, Kulasekararaj A, Grinfeld J, Speight B, Snape K, McVeigh TP & Snowden JA (2023) . British Journal of Haematology.
  • Snowden JA, Ahmedzai SH, Cox A, Cairns DA, Ashcroft AJ, Williams C, Cavenagh JD, Hockaday A, Brown JM, Brock IW , Morris TCM et al (2022) . Bone Marrow Transplantation, 57(10), 1507-1513.
  • Sharrack B, Petrie J, Coles A & Snowden JA (2022) . British Medical Journal (BMJ), 377.
  • Snowden JA, Sánchez-Ortega I, Corbacioglu S, Basak GW, Chabannon C, de la Camara R, Dolstra H, Duarte RF, Glass B, Greco R , Lankester AC et al (2022) . Bone Marrow Transplantation.
  • Hayden PJ, Roddie C, Bader P, Basak GW, Bonig H, Bonini C, Chabannon C, Ciceri F, Corbacioglu S, Ellard R , Sanchez-Guijo F et al (2022) . Annals of Oncology, 33(3), 259-275.
  • Sharrack B, Saccardi R, Alexander T, Badoglio M, Burman J, Farge D, Greco R, Jessop H, Kazmi M, Kirgizov K , Labopin M et al (2020) . Bone Marrow Transplantation, 55(2), 283-306.
  • Snowden JA, Saccardi R, Orchard K, Ljungman P, Duarte RF, Labopin M, McGrath E, Brook N, de Elvira CR, Gordon D , Poirel HA et al (2020) . Bone Marrow Transplantation, 55(4), 681-694.
  • Burt RK, Balabanov R, Burman J, Sharrack B, Snowden JA, Oliveira MC, Fagius J, Rose J, Nelson F, Barreira AA , Carlson K et al (2019) . Journal of the American Medical Association, 321(2), 165-174.
  • Snowden JA, McGrath E, Duarte RF, Saccardi R, Orchard K, Worel N, Kuball J, Chabannon C & Mohty M (2017) . Bone Marrow Transplant.
  • Snowden JA, Greenfield DM, Bird JM, Boland E, Bowcock S, Fisher A, Low E, Morris M, Yong K & Pratt G (2017) . British Journal of Haematology, 176(6), 888-907.

All publications

Books

  • (2021) . Springer International Publishing.
  • Burt RK, Farge D, Ruiz MA, Saccardi R & Snowden JA () . CRC Press.

Journal articles

  • Clark A, Kenyon M, Pagliuca A, Shah R, Tholouli E & Snowden JA (2025) . eJHaem, 6(5).
  • Clark A, Clouston H, Rao K, Folarin N, De la Fuente J, Hamblin A, Olavarria E, Richardson D, Talley P, Potter V , Loke J et al (2025) . Br J Haematol.
  • Greco R, Ruggeri A, McLornan DP, Snowden JA, Alexander T, Angelucci E, Averbuch D, Bazarbachi A, Hazenberg MD, Kalwak K , Kenyon M et al (2025) . Bone Marrow Transplant.
  • Muraro PA, Kazmi M, De Matteis E, Brittain G, Mariottini A, Nicholas R, Silber E, Mehra V, Gabriel I, Ciccarelli O , Lee J et al (2025) . Journal of Neurology, Neurosurgery & Psychiatry.
  • Del Papa N, Labopin M, Badoglio M, Farge D, Henes J, Snowden JA, Spierings J, Iannone C, Alexander T, SSc expert panelist group & Greco R (2025) . Bone Marrow Transplant, 1-4.
  • Alexander T, Roldan E, Del Papa N, Farge D, Henes J, Marjanovic Z, Puyade M, Snowden JA, Spierings J, de Vries-Bouwstra JK , Onida F et al (2025) . Bone Marrow Transplantation.
  • McLornan DP, Hazenberg MD, Ciceri F, Alexander T, Angelucci E, Averbuch D, Bazarbachi A, Chakraverty R, Booth C, Heemskerk MHM , Holler E et al (2025) . Bone Marrow Transplantation.
  • Kalincik T, Sharmin S, Roos I, Freedman MS, Atkins H, Massey J, Sutton I, Withers B, Burman J, Torkildsen Ø , Bø L et al (2025) . Brain.
  • Mizuno S, Gras L, Baaij LGA, Koster L, D'Souza A, Hari PN, Estrada-Merly N, Saber W, Cowan AJ, Iida M , Okamoto S et al (2025) . Haematologica.
  • Boffa G, Genchi A, Mariottini A, Brittain G, Snowden J, Alexander T, Badoglio M, Roldan Galvan E, Muraro PA, Sharrack B , Saccardi R et al (2025) . Multiple Sclerosis Journal.
  • Montoro J, Ferhat A-T, Dhedin N, Yakoub-Agha I, Versluis J, Blaise D, Balsat M, Forcade E, Castilla-Llorente C, Chevallier P , Roeven M et al (2025) . Bone Marrow Transplantation.
  • Kazmi M, Muraro PA, Mehra V, Gabriel I, De Matteis E, Brittain G, Mariottini A, Nicholas R, Silber E, Lee J , Pearce R et al (2025) . British Journal of Haematology.
  • Perruccio K, Ward KN, Tridello G, Knelange N, Zeiser R, Franke G-N, Sirvent A, Einsele H, Vicent MG, Navarro JMF , Contentin N et al (2025) . Bone Marrow Transplantation.
  • Brittain G, de Matteis E, Nicholas R, Silber E, Mehra V, Gabriel I, Lee J, Pearce R, Sormani MP, Signori A , Paul R et al (2025) . Neurology, 104(7_Supplement_1).
  • Barkauskiene R, Pryce A, Pearce R, Snowden JA, Malladi R, Potter V, Lee J, Wilson M, Cooper N, Apperley JF , Anthias C et al (2025) . Transplantation and Cellular Therapy, 31(8), 567.e1-567.e14.
  • Mellors J, Dhaliwal R, Longet S, Tipton T, McInnes I, Siebert S, Kearns P, Rea D, Cook G, Willicombe M , Thomas D et al (2025) . Nature Communications, 16(1).
  • Bekadja MA, Gras L, Baaij L, Koster L, Hamad N, Carpenter B, Nicholson E, Potter V, Broers AEC, Blaise D , Byrne JL et al (2025) . Cytotherapy.
  • Drozd-Sokołowska J, Tridello G, Verheggen I, Karakukcu M, Ben Abdeljelil N, Colita A, Aljurf M, Kröger N, Ozturk G, Passweg J , Gambella M et al (2025) . Bone Marrow Transplantation, 60(5).
  • Passweg JR, Baldomero H, Atlija M, Kleovoulou I, Witaszek A, Alexander T, Angelucci E, Averbuch D, Bazarbachi A, Ciceri F , Greco R et al (2025) . Bone Marrow Transplantation, 60(4), 519-528.
  • Muraro PA, Mariottini A, Greco R, Burman J, Iacobaeus E, Inglese M, Snowden JA, Alexander T, Amato MP, Bø L , Boffa G et al (2025) . Nature Reviews Neurology, 21(3), 140-158.
  • Passweg JR, Baldomero H, Alexander T, Angelucci E, Averbuch D, Bazarbachi A, Ciceri F, Raffaella G, Hazenberg MD, Kalwak K , McLornan DP et al (2025) . Bone Marrow Transplantation(60), 227-236.
  • Alexander T, Badoglio M, Labopin M, Daikeler T, Farge D, Kazmi M, Rovira M, Roldan E, Snowden J & Raffaella G (2025) . Bone Marrow Transplantation, 60(1), 110-113.
  • Montague-Hellen K, Greenfield DM, Snowden J & Nield A (2025) . Cancer Nursing Practice, 24(1), 25-31.
  • Mayor NP, Szydlo RM, Sheikh Y, Lee J, Pearce RM, Farrow C, Agapiou M, Rao K, Orchard K, Olavarria E , Marsh SGE et al (2024) . The Lancet Haematology, 11(12), E916-E926.
  • Colton H, Barratt N, Temperton N, Hornsby H, Angyal A, Grouneva I, Lindsey BB, Kearns P, Barnes E, Goodyear CS , Richter A et al (2024) . British Journal of Haematology, 205(6), 2206-2218.
  • Sweeney K, Niblock A, Greenfield D & Snowden J (2024) . eJHaem, 5(6), 1359-1362.
  • Hamad N, Takamatsu H, Gras L, Koster L, Baaij L, D'Souza A, Estrada-Merly N, Hari PN, Cowan AJ, Saber W , Iida M et al (2024) . Blood, 144(Supplement 1), 7848-7848.
  • Cowan AJ, Gras L, Takamatsu H, Koster L, Baaij L, Hamad N, D'Souza A, Estrada-Merly N, Hari PN, Saber W , Iida M et al (2024) . Blood, 144(Supplement 1), 2379-2379.
  • Beksac M, Iacobelli S, Gras L, Koster L, Baaij L, Hamad N, D'Souza A, Estrada-Merly N, Hari PN, Cowan AJ , Saber W et al (2024) . Blood, 144(Supplement 1), 4733-4733.
  • Chalandon Y, Bonneville EF, de Wreede LC, Koster L, Tuffnell J, Passweg J, Schetelig J, Platzbecker U, Yakoub-Agha I, Salmenniemi U , Verbeek M et al (2024) . Blood, 144(Supplement 1), 4894-4894.
  • Cook G, Ashcroft AJ, Senior E, Olivier C, Hockaday A, Richards J, Cavenagh JD, Snowden JA, Drayson MT, de Tute R , Roberts L et al (2024) . The Lancet Haematology, 11(11), e816-e829.
  • Parrish C, Welsh A, Ashcroft J, Olivier C, Hockaday A, Cavenagh J, Snowden J, Drayson M, De Tute R, Owen R , Yong K et al (2024) . Clinical Lymphoma Myeloma and Leukemia, 24, S37-S38.
  • Garderet L, Gras L, Koster L, Baaij L, Hamad N, Dsouza A, Estrada‐Merly N, Hari P, Saber W, Cowan AJ , Iida M et al (2024) . American Journal of Hematology, 99(11), 2084-2095.
  • Ismail A, Nitti R, Sharrack B, Badoglio M, Ambron P, Labopin M, Alexander T, Snowden JA & Greco R (2024) . Bone Marrow Transplantation, 59(11), 1614-1617.
  • Baldomero H, Neumann D, Hamad N, Atsuta Y, Sureda A, Iida M, Karduss A, Elhaddad AM, Bazuaye NG, Bonfim C , Camara RDL et al (2024) . Best Practice & Research Clinical Haematology, 37(2).
  • Brittain G, Roldan E, Alexander T, Saccardi R, Snowden JA, Sharrack B & Greco R (2024) . Annals of Neurology, 96(3), 441-452.
  • Styczynski J, Tridello G, Knelange N, Wendel L, Ljungman P, Mikulska M, Gil L, Cesaro S, Averbuch D, von dem Borne P , Xhaard A et al (2024) . Bone Marrow Transplantation, 59(10), 1402-1412.
  • Kelleher P, Greathead L, Whitby L, Brando B, Barnett D, Bloxham D, deTute R, Dunlop A, Farren T, Francis S , Payne D et al (2024) . Cytometry Part B: Clinical Cytometry, 106(6), 424-436.
  • Schoemans H, Burns LJ, Liptrott SJ, Murray J, Kenyon M, Barata A, Bolaños N, Scholl I, Hamilton B, Phelan R , Buchbinder D et al (2024) . Bone Marrow Transplantation, 59(9), 1286-1294.
  • Patel B, Kirkwood AA, Rowntree CJ, Alapi KZ, Barretta E, Clifton‐Hadley L, Creasey T, Lee S, Marks DI, Moorman AV , Morley N et al (2024) . HemaSphere, 8(6).
  • Alexander T, Tassy N, Domenech A, Kramer E, Jessop H, Kenyon M, Sharrack B, Saccardi R, Bolanos N, Snowden JA & Greco R (2024) . Journal of Allergy and Clinical Immunology: Global, 3(3).
  • Robin M, Iacobelli S, Koster L, Passweg J, Avenoso D, Wilson KMO, Salmenniemi U, Dreger P, von dem Borne P, Snowden JA , Robinson S et al (2024) . Bone Marrow Transplantation, 59(8), 1205-1205.
  • Wright J & Snowden JA (2024) . British Journal of Haematology.
  • Scheid C, Eikema D-J, van Gelder M, Salmenniemi U, Maertens J, Passweg J, Blaise D, Byrne JL, Kröger N, Sockel K , Chevallier P et al (2024) . Blood, 144(4), 445-456.
  • Atsuta Y, Baldomero H, Neumann D, Sureda A, DeVos JD, Iida M, Karduss A, Purtill D, Elhaddad AM, Bazuaye NG , Bonfim C et al (2024) . Haematologica, 109(10).
  • Goodyear CS, Patel A, Barnes E, Willicombe M, Siebert S, de Silva TI, Snowden JA, Lim SH, Bowden SJ, Billingham L , Richter A et al (2024) . The Lancet Rheumatology, 6(6), e339-e351.
  • Miller LJ, Halliday V, Snowden JA, Aithal GP, Lee J & Greenfield DM (2024) . Journal of Human Nutrition and Dietetics, 37(4), 1007-1021.
  • Bacigalupo A, Bonifazi F, Ciceri F, Gluckman E, Greco R, Nozzoli C, Lombardini L, Martino M, Rambaldi A, Rocha V , Ruggeri A et al (2024) . Bone Marrow Transplantation, 59, 1202-1203.
  • Brittain G, Cooper C, Glover R, Loban A, Muraro P, Papaioannou D, Roldan E, Sharrack B & Snowden J (2024) . Neurology, 102(7_supplement_1).
  • Garderet L, Gras L, Koster L, De Wreede L, Montserrat R, Vincent L, Fenk R, Karunanithi K, Deeren D, Kaufmann M , Kuball J et al (2024) . Haematologica, 109(8).
  • Kalincik T, Sharmin S, Roos I, Massey J, Sutton I, Withers B, Freedman MS, Atkins H, Krasulova E, Kubala Havrdova E , Trneny M et al (2024) . Journal of Neurology, Neurosurgery & Psychiatry, 95(8), 775-783.
  • Robin M, Iacobelli S, Koster L, Passweg J, Avenoso D, Wilson KMO, Salmenniemi U, Dreger P, von dem Borne P, Snowden JA , Robinson S et al (2024) . Bone Marrow Transplantation, 59(7), 928-935.
  • Passweg JR, Baldomero H, Ciceri F, de la Cámara R, Glass B, Greco R, Hazenberg MD, Kalwak K, McLornan DP, Neven B , Perić Z et al (2024) . Bone Marrow Transplantation, 59(6), 803-812.
  • Lindsay JO, Hind D, Swaby L, Berntsson H, Bradburn M, Bannur C U, Byrne J, Clarke C, Desoysa L, Din S , Emsley R et al (2024) . Efficacy and Mechanism Evaluation, 11(3).
  • Sanchez-Guijo F, Vives J, Ruggeri A, Chabannon C, Corbacioglu S, Dolstra H, Farge D, Gagelmann N, Horgan C, Kuball J , Neven B et al (2024) . Cytotherapy, 26(7), 681-685.
  • Greco R, Alexander T, Del Papa N, Müller F, Saccardi R, Sanchez-Guijo F, Schett G, Sharrack B, Snowden JA, Tarte K , Onida F et al (2024) . eClinicalMedicine, 69.
  • Gurnari C, Koster L, Baaij LGA, Heiblig M, Yakoub-Agha I, Collin M, Passweg JR, BULABOIS C-E, Khan AB, Loschi M , Carnevale-Schianca F et al (2024) . Blood Advances, 8(6), 1444-1448.
  • Lindsay JO, Hind D, Swaby E, Berntsson H, Bradburn M, Bannur U, Byrne J, Clarke C, Desoysa L, Dickins B , Din S et al (2024) . The Lancet Gastroenterology and Hepatology.
  • Brittain G, Petrie J, Duffy KEM, Glover R, Hullock K, Papaioannou D, Roldan E, Beecher C, Bursnall M, Ciccarelli O , Coles AJ et al (2024) . BMJ Open, 14(2).
  • Kulasekararaj A, Cavenagh J, Dokal I, Foukaneli T, Gandhi S, Garg M, Griffin M, Hillmen P, Ireland R, Killick S , Mansour S et al (2024) . British Journal of Haematology, 204(3), 784-804.
  • de Tute RM, Cook G, Cairns DA, Brown JM, Cavenagh J, Ashcroft AJ, Snowden JA, Yong K, Tholouli E, Jenner M , Hockaday A et al (2024) . Bone Marrow Transplantation, 59(3), 431-434.
  • Levine BL, Pasquini MC, Connolly JE, Porter DL, Gustafson MP, Boelens JJ, Horwitz EM, Grupp SA, Maus MV, Locke FL , Ciceri F et al (2024) . Nature Medicine, 30(2), 338-341.
  • Hughes SL, Prettyjohns MJ, Snowden JA & Sharrack B (2024) . Handb Clin Neurol, 202, 279-294.
  • Kirgizov K, Burman J, Snowden JA & Greco R (2024) . Handb Clin Neurol, 202, 249-258.
  • Moore J, Milliken S, Dodds A, Ma D & Snowden J (2024) . Bone Marrow Transplantation, 59(2), 291-292.
  • Duque-Afonso J, Finke J, Ngoya M, Galimard J-E, Craddock C, Raj K, Bloor A, Nicholson E, Eder M, Kim O , Valerius T et al (2024) . Bone Marrow Transplantation, 59, 247-254.
  • Murray SM, Pose E, Wittner M, Londoño M-C, Schaub G, Cook J, Dimitriadis S, Meacham G, Irwin S, Lim Z , Duengelhoef P et al (2024) . Journal of Hepatology, 80(1), 109-123.
  • Pagliuca S, Kulasekararaj AG, Eikema D-J, Piepenbroek B, Iftikhar R, Satti TM, Griffin M, Laurino M, Kupesiz A, Bertrand Y , Fattizzo B et al (2024) . Haematologica, 109(3).
  • Robin M, Iacobelli S, Passweg JR, Koster L, Potter V, Wilson K, Salmenniemi U, Dreger D, von dem Borne P, Snowden J , Robinson S et al (2023) . Blood, 142(Supplement 1), 473-473.
  • Garderet L, Gras L, Koster L, Rovira M, Vincent L, Kobbe G, Pillai S, Deeren D, Kaufmann M, Kuball J , Ozdogu H et al (2023) . Blood, 142(Supplement 1), 3403-3403.
  • Cook G, Ashcroft AJ, Senior ER, Olivier C, Hockaday A, Richards J, Cavenagh JD, Snowden J, Drayson M, de Tute RM , Owen R et al (2023) . Blood, 142(Supplement 1), 783-783.
  • Mizuno S, Gras L, Baaij L, Koster L, D'Souza A, Hari PN, Estrada-Merly N, Saber W, Cowan AJ, Iida M , Okamoto S et al (2023) . Blood, 142(Supplement 1), 785-785.
  • Gurnari C, Koster L, Baaij L, Heiblig M, Yakoub-Agha I, Passweg JR, Clay J, Kuball J, Rambaldi A, Hayden PJ , Badoglio M et al (2023) . Blood, 142(Supplement 1), 708-708.
  • Barnes E, Goodyear CS, Willicombe M, Gaskell C, Siebert S, I de Silva T, Murray SM, Rea D, Snowden JA, Carroll M , Pirrie S et al (2023) . Nature Medicine, 29(7), 1760-1774.
  • Beksac M, Iacobelli S, Koster L, Cornelissen J, Griskevicius L, Rabin NK, Stoppa AM, Meijer E, Mear J-B, Zeerleder S , Mayer J et al (2023) . Bone Marrow Transplantation, 58(9), 1065-1065.
  • Rejeski K, Subklewe M, Aljurf M, Bachy E, Balduzzi AC, Barba P, Bruno B, Benjamin R, Carrabba MG, Chabannon C , Ciceri F et al (2023) . Blood Journal.
  • von Asmuth EGJ, Putter H, Mohseny AB, Schilham MW, Snowden JA, Saccardi R & Lankester AC (2023) . Bone Marrow Transplantation, 58(9), 1017-1023.
  • Birck MG, Alexander T, Labopin M, Greco R, Badoglio M, Snowden J, Sureda Balari A, Uuema A, Van Biezen A, Lavoie JR , Gao J et al (2023) . Annals of the Rheumatic Diseases, 82, 964-965.
  • Kalincik T, Sharmin S, Roos I, Freedman MS, Atkins H, Burman J, Massey J, Sutton I, Withers B, Macdonell R , Grigg A et al (2023) . JAMA Neurology, 80(7), 702-713.
  • Beksac M, Iacobelli S, Koster L, Cornelissen J, Griskevicius L, Rabin NK, Stoppa AM, Meijer E, Mear J-B, Zeerleder S , Mayer J et al (2023) . Bone Marrow Transplantation, 58(8), 916-923.
  • Styczynski J, Tridello G, Koster L, Knelange N, Wendel L, van Biezen A, van der Werf S, Mikulska M, Gil L, Cordonnier C , Ljungman P et al (2023) . Bone Marrow Transplantation, 58(8), 881-892.
  • Greco R, Snowden JA, Knelange NS, Tridello G, Cacciatore C, Xhaard A, Ciceri F, Collin M, Ferra C, De Becker A , Averbuch D et al (2023) . Journal of Autoimmunity, 136.
  • Yakoub-Agha I, Greco R, Onida F, de la Cámara R, Ciceri F, Corbacioglu S, Dolstra H, Glass B, Kenyon M, McLornan DP , Neven B et al (2023) . Bone Marrow Transplantation.
  • Devillier R, Eikema D-J, Dufour C, Aljurf M, Wu D, Maschan A, Kulagin A, Halkes CJM, Collin M, Snowden J , Renard C et al (2023) . Haematologica.
  • Bruno A, Gurnari C, Alexander T, Snowden JA & Greco R (2023) . Journal of Allergy and Clinical Immunology.
  • Tridente A, Dempsey NC, Khalifa M, Goddard J, Shuker K, Hall J, Sorour Y, Wright J, Webber S, Mills GH & Snowden JA (2023) . Frontiers in Hematology, 2.
  • Saccardi R, Putter H, Eikema D-J, Busto MP, McGrath E, Middelkoop B, Adams G, Atlija M, Ayuk FA, Baldomero H , Beguin Y et al (2023) . Bone Marrow Transplantation.
  • Passweg JR, Baldomero H, Ciceri F, Corbacioglu S, de la Cámara R, Dolstra H, Glass B, Greco R, McLornan DP, Neven B , de Latour RP et al (2023) . Bone Marrow Transplantation.
  • Clark A, Thomas S, Hamblin A, Talley P, Kulasekararaj A, Grinfeld J, Speight B, Snape K, McVeigh TP & Snowden JA (2023) . British Journal of Haematology.
  • Waszczuk-Gajda A, Gras L, de Wreede LC, Sirait T, Illes A, Ozkurt ZN, Snowden JA, Arat M, Bulabois CE, Niederland J , Sever M et al (2023) . Bone Marrow Transplantation.
  • Tokaz MC, Baldomero H, Cowan AJ, Saber W, Greinix H, Koh MBC, Kröger N, Mohty M, Galeano S, Okamoto S , Chaudhri N et al (2023) . Transplantation and Cellular Therapy, 29(4), 279.e1-279.e10.
  • Miller PDE, Patel SR, Skinner R, Dignan F, Richter A, Jeffery K, Khan A, Heath PT, Clark A, Orchard K , Snowden JA et al (2023) . Journal of Infection, 86(1), 1-8.
  • Chalandon Y, Sbianchi G, Gras L, Koster L, Apperley J, Byrne J, Salmenniemi U, Sengeloev H, Aljurf M, Helbig G , Kinsella F et al (2023) . American Journal of Hematology, 98(1), 112-121.
  • Brittain G, Coles AJ, Giovannoni G, Muraro PA, Palace J, Petrie J, Roldan E, Scolding NJ, Snowden JA & Sharrack B (2023) . Practical Neurology, 23(2), 139-145.
  • Ruggeri A, De Wreede LC, Müller CR, Crivello P, Bonneville EF, Petersdorf EW, Socié G, Dubois V, Niittyvuopio R, Peräsaari J , Yakoub-Agha I et al (2023) . Haematologica, 108(2), 645-652.
  • Hayden PJ, Eikema D-J, Koster L, Snowden JA, Caillot D, Van Gorkom G, Griskevicius L, Arcese W, Crawley C, Musso M , Bulabois C-E et al (2022) . Blood, 140(Supplement 1), 10434-10436.
  • Duque Afonso J, Finke J, Ngoya M, Galimard J-E, Craddock C, Raj K, Bloor A, Nicholson E, Eder M, Orchard KH , Valerius T et al (2022) . Blood, 140(Supplement 1), 2110-2112.
  • Patel Wrench B, Kirkwood AA, Alapi KZ, Clifton-Hadley L, Lee S, Marks DI, Moorman AV, Morley NJ, Patrick P, Rana Z , Rowntree CJ et al (2022) . Blood, 140(Supplement 1), 6125-6126.
  • Doglio M, Alexander T, Del Papa N, Snowden JA & Greco R (2022) . Journal of Allergy and Clinical Immunology, 150(6), 1289-1301.
  • Penny HA, Rej A, Baggus EMR, Coleman SH, Ward R, Wild G, Bouma G, Trott N, Snowden JA, Wright J , Cross SS et al (2022) . Nutrients, 14(13).
  • Lawless S, Iacobelli S, Knelange NS, Chevallier P, Blaise D, Milpied N, Foà R, Cornelissen JJ, Lioure B, Benjamin R , Poiré X et al (2022) . Haematologica.
  • Jones GL, Moss RH, Darby F, Mahmoodi N, Phillips B, Hughes J, Vogt KS, Greenfield DM, Brauten-Smith G, Gath J , Campbell T et al (2022) . Frontiers in Oncology, 12.
  • Snowden JA, Ahmedzai SH, Cox A, Cairns DA, Ashcroft AJ, Williams C, Cavenagh JD, Hockaday A, Brown JM, Brock IW , Morris TCM et al (2022) . Bone Marrow Transplantation, 57(10), 1507-1513.
  • Sharrack B, Petrie J, Coles A & Snowden JA (2022) . British Medical Journal (BMJ), 377.
  • Wolf J, Lee J, Pearce R, Wilson M, Snowden JA & Orchard K (2022) . British Journal of Haematology, 198(4).
  • Sharrack B, Snowden J & Muraro P (2022) . Journal of Neurology, Neurosurgery & Psychiatry, 93(6), A19.2-A19.
  • Snowden JA, Sánchez-Ortega I, Corbacioglu S, Basak GW, Chabannon C, de la Camara R, Dolstra H, Duarte RF, Glass B, Greco R , Lankester AC et al (2022) . Bone Marrow Transplantation.
  • Duque-Afonso J, Finke J, Labopin M, Craddock C, Protheroe R, Kottaridis P, Tholouli E, Byrne JL, Orchard K, Salmenniemi U , Hilgendorf I et al (2022) . Bone Marrow Transplantation, 57(8), 1269-1276.
  • Phelan R, Im A, Hunter RL, Inamoto Y, Lupo-Stanghellini MT, Rovo A, Badawy SM, Burns L, Eissa H, Murthy HS , Prasad P et al (2022) . Bone Marrow Transplantation, 57(7), 1150-1163.
  • Cartwright A, Snowden JA, Whitehouse H, Scott S & Whitby L (2022) . Journal of Clinical Pathology.
  • Achini‐Gutzwiller FR, Snowden JA, Corbacioglu S, Greco R, Greco R, Alexander T, Snowden J, Badoglio M, Labopin M, Abinun M , Apte S et al (2022) . British Journal of Haematology, 198(1), 24-45.
  • Hough R, Lopes A, Patrick P, Russell N, Raj K, Tholouli E, A. Snowden J, Collin M, El-Mehidi N, Lawrie A , Clifton-Hadley L et al (2022) . Blood Advances, 6(7), 2414-2426.
  • Hernández-Boluda J-C, Pereira A, Zinger N, Gras L, Martino R, Nikolousis E, Finke J, Chinea A, Rambaldi A, Robin M , Saccardi R et al (2022) . Bone Marrow Transplantation, 57(6), 1051-1051.
  • Putter H, Eikema D-J, de Wreede LC, McGrath E, Sánchez-Ortega I, Saccardi R, Snowden JA & van Zwet EW (2022) . Statistical Methods in Medical Research, 31(6), 1171-1183.
  • Passweg JR, Baldomero H, Chabannon C, Corbacioglu S, de la Cámara R, Dolstra H, Glass B, Greco R, Mohty M, Neven B , Peffault de Latour R et al (2022) . Bone Marrow Transplantation, 57, 742-752.
  • Drozd-Sokołowska J, Gras L, Zinger N, Snowden JA, Arat M, Basak G, Pouli A, Crawley C, Wilson KMO, Tilly H , Byrne J et al (2022) . Bone Marrow Transplantation, 57(4), 633-640.
  • Montoto S, Snowden JA, Chabannon C, Corbacioglu S, de la Camara R, Dolstra H, Greco R, Gusi A, Hamad N, Kenyon M , Kröger N et al (2022) . Bone Marrow Transplantation, 57(3), 343-346.
  • Cencioni MT, Genchi A, Brittain G, de Silva TI, Sharrack B, Snowden JA, Alexander T, Greco R & Muraro PA (2022) . Frontiers in Immunology, 12.
  • Ros-Soto J, Snowden JA, Szydlo R, Nicholson E, Madrigal A, Easdale S, Potter M, Ethell M & Anthias C (2022) . Transplantation and Cellular Therapy, 28(4), 183.e1-183.e8.
  • Hernández-Boluda J-C, Pereira A, Zinger N, Gras L, Martino R, Nikolousis E, Finke J, Chinea A, Rambaldi A, Robin M , Saccardi R et al (2022) . Bone Marrow Transplantation, 57(3), 416-422.
  • Hayden PJ, Roddie C, Bader P, Basak GW, Bonig H, Bonini C, Chabannon C, Ciceri F, Corbacioglu S, Ellard R , Sanchez-Guijo F et al (2022) . Annals of Oncology, 33(3), 259-275.
  • Czerw T, Iacobelli S, Malpassuti V, Koster L, Kröger N, Robin M, Maertens J, Chevallier P, Watz E, Poiré X , Snowden JA et al (2022) . Bone Marrow Transplantation, 57(2), 261-270.
  • Petit AF, Kulasekararaj AG, Eikema D, Maschan A, Adjaoud D, Kulagin A, Grassi A, Fagioli F, Griskevicius L, Snowden JA , Johansson JJ et al (2022) . American Journal of Hematology, 97(1).
  • Phelan R, Im A, Hunter RL, Inamoto Y, Lupo-Stanghellini MT, Rovo A, Badawy SM, Burns L, Eissa H, Murthy HS , Prasad P et al (2022) . Transplantation and Cellular Therapy, 28(6), 335.e1-335.e17.
  • Masouridi-Levrat S, Olavarria E, Iacobelli S, Aljurf M, Morozova E, Niittyvuopio R, Sengeloev H, Reményi P, Helbig G, Browne P , Ganser A et al (2022) . Bone Marrow Transplantation, 57(1), 23-30.
  • Niederwieser D, Baldomero H, Bazuaye N, Bupp C, Chaudhri N, Corbacioglu S, Elhaddad A, Frutos C, Galeano S, Hamad N , Hamidieh AA et al (2022) . Haematologica, 107(5), 1045-1053.
  • Marzolini MAV, Mehra V, Thomson KJ, Tholouli E, Bloor AJC, Parker A, Lovell R, Orchard K, Publicover A, Nicholson E , Snowden JA et al (2021) . Blood Advances, 5(21), 4500-4503.
  • Lwin SM, Snowden JA & Griffiths CEM (2021) . British Journal of Dermatology, 185(5), 887-898.
  • Alexander T, Snowden JA, Burman J, Chang H-D, Del Papa N, Farge D, Lindsay JO, Malard F, Muraro PA, Nitti R , Salas A et al (2021) . Frontiers in Oncology, 11.
  • Snowden JA, McGrath E, Orchard K, Kröger N, Sureda A & Gratwohl A (2021) . Bone Marrow Transplantation, 56(12), 2876-2881.
  • Peric Z, Peczynski C, Polge E, Kröger N, Sengeloev H, Radujkovic A, Helbig G, Russell N, Bunjes D, Socié G , Potter V et al (2021) . Bone Marrow Transplantation, 56(12), 3084-3087.
  • Mawson S, Keen C, Skilbeck J, Ross H, Smith L, Dixey J, Walters SJ, Simpson R, Greenfield DM & Snowden JA (2021) . Physiotherapy, 113, 88-99.
  • Colton H, Greenfield DM, Snowden JA, Miller PDE, Morley NJ, Wright J, Darton TC, Evans CM & de Silva TI (2021) . Vaccine, 39(34), 4778-4783.
  • Greenfield DM, Salooja N, Peczynski C, van der Werf S, Schoemans H, Hill K, Cortelezzi A, Lupo-Stangellini M, Özkurt ZN, Arat M , Metzner B et al (2021) . Bone Marrow Transplantation, 56(11), 2820-2825.
  • Greco R, Alexander T, Burman J, Del Papa N, de Vries-Bouwstra J, Farge D, Henes J, Kazmi M, Kirgizov K, Muraro PA , Ricart E et al (2021) . Bone Marrow Transplantation, 56, 1493-1508.
  • Puyade M, Patel A, Lim YJ, Blank N, Badoglio M, Gualandi F, D. D, Maximova N, Greco R, Alexander T & Snowden JA (2021) . Frontiers in Immunology, 12.
  • Burt RK, Muraro PA, Farge D, Oliveira MC, Snowden JA, Saccardi R, Han X, Quigley K, Bueno V, Frasca D , Fedorenko D et al (2021) . Bone Marrow Transplantation, 56(7), 1509-1517.
  • Burt RK, Tappenden P, Balabanov R, Han X, Quigley K, Snowden JA & Sharrack B (2021) . Frontiers in Neurology, 12.
  • Greco R, Peccatori J, Bonifazi F, Snowden JA & Ciceri F (2021) . Frontiers in Immunology, 12.
  • Passweg JR, Baldomero H, Chabannon C, Basak GW, de la Cámara R, Corbacioglu S, Dolstra H, Duarte R, Glass B, Greco R , Lankester AC et al (2021) . Bone Marrow Transplantation, 56(7), 1651-1664.
  • Gratwohl A, Passweg J, Baldomero H, Orchard K, Kröger N & Snowden JA (2021) . British Journal of Haematology, 192(6).
  • Das J, Snowden JA, Burman J, Freedman MS, Atkins H, Bowman M, Burt RK, Saccardi R, Innocenti C, Mistry S , Laud PJ et al (2021) . Multiple Sclerosis Journal, 27(8), 1198-1204.
  • Orchard K, Dignan FL, Lee J, Pearce R, Desai M, McFarlane E, Parkin A, Shearn P & Snowden JA (2021) . British Journal of Haematology, 192(3), 467-473.
  • Jackson GH, Pawlyn C, Cairns DA, de Tute RM, Hockaday A, Collett C, Jones JR, Kishore B, Garg M, Williams CD , Karunanithi K et al (2021) . PLOS Medicine, 18(1).
  • Kass-Iliyya L, Snowden JA, Thorpe A, Jessop H, Chantry AD, Sarrigiannis PG, Hadjivassiliou M & Sharrack B (2021) . Journal of Neurology, 268(1), 265-275.
  • Aljurf M, Snowden JA, Hayden P, Orchard KH & McGrath E (2021) Introduction. Quality Management and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular Therapy the Jacie Guide, v-vi.
  • Handforth C, Burkinshaw R, Freeman J, Brown JE, Snowden JA, Fearnside J, Coleman RE & Greenfield DM (2021) . Supportive Care in Cancer, 29(2), 1145-1145.
  • Bazarbachi AH, Al Hamed R, Labopin M, Halaburda K, Labussiere H, Bernasconi P, Schroyens W, Gandemer V, Schaap NPM, Loschi M , Jindra P et al (2021) . Bone Marrow Transplantation, 56(4), 917-927.
  • Alexander T, Greco R & Snowden JA (2021) . Annual Review of Medicine, 72(1), 215-228.
  • Dignan FL, Hamblin A, Chong A, Lee J, Kenyon M, Miller P, Gilleece M, Hunter H & Snowden JA (2021) . Bone Marrow Transplantation, 56(3), 673-678.
  • Kelsey P, Pearce R, Perry J, Kirkland K, Paul R, Lambert J, Peniket A, Malladi R, Snowden JA & Morley N (2021) . Bone Marrow Transplantation, 56(3), 730-732.
  • Ljungman P, Mikulska M, de la Camara R, Basak GW, Chabannon C, Corbacioglu S, Duarte R, Dolstra H, Lankester AC, Mohty M , Montoto S et al (2021) . Bone Marrow Transplantation, 56(3), 755-755.
  • Ljungman P, De La Camara R, Mikulska M, Tridello G, Aguado B, Beguin Y, Martino Bufarull R, Ciceri F, Corral LL, Crippa C , Deeren D et al (2020) . Blood, 136(Supplement 1), 32-33.
  • Roberts F, Hobbs H, Jessop H, Bozzolini C, Burman J, Greco R, Ismail A, Kazmi M, Kirgizov K, Mancardi G , Mawson S et al (2020) . Frontiers in Neurology, 11.
  • Puyade M, Patel A, Yeong LL, Blank N, Badoglio M, Gualandi F, Ma D, Maximova N, Grecco R, Alexander T & Snowden J (2020) . La Revue de Médecine Interne, 41, A72-A73.
  • Petit AF, Eikema D-J, Maschan A, Adjaoud D, Kulagin A, Rambaldi A, Fagioli F, Griškevičius L, Snowden JA, Johansson J-E , Dalle J-H et al (2020) . Blood, 136(Supplement 1), 11-13.
  • Devillier R, Eikema D-J, Bosman P, Dufour C, Aljurf M, Wu D, Maschan A, Afanasyev BV, Halkes C, Collin MP , Snowden JA et al (2020) . Blood, 136(Supplement 1), 3-4.
  • Scheid C, Eikema D-J, Niittyvuopio R, Maertens J, Passweg J, Blaise D, Byrne J, Kröger N, Bornhäuser M, Chevallier P , Bourhis J-H et al (2020) . Blood, 136(Supplement 1), 39-40.
  • Ghorashian S, Furness C, Cummins M, Snowden JA, O'Reilly MA, Roddie C, Neill L, Nicholson E, Besley C, Chaganti S , Gillson J et al (2020) . Blood, 136(Supplement 1), 18-19.
  • Ljungman P, De La Camara R, Mikulska M, Tridello G, Aguado B, Beguin Y, Martino Bufarull R, Ciceri F, Corral LL, Crippa C , Deeren D et al (2020) COVID-19 and Stem Cell Transplantation; Results from the Prospective Survey By the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation (EBMT) and the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH). Blood, 136(20), 32-33.
  • Burt RK, Tappenden P, Han X, Quigley K, Arnautovic I, Sharrack B, Snowden JA & Hartung D (2020) . Multiple Sclerosis and Related Disorders, 45.
  • Das J, Sharrack B & Snowden JA (2020) . Expert Review of Neurotherapeutics, 20(12), 1299-1313.
  • Kinsella FAM, Bencito A, Kulik D, Hurst E, Gilleece M, Snowden JA, Malladi R, Scarisbrick J, Gennery A & Alfred A (2020) . Leukemia & Lymphoma, 61(14), 3511-3514.
  • Schiepatti A, Sanders DS, Aziz I, De Silvestri A, Goodwin J, Key T, Quaye L, Giuffrida P, Vanoli A, Paulli M , Cross SS et al (2020) . European Journal of Gastroenterology & Hepatology, 32(8), 938-949.
  • Styczynski J, Tridello G, Gil L, Ljungman P, Mikulska M, van der Werf S, Knelange NS, Averbuch D, Socié G, Veelken H , Dalle J-H et al (2020) . Acta Haematologica Polonica, 51(2), 73-80.
  • Laurent C, Marjanovic Z, Henes J, Farge D, Badoglio M, Snowden J, Fain O, Alexander T, Oliveira MC & Mekinian A (2020) . Annals of the Rheumatic Diseases, 79, 385-385.
  • Gratwohl A, Snowden JA & Brand R (2020) . British Journal of Haematology, 190(2).
  • Ljungman P, Mikulska M, de la Camara R, Basak GW, Chabannon C, Corbacioglu S, Duarte R, Dolstra H, Lankester AC, Mohty M , Montoto S et al (2020) . Bone Marrow Transplantation, 55(11), 2071-2076.
  • Das J, Gill A, Lo C, Chan-Lam N, Price S, Wharton SB, Jessop H, Sharrack B & Snowden JA (2020) . Frontiers in Immunology, 11.
  • Alexander T, Badoglio M, Henes J, Heesen C, Arnold R, Radbruch A, Snowden JA & Hiepe F (2020) . Zeitschrift für Rheumatologie, 79(5), 419-428.
  • Laurent C, Marjanovic Z, Ricard L, Henes J, Dulery R, Badoglio M, Farge D, Snowden JA, Moraes D, Dias J , Mohty M et al (2020) . Bone Marrow Transplantation, 55(11), 2109-2113.
  • Smith R, Snowden J & Akil M (2020) . Rheumatology, 59(Supplement_2).
  • Sharrack B, Saccardi R, Alexander T, Manuela B, Burman J, Farge D, Greco R, Jessop H, Kazmi M, Kirgizov K , Labopin M et al (2020) . Neurology, 94(15_supplement).
  • Das J, Gill A, Lo C, Chan-Lam N, Price S, Wharton S, Jessop H, Sharrack B & Snowden J (2020) . Neurology, 94(15_supplement).
  • Bell S, Snowden J, Jessop H, Das J, Ismail A & Sharrack B (2020) . Neurology, 94(15_supplement).
  • Sandler RD, Tattersall RS, Schoemans H, Greco R, Badoglio M, Labopin M, Alexander T, Kirgizov K, Rovira M, Saif M , Saccardi R et al (2020) . Frontiers in Immunology, 11.
  • Anthias C, Apperley J, Bloor A, Byrne J, Collin M, Crawley C, Craddock C, Finnegan D, Gilleece M, Gribben J , Hunter A et al (2020) . Bone Marrow Transplantation, 55(9), 1840-1843.
  • Passweg JR, Baldomero H, Chabannon C, Basak GW, Corbacioglu S, Duarte R, Dolstra H, Lankester AC, Mohty M, Montoto S , Peffault de Latour R et al (2020) . Bone Marrow Transplantation, 55(8), 1604-1613.
  • Sharrack B, Saccardi R, Alexander T, Badoglio M, Burman J, Farge D, Greco R, Jessop H, Kazmi M, Kirgizov K , Labopin M et al (2020) . Bone Marrow Transplantation, 55(2), 283-306.
  • Penny HA, Baggus EMR, Rej A, Snowden JA & Sanders DS (2020) . Nutrients, 12(1).
  • Alexander T, Samuelson C, Daikeler T, Henes J, Akil M, Skagerlind L, Ehninger G, Jantunen E, Badoglio M, Farge D & Snowden JA (2020) . Bone Marrow Transplantation, 55(7), 1512-1515.
  • Snowden JA, Saccardi R, Orchard K, Ljungman P, Duarte RF, Labopin M, McGrath E, Brook N, de Elvira CR, Gordon D , Poirel HA et al (2020) . Bone Marrow Transplantation, 55(4), 838-839.
  • Yakoub-Agha I, Chabannon C, Bader P, Basak GW, Bonig H, Ciceri F, Corbacioglu S, Duarte RF, Einsele H, Hudecek M , Kersten MJ et al (2020) . Haematologica, 105(2), 297-316.
  • Tappenden P, Wang Y, Sharrack B, Burman J, Kazmi M, Saccardi R, Bermejo I, Harvey R, Badoglio M, Farge D & Snowden JA (2020) . Bone Marrow Transplantation, 55(7), 1473-1475.
  • Domingo-Domènech E, Boumendil A, Climent F, Sengeloev H, Wahlin B, Wattad W, Arat M, Finel H, Schapp N, Ganser A , Yeshurun M et al (2020) . Bone Marrow Transplantation, 55(4), 796-803.
  • Petersdorf EW, Carrington M, O'hUigin C, Bengtsson M, De Santis D, Dubois V, Gooley T, Horowitz M, Hsu K, Madrigal JA , Maiers MJ et al (2020) . The Lancet Haematology, 7(1), e50-e60.
  • Snowden JA, Saccardi R, Orchard K, Ljungman P, Duarte RF, Labopin M, McGrath E, Brook N, de Elvira CR, Gordon D , Poirel HA et al (2020) . Bone Marrow Transplantation, 55(4), 681-694.
  • González-Barca E, Boumendil A, Blaise D, Trněný M, Masszi T, Finel H, Michieli MG, Bittenbring JT, Gritti G, Snowden JA , Bishton M et al (2020) . Bone Marrow Transplantation, 55(2), 393-399.
  • Styczyński J, Tridello G, Koster L, Iacobelli S, van Biezen A, van der Werf S, Mikulska M, Gil L, Cordonnier C, Ljungman P , Averbuch D et al (2020) . Bone Marrow Transplantation, 55(1), 126-136.
  • Sandler RD, Carter S, Kaur H, Francis S, Tattersall RS & Snowden JA (2020) . Bone Marrow Transplantation, 55(2), 307-316.
  • Pasquini MC, Srivastava A, Ahmed SO, Aljurf M, Atsuta Y, Doleysh C, Galeano S, Gluckman E, Greinix H, Hale G , Hari P et al (2020) . Hematology/Oncology and Stem Cell Therapy, 13(3), 131-142.
  • Snowden JA, Hawkey C, Hind D, Swaby L, Mellor K, Emsley R, Mandefield L, Lee E, Badoglio M, Polge E , Labopin M et al (2019) . BMC Gastroenterology, 19(1).
  • Czerw T, Malpassuti V, Iacobelli S, Koster L, Kröger N, Robin M, Maertens J, Chevallier P, Mielke S, Poire X , Snowden JA et al (2019) . Blood, 134(Supplement_1), 3338-3338.
  • Bazarbachi AH, Al Hamed R, Labopin M, Halaburda K, Labussière-Wallet H, Bernasconi P, Schroyens W, Gandemer V, Schaap N, Rohrlich PS , Jindra P et al (2019) . Blood, 134(Supplement_1), 4483-4483.
  • Saccardi R, Badoglio M, Burman J, Helbig G, Kazmi MA, Mancardi G, Mielke S, Moore J, Muraro P, Sanz J , Sharrack B et al (2019) . Blood, 134(Supplement_1), 3313-3313.
  • Waszczuk-Gajda A, Wang J, de Wreede LC, Sirait T, Ozkurt ZN, Snowden JA, Dreger P, Illés Á, Arat M, Bulabois C-E , Baurmann H et al (2019) . Blood, 134(Supplement_1), 4574-4574.
  • Creasey T, Barretta E, Kirkwood AA, Schwab C, Patrick P, Clifton-Hadley L, Wrench B, Menne TF, McMillan AK, Morley NJ , Snowden JA et al (2019) . Blood, 134(Supplement_1), 2746-2746.
  • Walsh JS, Marshall H, Smith IL, Greenfield DM, Swain J, Best E, Ashton J, Brown JM, Huddart R, Coleman RE , Snowden JA et al (2019) . PLOS Medicine, 16(11).
  • Ismail A, Sharrack B, Saccardi R, Moore JJ & Snowden JA (2019) . Current Opinion in Supportive & Palliative Care, 13(4), 394-401.
  • Duarte RF, Labopin M, Bader P, Basak GW, Bonini C, Chabannon C, Corbacioglu S, Dreger P, Dufour C, Gennery AR , Kuball J et al (2019) . Bone Marrow Transplant, 54(10), 1525-1552.
  • Passweg JR, Baldomero H, Basak GW, Chabannon C, Corbacioglu S, Duarte R, Kuball J, Lankester A, Montoto S, de Latour RP , Snowden JA et al (2019) . Bone Marrow Transplantation, 54(10), 1575-1585.
  • Miller PDE, Snowden JA, De Latour RP, Iacobelli S, Eikema D-J, Knol C, Marsh JCW, Rice C, Koh M, Fagioli F , Chaganti S et al (2019) . Bone Marrow Transplantation.
  • Francis S, Thomas S, Luben R, Sousos N, Mead A, Snowden JA & Zeidler MP (2019) . British Journal of Haematology, 187(3).
  • Snowden JA, Badoglio M & Alexander T (2019) . Expert Review of Clinical Immunology, 15(10), 981-985.
  • Halkes C, de Wreede LC, Knol C, Simand C, Aljurf M, Tbakhi A, Vazquez L, Bloor A, Wagner‐Drouet E, Vural F , Bodova I et al (2019) . American Journal of Hematology, 94(11).
  • Shouval R, Fein JA, Labopin M, Kröger N, Duarte RF, Bader P, Chabannon C, Kuball J, Basak GW, Dufour C , Galimard J-E et al (2019) . The Lancet Haematology, 6(11), e573-e584.
  • Gratwohl A, Duarte R, Snowden JA, van Biezen A, Baldomero H, Apperley J, Cornelissen J, Greinix HT, Grath EM, Mohty M , Kroeger N et al (2019) . EClinicalMedicine, 15, 33-41.
  • Ahmedzai SH, Snowden JA, Ashcroft AJ, Cairns DA, Williams C, Hockaday A, Cavenagh JD, Ademokun D, Tholouli E, Allotey D , Dhanapal V et al (2019) . Journal of Clinical Oncology, 37(19), 1617-1628.
  • Jessop H, Farge D, Saccardi R, Alexander T, Rovira M, Sharrack B, Greco R, Wulffraat N, Moore J, Kazmi M , Badoglio M et al (2019) . Bone Marrow Transplant, 54(7), 933-942.
  • Morley N, Kirkwood A, Moorman A, Clifton‐Hadley L, Moreira L, Rowntree C, Wrench B, Marwood E, Patrick P, Snowden JA , Marks DI et al (2019) . HemaSphere, 3(S1), 38-39.
  • Ros-Soto J, Snowden JA, Salooja N, Gilleece M, Parker A, Greenfield DM, Anthias C, Alfred A, Harrington A, Peczynski C , Peggs K et al (2019) . Biology of Blood and Marrow Transplantation, 25(10), 2079-2085.
  • Hayden PJ, Sirait T, Koster L, Snowden JA & Yakoub-Agha I (2019) . Current Research in Translational Medicine, 67(3), 79-88.
  • Pasquini MC, Srivastava A, Ahmed SO, Aljurf M, Atsuta Y, Doleysh C, Galeano S, Gluckman E, Greinix H, Hale GA , Hari P et al (2019) . Biology of Blood and Marrow Transplantation, 25(12), 2322-2329.
  • Horton MC, Nopoulos P, Nance M, Landwehrmyer GB, Barker RA, Squitieri F, Burgunder J-M & Quarrell O (2019) . Journal of Huntington's Disease, 8(2), 181-193.
  • Das J, Sharrack B & Snowden JA (2019) . Current Hematologic Malignancy Reports, 14(2), 136-136.
  • Das J, Sharrack B & Snowden JA (2019) . Current Hematologic Malignancy Reports, 14(2), 127-135.
  • Galleu A, Milojkovic D, Deplano S, Szydlo R, Loaiza S, Wynn R, Marks DI, Richardson D, Orchard K, Kanfer E , Tholouli E et al (2019) . British Journal of Haematology, 185(1), 89-92.
  • Cook G, Royle K, O'Connor S, Cairns DA, Ashcroft AJ, Williams CD, Hockaday A, Cavenagh JD, Snowden JA, Ademokun D , Tholouli E et al (2019) . British Journal of Haematology, 185(3), 450-467.
  • Burt RK, Balabanov R, Burman J, Sharrack B, Snowden JA, Oliveira MC, Fagius J, Rose J, Nelson F, Barreira AA , Carlson K et al (2019) . Journal of the American Medical Association, 321(2), 165-174.
  • Miller PDE, de Silva TI, Leonard H, Anthias C, Hoschler K, Goddard K, Peggs K, Madrigal A & Snowden JA (2019) . Vaccine, 37(3), 452-457.
  • Samarasinghe S, Clesham K, Iacobelli S, Sbianchi G, Knol C, Hamladji RM, Socié G, Aljurf M, Koh M, Sengeloev H , Dalle JH et al (2019) . American Journal of Hematology, 94(1), 80-86.
  • Scott SD, Fletcher M, Whitehouse H, Whitby L, Yuan C, Mazzucchelli S, Lin P, de Tute R, Dorwal P, Wallace PK , Tembhare P et al (2019) . Cytometry Part B: Clinical Cytometry, 96(3), 201-208.
  • Paton-Hough J, Tazzyman S, Evans H, Lath D, Down JM, Green AC, Snowden JA, Chantry AD & Lawson MA (2019) . Journal of Bone and Mineral Research, 34(5), 783-796.
  • Ros-Soto J, Anthias C, Madrigal A & Snowden JA (2019) . Bone Marrow Transplantation, 54(6), 810-820.
  • Handforth C, Burkinshaw R, Freeman J, Brown JE, Snowden JA, Coleman RE & Greenfield DM (2019) . Supportive Care in Cancer, 27(5), 1755-1763.
  • Spearing R, Bradstock K & Snowden JA (2019) . Bone Marrow Transplantation, 54(2), 173-174.
  • Striha A, Ashcroft AJ, Hockaday A, Cairns DA, Boardman K, Jacques G, Williams C, Snowden JA, Garg M, Cavenagh J , Yong K et al (2018) . Trials, 19.
  • Robinson S, Boumendil A, Khvedelidze I, Finel H, Peggs K, Malladi RK, Potter V, Tsoulkani A, Vandenberghe E, Chalandon Y , Finke J et al (2018) . Blood, 132(Supplement 1), 2070-2070.
  • Stewart GR, Tazzyman S, Lath D, Down J, Snowden JA, Lawson M, Muthana M & Chantry AD (2018) . Blood, 132(Supplement 1), 3213-3213.
  • Mahmoodi N, Bekker HL, King NV, Hughes J, Jones GL & Team CFMR (2018) . BMC Medical Informatics and Decision Making, 18.
  • Joyutpal D, John S, Sona M, Simon B, Helen J & Basil S (2018) . Journal of Neurology, Neurosurgery & Psychiatry, 89(10), A28.2-A28.
  • Brierley CK, Castilla-Llorente C, Labopin M, Badoglio M, Rovira M, Ricart E, Dierickx D, Vermeire S, Hasselblatt P, Finke J , Onida F et al (2018) . Journal of Crohn's and Colitis, 12(9), 1097-1103.
  • Passweg JR, Baldomero H, Bader P, Basak GW, Bonini C, Duarte R, Dufour C, Kroeger N, Kuball J, Lankester A , Montoto S et al (2018) . Bone Marrow Transplantation, 53(9), 1139-1148.
  • (2018) Bone Research Society Abstracts. JBMR plus, 2(Suppl ), 1-50.
  • Snowden JA, Sharrack B, Akil M, Kiely DG, Lobo A, Kazmi M, Muraro PA & Lindsay J (2018) . Clinical Medicine, 18(4), 329-334.
  • Snowden J & Chowdhury TA (2018) . Clinical Medicine, 18(4), 340-341.
  • Paviglianiti A, Tozatto Maio K, Rocha V, Gehlkopf E, Milpied N, Esquirol A, Chevallier P, Blaise D, Gac A-C, Leblond V , Cahn JY et al (2018) . Biology of Blood and Marrow Transplantation, 24(11), 2265-2270.
  • Alexander T, Farge D, Badoglio M, Lindsay JO, Muraro PA & Snowden JA (2018) . Journal of Autoimmunity, 92, 35-46.
  • Mohty M, Duarte RF, Kuball J, Bader P, Basak GW, Bonini C, Carreras E, Chabannon C, Dufour C, Gennery A , Lankester A et al (2018) . Bone Marrow Transplantation, 53(12), 1548-1552.
  • Pockley AG, Lindsay JO, Foulds GA, Rutella S, Gribben JG, Alexander T, Snowden JA, Party EBMTADW & Investigators AS (2018) . Frontiers in Immunology, 9.
  • Snowden JA, Panés J, Alexander T, Allez M, Ardizzone S, Dierickx D, Finke J, Hasselblatt P, Hawkey C, Kazmi M , Lindsay JO et al (2018) . Journal of Crohn's and Colitis, 12(4), 476-488.
  • Keen C, Skilbeck J, Ross H, Smith L, Collins K, Dixey J, Walters S, Greenfield D, Snowden J & Mawson SJ (2018) . BMJ Open, 8(3).
  • Cesaro S, Tridello G, Blijlevens N, Ljungman P, Craddock C, Michallet M, Martin A, Snowden JA, Mohty M, Maertens J , Passweg J et al (2018) . Clinical Infectious Diseases, 67(4), 564-572.
  • Gagelmann N, Eikema D-J, Iacobelli S, Koster L, Nahi H, Stoppa A-M, Masszi T, Caillot D, Lenhoff S, Udvardy M , Crawley C et al (2018) . Haematologica, 103(5), 890-897.
  • Holbro A, Baldomero H, Lanza F, Chabannon C, Snowden JA, Buser A, Infanti L, Worel N, Sureda A, Badoglio M , Passweg J et al (2018) . Cytotherapy, 20(3), 453-460.
  • Brierley C, Castilla-Llorente C, Labopin M, Badoglio M, Rovira M, Ricart E, Dierickx D, Vermeire S, Hasselblatt P, Finke J , Onida F et al (2018) . Journal of Crohn's and Colitis, 12(supplement_1), S014-S015.
  • Snowden J, Panes J, Alexander T, Allez M, Ardizzone S, Dierickx D, Finke J, Hasselblatt P, Hawkey C, Kazmi M , Lindsay J et al (2018) . Journal of Crohn's and Colitis, 12(supplement_1), S070-S071.
  • Ring ES, Lawson MA, Snowden JA, Jolley I & Chantry AD (2018) . Calcified Tissue International, 102(2), 196-209.
  • Shanklin VE, Snowden JA & Greenfield DM (2018) . European Journal of Cancer Care, 27(2).
  • Snowden JA, Badoglio M, Labopin M, Giebel S, McGrath E, Marjanovic Z, Burman J, Moore J, Rovira M, Wulffraat NM , Kazmi M et al (2017) . Blood Advances, 1(27), 2742-2755.
  • Shouval R, Fein J, Labopin M, Kröger N, Duarte RF, Bader P, Chiara B, Kuball J, Basak G, Dufour C , Lankester A et al (2017) . Blood, 130(Suppl_1), 668-668.
  • Chabannon C, Kuball J, Mcgrath E, Bader P, Dufour C, Lankester A, Basak GW, Montoto S, Nagler A, Snowden JA , Styczynski J et al (2017) . Bone Marrow Transplantation, 52(12), 1588-1589.
  • Burt RK, Snowden JA, Burman J, Oliveira MC & Sharrack B (2017) . Science, 358(6363), 602-602.
  • Martin M, Fornecker L-M, Marcellin L, Mousseaux E, Hij A, Snowden JA, Farge D & Martin T (2017) . Bone Marrow Transplantation, 52(12), 1674-1677.
  • Miller PDE, de Silva TI, Skinner R, Gilleece M, Peniket A, Hamblin A, Greenfield D, Anthias C, Peggs K, Madrigal A & Snowden JA (2017) . Bone Marrow Transplantation, 52(7), 1082-1082.
  • Douglas KW, Gilleece M, Hayden P, Hunter H, Johnson PRE, Kallmeyer C, Malladi RK, Paneesha S, Pawson R, Quinn M , Raj K et al (2017) . Journal of Clinical Apheresis.
  • Chinnaiya K, Lawson MA, Thomas S, Haider MT, Down J, Chantry AD, Hughes D, Green A, Sayers JR, Snowden JA & Zeidler MP (2017) . Haematologica, 102(6).
  • Killick SB, Bown N, Cavenagh J, Dokal I, Foukaneli T, Hillmen P, Ireland R, Kulasekararaj A, Mufti G, Snowden JA , Samarasinghe S et al (2017) . Br J Haematol.
  • Farge D, Burt RK, Oliveira MC, Mousseaux E, Rovira M, Marjanovic Z, de Vries-Bouwstra J, Del Papa N, Saccardi R, Shah SJ , Lee DC et al (2017) . Bone Marrow Transplantation .
  • Hamblin A, Greenfield DM, Gilleece M, Salooja N, Kenyon M, Morris E, Glover N, Miller P, Braund H, Peniket A , Shaw BE et al (2017) . Bone Marrow Transplantation, 52, 889-894.
  • Snowden JA, O'Connell S, Hawkins J, Dalley C, Jack A, Mannari D, McNamara C, Scott M, Shenton G, Soilleux E & Macbeth F (2017) . Journal of Clinical Pathology, 70(6), 461-468.
  • Sezer O, Beksac M, Hajek R, Sucak G, Cagirgan S, Linkesch W, Meltem Akay O, Gülbas Z, Nahi H, Plesner T , Snowden JA et al (2017) . Br J Haematol.
  • Kühl JS, Suarez F, Gillett GT, Hemmati PG, Snowden JA, Stadler M, Vuong GL, Aubourg P, Köhler W & Arnold R (2017) . Brain, 140(4), 953-966.
  • Snowden JA, McGrath E, Duarte RF, Saccardi R, Orchard K, Worel N, Kuball J, Chabannon C & Mohty M (2017) . Bone Marrow Transplant.
  • Burman J, Kirgizov K, Carlson K, Badoglio M, Mancardi GL, De Luca G, Casanova B, Ouyang J, Bembeeva R, Haas J , Bader P et al (2017) . Bone Marrow Transplantation.
  • Passweg JR, Baldomero H, Bader P, Bonini C, Duarte RF, Dufour C, Gennery A, Kröger N, Kuball J, Lanza F , Montoto S et al (2017) . Bone Marrow Transplantation, 52(6), 811-817.
  • Snowden JA, Greenfield DM, Bird JM, Boland E, Bowcock S, Fisher A, Low E, Morris M, Yong K & Pratt G (2017) . British Journal of Haematology, 176(6), 888-907.
  • Gratwohl A, Sureda A, Cornelissen J, Apperley J, Dreger P, Duarte R, Greinix HT, Mc Grath E, Kroeger N, Lanza F , Nagler A et al (2017) . Leukemia.
  • Jones GL, Hughes J, Mahmoodi N, Greenfield D, Brauten-Smith G, Skull J, Gath J, Yeomanson D, Baskind E, Snowden JA , Jacques RM et al (2017) . BMJ OPEN, 2017(7).
  • Snowden JA & Hill GR (2017) . British Journal of Haematology, 177(3), 341-342.
  • Lawless S, Iacobelli S, van Biezen A, Koster L, Chevallier P, Blaise D, Foa R, Tabrizi R, Schaap N, Lenhoff S , Russell N et al (2017) . Clinical Lymphoma Myeloma and Leukemia, 17(1), e23-e23.
  • Miller PD, de Silva TI, Skinner R, Gilleece M, Peniket A, Hamblin A, Greenfield D, Anthias C, Peggs K, Madrigal A & Snowden JA (2017) . Bone Marrow Transplant, 52, 775-777.
  • Watson MB, Clouston HJ, Snowden JA, Wilson G, Durkie M, Ward R, Kaur H, Travis D & Barnett D (2017) . British Journal of Haematology, 176(1), 139-141.
  • Bell SM, Sharrack B & Snowden J (2016) . Expert Opin Biol Ther.
  • DeFilipp Z, Duarte RF, Snowden JA, Majhail NS, Greenfield DM, Miranda JL, Arat M, Baker KS, Burns LJ, Duncan CN , Gilleece M et al (2016) . Bone Marrow Transplantation.
  • Cook G, Ashcroft AJ, Cairns DA, Williams CD, Brown JM, Cavenagh JD, Snowden JA, Parrish C, Yong K, Cavet J , Hunter H et al (2016) . Lancet Haematol, 3(7), e340-e351.
  • Parrish C, Morris CTCM, Williams CD, Cairns DA, Cavenagh J, Snowden JA, Ashcroft J, Cavet J, Hunter H, Bird JM , Chalmers A et al (2016) . Biology of Blood and Marrow Transplantation, 22(6), 1009-1016.
  • Oliveira MC, Labopin M, Henes J, Moore J, Papa ND, Cras A, Sakellari I, Schroers R, Scherer HU, Cuneo A , Kyrcz-Krzemien S et al (2016) . Bone Marrow Transplantation, 51(6), 889-889.
  • Kelsey PJ, Oliveira M-C, Badoglio M, Sharrack B, Farge D & Snowden JA (2016) . Current Research in Translational Medicine, 64(2), 71-82.
  • Samuelson C, O'Toole L, Boland E, Greenfield D, Ezaydi Y, Ahmedzai SH & Snowden JA (2016) . Hematology, 21(5), 272-279.
  • DeFilipp Z, Duarte RF, Snowden JA, Majhail NS, Greenfield DM, Miranda JL, Arat M, Baker KS, Burns LJ, Duncan CN , Gilleece M et al (2016) . Biology of Blood and Marrow Transplantation, 22(8), 1493-1503.
  • Baliousis M, Rennoldson M & Snowden JA (2016) . Psycho-Oncology, 25(4), 400-411.
  • Berndt SI, Camp NJ, Skibola CF, Vijai J, Wang Z, Gu J, Nieters A, Kelly RS, Smedby KE, Monnereau A , Cozen W et al (2016) . Nature Communications, 7.
  • Snowden JA (2016) . Blood, 127(1), 8-10.
  • Snowden JA, Danby R, Ruggeri A, Marks DI, Hough RE, Pagliuca A, Potter M, Russell N, Craddock C, Clark A , Miller P et al (2016) . British Journal of Haematology, 172(3), 478-481.
  • Oliveira MC, Labopin M, Henes J, Moore J, Papa ND, Cras A, Sakellari I, Schroers R, Scherer HU, Cuneo A , Kyrcz-Krzemien S et al (2016) . Bone Marrow Transplant, 51(4), 501-505.
  • Hough R, Danby R, Russell N, Marks D, Veys P, Shaw B, Wynn R, Vora A, Mackinnon S, Peggs KS , Crawley C et al (2016) . British Journal of Haematology, 172(3), 360-370.
  • Killick SB, Bown N, Cavenagh J, Dokal I, Foukaneli T, Hill A, Hillmen P, Ireland R, Kulasekararaj A, Mufti G , Snowden JA et al (2016) . British Journal of Haematology, 172(2), 187-207.
  • Craddock C, Jilani N, Siddique S, Yap C, Khan J, Nagra S, Ward J, Ferguson P, Hazlewood P, Buka R , Vyas P et al (2016) . Biology of Blood and Marrow Transplantation, 22(2), 385-390.
  • Greenfield DM, Blewitt A, Coleman RE, Walsh JS, Snowden JA, Ross RJM & Han TS (2016) . Clinical Endocrinology, 84(2), 296-304.
  • Cook G, Williams C, Cairns DA, Hockaday A, Cavenagh J, Snowden JA, Parrish C, Yong KL, Cavet J, Hunter H , Bird J et al (2015) . Blood, 126(23), 394-394.
  • Gratwohl A, Sureda A, Baldomero H, Gratwohl M, Dreger P, Kröger N, Ljungman P, McGrath E, Mohty M, Nagler A , Rambaldi A et al (2015) . EBioMedicine, 2(12), 2101-2109.
  • Sezer O, Terpos E, Hajek R, Sucak G, Cagirgan S, Linkesch W, Akay OM, Armbrecht G, Plesner T, Snowden JA , Nahi H et al (2015) . Clinical Lymphoma Myeloma and Leukemia, 15, e129-e130.
  • Pratt G, Bowcock S, Chantry A, Cook G, Jackson G, Lai M, Low E, Mulholland N, Owen R, Rabin N , Ramasamy K et al (2015) . British Journal of Haematology, 171(1), 1-10.
  • Thomas SJ, Snowden JA, Zeidler MP & Danson SJ (2015) . British Journal of Cancer, 113(3), 365-371.
  • Brierley D, Slater DN, Snowden J, Holt D & Hegarty A (2015) . Dental Update, 42(6), 584-585.
  • Thomas S, Fisher KH, Snowden JA, Danson SJ, Brown S & Zeidler MP (2015) . PLoS ONE, 10(7).
  • Lawson MA, Paton-Hough JM, Evans HR, Walker RE, Harris W, Ratnabalan D, Snowden JA & Chantry AD (2015) . PLOS ONE, 10(3).
  • Thomas S, Fisher K, Snowden J, Danson S, Brown S & Zeidler M (2015) . The Lancet, 385, S98-S98.
  • Alexander T, Bondanza A, Muraro PA, Greco R, Saccardi R, Daikeler T, Kazmi M, Hawkey C, Simoes BP, Leblanc K , Fibbe WE et al (2015) . Bone Marrow Transplantation, 50(2), 173-180.
  • Dalley C, Basarir H, Wright JG, Fernando M, Pearson D, Ward SE, Thokula P, Krishnankutty A, Wilson G, Dalton A , Talley P et al (2015) . Journal of Clinical Pathology, 68(4), 292-300.
  • Snarski E, Snowden JA, Oliveira MC, Simoes B, Badoglio M, Carlson K, Burman J, Moore J, Rovira M, Clark RE , Saiz A et al (2015) . Bone Marrow Transplantation, 50(2), 216-220.
  • Clark JR, Scott SD, Jack AL, Lee H, Mason J, Carter GI, Pearce L, Jackson T, Clouston H, Sproul A , Keen L et al (2015) . British Journal of Haematology, 168(1), 26-37.
  • Walker RE, Lawson MA, Buckle CH, Snowden JA & Chantry AD (2014) . British Medical Bulletin, 111(1), 117-138.
  • Sloot S, Boland J, Snowden JA, Ezaydi Y, Foster A, Gethin A, Green T, Chopra L, Verhagen S, Vissers K , Engels Y et al (2014) . Supportive Care in Cancer, 23(3), 671-678.
  • Dharmagunawardena R, Pearce RM, Thomas G, Kirkland K, Perry J, Apperley JF, Medd P, Wilson KMO, Orchard K, Jackson G , Snowden JA et al (2014) . Bone Marrow Transplantation, 49(11), 1442-1443.
  • Cook G, Parrish C, O'Connor S, Williams C, Brown JM, Cairns DA, Fletcher M, Chalmers A, Cavenagh J, Snowden JA , Ashcroft AJ et al (2014) . The Lancet Oncology.
  • Greenfield DM, Boland E, Ezaydi Y, Ross RJ, Ahmedzai SH & Snowden JA (2014) . Bone Marrow Transplant.
  • Boland EG, Selvarajah D, Hunter M, Ezaydi Y, Tesfaye S, Ahmedzai SH, Snowden JA & Wilkinson ID (2014) . PLoS One, 9(5), e96474.
  • Pratt G, Jenner M, Owen R, Snowden JA, Ashcroft J, Yong K, Feyler S, Morgan G, Cavenagh J, Cook G , Low E et al (2014) . British Journal of Haematology, 167(1), 131-133.
  • Snowden JA, Ansari A, Sachchithanantham S, Jackson G, Thompson N, Lobo A, Sanderson J & Kazmi M (2014) . QJM, 107(11), 871-877.
  • Boland EG, Boland JW, Ezaydi Y, Greenfield DM, Ahmedzai SH & Snowden JA (2014) . Support Care Cancer, 22(10), 2615-2620.
  • Greenfield DM, Boland E, Ezaydi Y, Ross RJM, Ahmedzai SH, Snowden JA & Late Effects Group (2014) . Bone Marrow Transplant, 49(7), 907-912.
  • Rabin N, Lai M, Pratt G, Morgan G, Snowden J, Bird J, Cook G, Bowcock S, Owen R, Yong K , Wechalaker A et al (2014) . International Journal of Laboratory Hematology.
  • Horne B, Gilleece M, Jackson G, Snowden JA, Liebersbach S, Velikova G & Wright P (2014) . Eur J Cancer Care (Engl), 23(3), 349-362.
  • Pechlivanoglou P, Le HH, Daenen S, Snowden JA & Postma MJ (2014) . Journal of Antimicrobial Chemotherapy, 69(1), 1-11.
  • Marsh JC, Pearce RM, Koh MBC, Lim Z, Pagliuca A, Mufti GJ, Perry J, Snowden JA, Vora AJ, Wynn RT , Russell N et al (2014) . Bone Marrow Transplant, 49(1), 42-48.
  • Snarski E, Snowden JA, Badoglio M, Carlson K, Burman J, Oliveira MC, Moore J, Tan J, Rovira M, Clark RE , Saiz A et al (2013) . Blood, 122(21), 4640-4640.
  • Snowden JA, Danby R, Ruggeri A, Marks DI, Hough RE, Pagliuca A, Potter M, Russell N, Craddock C, Clark A , Gluckman E et al (2013) . Blood, 122(21), 3394-3394.
  • Ashcroft J, de Tute RM, Cairns DA, Fletcher M, Owen RG, Rawstron A, O'Connor SJM, Williams CD, Snowden JA, Cavenagh JD , Parrish C et al (2013) . Blood, 122(21), 3378-3378.
  • Cook G, Williams CD, Cairns DA, Fletcher M, Cavenagh JD, Snowden JA, Parrish C, Ashcroft J, Yong KL, Cavet J , Hunter H et al (2013) . Blood, 122(21), 765-765.
  • Cook G, Ashcroft J, Williams CD, Cairns DA, Fletcher M, Parrish C, Cavenagh JD, Snowden JA, O'Connor SJ, Owen RG , Brown J et al (2013) . Blood, 122(21), 1884-1884.
  • Morris TCM, Williams C, Bell S, Fletcher M, Szubert A, Brown J, Cavenagh J, Snowden J, Ashcroft J, Yong K , Cavet J et al (2013) . British Journal of Haematology.
  • Berndt SI, Chung CC, Chanock SJ, Rothman N, Skibola CF, Conde L, Joseph V, Klein RJ, Camp NJ, Cannon-Albright LA , Nieters A et al (2013) . Nature Genetics.
  • Gesundheit B, Rosenzweig JP, Naor D, Melamed M, Lerer B, Zachor DA, Procházka V, Kristt DA, Steinberg A, Shulman C , Hwang P et al (2013) . Journal of Autoimmunity.
  • Martínez C, Canals C, Sarina B, Alessandrino EP, Karakasis D, Pulsoni A, Sica S, Trneny M, Snowden JA, Kanfer E , Milpied N et al (2013) . Ann Oncol, 24(9), 2430-2434.
  • Pratt G, Bowcock S, Lai M, Bell S, Bird J, D'Sa S, Yong K, Cavenagh J, Cook G, Morgan G , Davies F et al (2013) . International Journal of Laboratory Hematology.
  • Boland E, Eiser C, Ezaydi Y, Greenfield DM, Ahmedzai SH & Snowden JA (2013) . J Pain Symptom Manage, 46(5), 671-680.
  • Snowden JA, Akil M & Kiely DG (2013) . Lancet, 381(9872), 1081-1083.
  • Murng SHK, Follows L, Whitfield P, Snowden JA, Swallow K, Green K, Sargur R & Egner W (2013) . Clinical and Experimental Immunology, 171(2), 201-209.
  • Cook G, Williams C, Szubert A, Yong K, Cavet J, Hunter H, Bird J, Bell S, O'Connor S, Cavenagh J , Snowden JA et al (2013) Superior response durability following a second autologous stem cell transplant (ASCT) for relapsed multiple myeloma (MM): results from the BSBMT/UKMF myeloma X (Intensive) trial. BRITISH JOURNAL OF HAEMATOLOGY, 161, 8-8.
  • Alix JJP, Blackburn DJ, Sokhi D, Craven I, Sharrack B & Snowden JA (2013) . J Neurol, 260(3), 914-916.
  • Rabusin M, Snowden JA, Veys P, Quartier P, Dalle JH, Dhooge C, Di Bartolomeo P, Gonzalez-Vicent M, Gibson B, Iriondo A , Juergens H et al (2013) . Biology of Blood and Marrow Transplantation, 19(4), 666-669.
  • Farge-Bancel D, Marjanovic Z, Hadj Khelifa S, Ruggeri A-L, Martin T, Deligny C, Duran J-M, Sarrot-Reynauld F, Adoue D, Constans J , Philippe P et al (2012) . La Revue de Médecine Interne, 33, A79-A80.
  • Samuelson C, Dalley C, Ezaydi Y, Snowden JA & Collins N (2012) . British Journal of Haematology.
  • Bansal T, Garg A, Snowden JA & McKane W (2012) . Nephron Clinical Practice, 120(4), c228-c235.
  • Snowden JA, Saccardi R, Allez M, Ardizzone S, Arnold R, Cervera R, Denton C, Hawkey C, Labopin M, Mancardi G , Martin R et al (2012) . Bone Marrow Transplantation, 47(6), 770-790.
  • Patrick KL, Snowden JA, Wilson G, Collins N & Dalley CD (2012) . Br J Haematol, 158(3), 419-420.
  • Snowden JA, Pearce RM, Lee J, Kirkland K, Gilleece M, Veys P, Clark RE, Kazmi M, Abinun M, Jackson GH , MacKinnon S et al (2012) . British Journal of Haematology, 157(6), 742-746.
  • Snowden JA, Pearce RM, Lee J, Kirkland K, Gilleece M, Veys P, Clark RE, Kazmi M, Abinun M, Jackson GH , Mackinnon S et al (2012) . Br J Haematol, 157(6), 742-746.
  • Cachia E, Eiser C, Ezaydi Y, Greenfield D, Ahmedzai S & Snowden J (2012) . BMJ Supportive & Palliative Care, 2(Suppl 1), A3.2-A3.
  • Goodyear OC, Dennis M, Jilani NY, Loke J, Siddique S, Ryan G, Nunnick J, Khanum R, Raghavan M, Cook M , Snowden JA et al (2012) . Blood, 119(14), 3361-3369.
  • Nield A, Ward S, Goddard Y, Harrison S, McGoldrick R, Downes T, Ezaydi Y, Jessop H, Fairley V, Beadle H , Ritson M et al (2012) Using the clinical microsystems approach to enable ambulatory care to be a treatment option for patients with haematological malignancies. BONE MARROW TRANSPLANTATION, 47, S459-S459.
  • Tailor IK, Cook J, Reilly JT, Dalley CD, Ezaydi Y, Kelsey PJ & Snowden JA (2012) . British Journal of Haematology, 156(2), 289-291.
  • Taylor N, Absolom K, Snowden J, Eiser C & Late Effects Group Sheffield (2012) . Eur J Cancer Care (Engl), 21(1), 52-58.
  • Tailor IK, Akil M, Rennie I, Ross RJ & Snowden JA (2012) . QJM, 105(4), 369-371.
  • Marsh JCW, Pearce RM, Koh MB, Tang D, Lim Z, Pagliuca A, Mufti GJ, Snowden J, Vora AJ, Gibson B , Gilleece MH et al (2011) . Blood, 118(21), 52-52.
  • Dennis M, Goodyear O, Loke J, Jilani N, Siddique S, Ryan G, Khanum R, Snowden J, Griffiths M, Russell NH , Yin J et al (2011) . Blood, 118(21), 324-324.
  • Daikeler T, Labopin M, Di Gioia M, Abinun M, Alexander T, Miniati I, Gualandi F, Fassas A, Martin T, Schwarze CP , Wulffraat N et al (2011) . Blood, 118(6), 1693-1698.
  • Bird JM, Owen RG, D'Sa S, Snowden JA, Pratt G, Ashcroft J, Yong K, Cook G, Feyler S, Davies F , Morgan G et al (2011) Guidelines for the diagnosis and management of multiple myeloma 2011. British Journal of Haematology.
  • Bird JM, Owen RG, D'Sa S, Snowden JA, Pratt G, Ashcroft J, Yong K, Cook G, Feyler S, Davies F , Morgan G et al (2011) . British Journal of Haematology, 154(1), 32-75.
  • Snowden JA, Ahmedzai SH, Ashcroft J, D'Sa S, Littlewood T, Low E, Lucraft H, Maclean R, Feyler S, Pratt G , Bird JM et al (2011) . Br J Haematol, 154(1), 76-103.
  • Snowden JA, Pamphilon D, Kirkland K & Jackson GH (2011) . BMJ, 342(7802).
  • Hossain R, Snowden JA, Bansal T & McKane W (2011) . Cellular Therapy and Transplantation, 3(10).
  • Morris C, Cook G, Streetly M, Kettle P, Drake M, Quinn M, Cavet J, Tighe J, Kazmi M, Ashcroft J , Cook M et al (2011) . British Journal of Haematology, 153(5), 666-668.
  • Daikeler T, Labopin M, di Gioia M, Abinun M, Alexander T, Miniati I, Gualandi F, Fassas A, Martin T, Schwarze C-P , Wulffraat N et al (2010) . Blood, 116(21), 2322-2322.
  • Chakraverty R, Orti G, Roughton M, Shen J, Fielding A, Kottaridis P, Milligan D, Collin M, Crawley C, Johnson P , Clark A et al (2010) . Blood, 116(16), 3080-3088.
  • Walsh JS, Eastell R, Coleman RE, Snowden JA, Shalet SM, Ross RJ & Greenfield DM (2010) . Bone, 47, S189-S190.
  • Nabhan SK, Bitencourt MA, Duval M, Abecasis M, Dufour C, Boudjedir K, Rocha V, Socié G, Passweg J, Goi K , Sanders J et al (2010) . Haematologica, 95(10), 1783-1787.
  • Martinez C, Canals C, Alessandrino E, Karakasis D, Leone G, Trneny M, Snowden J, Apperley J, Milpied N & Sureda A (2010) . Journal of Clinical Oncology, 28(15_suppl), 8060-8060.
  • Burt RK, Abinun M, Farge-Bancel D, Fassas A, Hiepe F, Havrdová E, Ikehara S, Loh Y, Champ AMDH, Voltarelli JC , Snowden J et al (2010) . Science, 328(5980), 825-826.
  • Ansari A, Patel N, Sachchithanantham S, Jackson G, Thompson N, Snowden J, Lobo AJ, Sanderson JD & Kazmi M (2010) . Gastroenterology, 138(5), S-570.
  • Arachchillage DRJ, Dalley CD, Reilly JT, Wilson G, Collins N & Snowden JA (2010) . BRIT J HAEMATOL, 149(2), 298-299.
  • Greenfield DM, Walters SJ, Coleman RE, Hancock BW, Snowden JA, Shalet SM, DeRogatis LR & Ross RJM (2010) . Cancer, 116(6), 1592-1601.
  • Martinez C, Canals C, Alessandrino E, Karakasis D, Leone G, Trneny M, Snowden J, Apperley J, Milpied N & Sureda A (2010) Relapse of Hodgkin's lymphoma (HL) after autologous stem cell transplantation (ASCT): Prognostic factors in 462 patients registered in the database of the EBMT. JOURNAL OF CLINICAL ONCOLOGY, 28(15).
  • Craddock C, Nagra S, Peniket A, Brookes C, Buckley L, Nikolousis E, Duncan N, Tauro S, Yin J, Liakopoulou E , Kottaridis P et al (2010) . HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 95(6), 989-995.
  • Tappenden P, Saccardi R, Confavreux C, Sharrack B, Muraro PA, Mancardi GL, Kozak T, Farge-Bancel D, Madan J, Rafia R , Akehurst R et al (2010) . Bone Marrow Transplant, 45(6), 1014-1021.
  • Heath DJ, Chantry AD, Buckle CH, Coulton L, Shaughnessy JD, Evans HR, Snowden JA, Stover DR, Vanderkerken K & Croucher PI (2009) . J Bone Miner Res, 24(3), 425-436.
  • Snowden JA, Martin-Rendon E & Watt SM (2009) . Transfusion Medicine, 19(5), 223-234.
  • Martin-Rendon E, Snowden JA & Watt SM (2009) . Transfusion Medicine, 19(4), 159-171.
  • Greenfield DM, Absolom K, Eiser C, Walters SJ, Michel G, Hancock BW, Snowden JA & Coleman RE (2009) . Br J Cancer, 101(4), 568-574.
  • Absolom K, Eiser C, Michel G, Walters SJ, Hancock BW, Coleman RE, Snowden JA & Greenfield DM (2009) . Br J Cancer, 101(4), 561-567.
  • Sorour Y, Dalley CD, Snowden JA, Cross NCP & Reilly JT (2009) . British Journal of Haematology, 146(2), 225-227.
  • Kazmi M, Ansari A, Sanderson J, Jackson G, Lobo A, Thompson N & Snowden J (2009) Autologous stem cell transplant for severe refractory Crohn's disease: The UK experience. BONE MARROW TRANSPLANTATION, 43, S275-S275.
  • Sorour Y, Dalley C, Snowden JA, Cross NCP & Reilly JT (2009) A novel resistant FIP1L1-PDGFRa mutation in acute myeloid leukaemia, resistance to imatinib mesylate and allogeneic haemopoietic stem cell transplantation. BONE MARROW TRANSPLANTATION, 43, S96-S97.
  • Krishna R, Day V, Snowden JA, Pawson D, Birchall C, El-Ghariani K, Cook G & Lubenko A (2009) Immediate plasma removal and cryopreservation in HAS/DMSO corrects reduced CD34+cell viability in cryopreserved cell harvests from patients with systemic amyloidosis. BONE MARROW TRANSPLANTATION, 43, S107-S107.
  • Snowden JA, Kapoor S & Wilson AG (2008) . Autoimmunity, 41(8), 625-631.
  • Krishna R, Sorour Y, Goepel JR, Kirkbride P, Smith DJ, Ezaydi Y, Dalley CD & Snowden JA (2008) . CLINICAL ONCOLOGY, 20(10), 769-771.
  • Sorour Y, Webber SJ, Wright JG, Morley NJ, Reilly JT, Dalley CD & Snowden JA (2008) . Blood, 112(11), 2391-2391.
  • Cutting RJ, Welch E, Channer J, Ezaydi Y, Talley P, Reilly JT & Snowden JA (2008) . Bone Marrow Transplantation, 42(9), 631-633.
  • Absolom K, Eiser C, Turner L, Ledger W, Ross R, Davies H, Coleman R, Hancock B, Snowden J, Greenfield D & Late Effects Group Sheffield (2008) . Hum Reprod, 23(11), 2506-2512.
  • Cutting R, Dalley C, Ezaydi Y, Winfield D & Snowden JA (2008) . British Journal of Haematology, 142(3), 486-487.
  • Sorour Y, Webber SJ, Wright JG, Morley NJ, Reilly JT, Dalley CD & Snowden JA (2008) Outcomes of Patients with Haematological Malignancies Admitted to Either High Dependency Unit (HDU) or Intensive Care Unit (ICU) with or without Haemopoeitic Stem Cell Transplantation (HSCT): Analysis of Prognostic Factors for Survival. BLOOD, 112(11), 833-834.
  • Morris ES, Darbyshire P, Fairlie F, Dalley CD & Snowden JA (2008) . British Journal of Haematology, 140(1), 113.
  • Kapoor S, Wilson AG, Sharrack B, Lobo A, Akil M, Sun L, Dalley CD & Snowden JA (2007) . Hematology, 12(3), 179-191.
  • Chakraverty R, Manji N, Clark R, Crawley C, Johnson P, Liakopoulou E, Marsh J, Milligan D, Morris E, Peggs K , Thomson K et al (2007) . Blood, 110(11), 1055-1055.
  • Craddock CF, Tauro S, Gregory JE, Buckley L, Ward J, Kottaridis P, Thelouli E, Thomson K, Milligan D, Das-Gupta E , Liakpopoulou E et al (2007) . Blood, 110(11), 326-326.
  • Feyler S, Rawstron A, Jackson G, Snowden JA, Cocks K & Johnson RJ (2007) . British Journal of Haematology, 139(3), 429-433.
  • Morris ES, Sharrack B, Dalley CD & Snowden JA (2007) . Bone Marrow Transplant, 40(10), 1003-1004.
  • Greenfield DM, Walters SJ, Coleman RE, Hancock BW, Eastell R, Davies HA, Snowden JA, Derogatis L, Shalet SM & Ross RJM (2007) . J Clin Endocrinol Metab, 92(9), 3476-3482.
  • Eiser C, Absolom K, Greenfield D, Snowden J, Coleman R, Hancock B, Davies H & Late Effects Group, Sheffield (LEGS) (2007) . J Cancer Surviv, 1(1), 75-86.
  • Chantry AD, Snowden JA, Craddock C, Peggs K, Roddie C, Craig JIO, Orchard K, Towlson KE, Pearce RM, Marks DI & BSBMT Clinical Trials Committee (2006) . Biol Blood Marrow Transplant, 12(12), 1310-1317.
  • Burt RK, Marmont A, Oyama Y, Slavin S, Arnold R, Hiepe F, Fassas A, Snowden J, Schuening F, Myint H , Patel DD et al (2006) . Arthritis and Rheumatism, 54(12), 3750-3760.
  • Cutting RJ & Snowden JA (2006) . British Journal of Haematology, 134(6), 646.
  • Bird JM, Fuge R, Sirohi B, Apperley JF, Hunter A, Snowden J, Mahendra P, Milligan D, Byrne J, Littlewood T , Fegan C et al (2006) . BRIT J HAEMATOL, 134(4), 385-390.
  • Cutting R, Ezaydi Y, Edbrooke D, El-Ghariani K, Stamps R & Snowden JA (2006) . Bone Marrow Transplantation, 38(4), 317-318.
  • Feyler S, Rawstron A, Jackson G, Snowden J, Hawkins K & Johnson RJ (2005) . Blood, 106(11), 641-641.
  • Harrison CN, Campbell PJ, Buck G, Wheatley K, East CL, Bareford D, Wilkins BS, van der Walt JD, Reilly JT, Grigg AP , Revell P et al (2005) Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. NEW ENGL J MED, 353(1), 33-45.
  • Gratwohl A, Passweg J, Bocelli-Tyndall C, Fassas A, van Laar JM, Farge D, Andolina M, Arnold R, Carreras E, Finke J , Kötter I et al (2005) . Bone Marrow Transplantation, 35(9), 869-879.
  • Hough RE, Snowden JA & Wulffraat NM (2005) . British Journal of Haematology, 128(4), 432-459.
  • Ponchel F, Verburg RJ, Bingham SJ, Brown AK, Moore J, Protheroe A, Short K, Lawson CA, Morgan AW, Quinn M , Buch M et al (2005) . Arthritis Res Ther, 7(1), R80-R92.
  • Burt RK, Kallunian K, Patel D, Thomas J, Yeager A, Traynor A, Heipe F, Arnold R, Marmont A, Collier D , Glatstein E et al (2004) . Bone Marrow Transplantation, 34(9), 745-751.
  • Snowden JA, Passweg J, Moore JJ, Milliken S, Cannell P, Van Laar JM, Verburg R, Szer J, Taylor K, Joske D , Rule S et al (2004) Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: A report from the EBMT and ABMTR. J RHEUMATOL, 31(3), 482-488.
  • Burt RK, Marmont A, Arnold R, Heipe F, Firestein GS, Carrier E, Hahn B, Barr W, Oyama Y, Snowden J , Kalunian K et al (2003) . Bone Marrow Transplant, 32 Suppl 1, S49-S51.
  • Moore JJ, Snowden J, Pavletic S, Barr W & Burt R (2003) . Bone Marrow Transplant, 32 Suppl 1, S53-S56.
  • Gorin NC (2003) . Blood, 102(8), 3043-3051.
  • Moore J, Milliken S, Ma D, Biggs J, Brooks P & Snowden J (2003) . Arthritis & Rheumatism, 48(5), 1464-1466.
  • Moore J, Milliken S, Ma D, Biggs J, Brooks P & Snowden J (2003) . ARTHRITIS AND RHEUMATISM, 48(5), 1464-1466.
  • van Laar JM & Pavletic SZ (2003) . Arthritis & Rheumatism, 48(5), 1463-1464.
  • Moore J, Brooks P, Milliken S, Biggs J, Ma D, Handel M, Cannell P, Will R, Rule S, Joske D , Langlands B et al (2002) . ARTHRITIS RHEUM, 46(9), 2301-2309.
  • Bingham S, Ponchel F, Veale D, Reece R, Fearon U, Isaacs J, McGonagle D, Snowden J, Morgan G & Emery P (2002) . Clinical Science, 103(s47), 33P-33P.
  • Miall F, Rye A, Fraser M, Hunter A & Snowden JA (2002) . Bone Marrow Transplantation, 29(6), 541-542.
  • Bingham S, Veale D, Fearon U, Isaacs JD, Morgan G, Emery P, McGonagle D, Reece R, Clague R & Snowden JA (2002) . Arthritis and Rheumatism, 46(3), 837-839.
  • Bingham SJ, Snowden J, Morgan G & Emery P (2002) . Int Immunopharmacol, 2(4), 399-414.
  • Bingham S, Griffiths B, McGonagle D, Snowden JA, Morgan G & Emery P (2001) . British Journal of Haematology, 113(3), 840-841.
  • Kashyap A & Snowden J (2001) Considerations in the selection of an appropriate conditioning regimen for the treatment of rheumatoid arthritis by autologous peripheral blood stem cell transplantation.. J Rheumatol Suppl, 64, 39-41.
  • Burt RK, Fassas A, Snowden J, van Laar JM, Kozak T, Wulffraat NM, Nash RA, Dunbar CE, Arnold R, Prentice G , Bingham S et al (2001) . Bone Marrow Transplant, 28(1), 1-12.
  • Bingham S, Veale D, Reece R, Fearon U, Isaacs J, McGonagle D, Snowden J, Morgan G & Emery P (2001) Long-term follow-up of highly selected autologous stem cell transplantation in severe rheumatoid arthritis with studies of synovial response and peripheral blood lymphocyte (PBL) reconstitution. RHEUMATOLOGY, 40, 83-83.
  • Snowden J (2001) High dose therapy and autologous hemopoietic stem cell transplantation in rheumatoid arthritis--the feasibility of phase III trials.. J Rheumatol Suppl, 64, 55-59.
  • Bingham SJ, Snowden J, McGonagle D, Richards S, Isaacs J, Morgan G & Emery P (2001) Autologous stem cell transplantation for rheumatoid arthritis--interim report of 6 patients.. J Rheumatol Suppl, 64, 21-24.
  • Bingham SJ, Snowden JA & Emery P (2000) . Annals of Medicine, 32(9), 615-621.
  • Mainwaring CJ, Walewska R, Snowden J, Winfield DA, Ng JP, Chan-Lam D, Nolan B, Booker DJ, Stamps R & Sokol RJ (2000) . Br J Haematol, 109(3), 641-643.
  • Snowden JA, Hill GR, Hunt P, Carnoutsos S, Spearing RL, Espiner E & Hart DNJ (2000) . Bone Marrow Transplantation, 26(3), 309-313.
  • Snowden JA & Brooks PM (2000) . RHEUMATOLOGY, 39(6), 681-682.
  • Hawkey CJ, Snowden JA, Lobo A, Beglinger C & Tyndall A (2000) . GUT, 46(6), 869-872.
  • Snowden JA, Nivison-Smith I, Atkinson K, Fay K, Concannon A, Dodds A, Milliken S & Biggs J (2000) . Bone Marrow Transplantation, 25(1), 119-120.
  • Snowden JA (2000) . Japanese Journal of Clinical Immunology, 23(4), 257-260.
  • Snowden JA (2000) . Japanese Journal of Clinical Immunology, 23(6), 490-493.
  • Snowden JA, Biggs JC, Milliken ST, Fuller A & Brooks PM (1999) A phase I/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis. Arthritis and Rheumatism, 42(11), 2286-2292.
  • Tyndall A, Fassas A, Passweg J, Ruiz de Elvira C, Attal M, Brooks P, Black C, Durez P, Finke J, Forman S , Fouillard L et al (1999) . Bone Marrow Transplant, 24(7), 729-734.
  • Snowden JA & Brooks PM (1999) . Current Opinion in Rheumatology, 11(3), 167-172.
  • Snowden JA, Nivison-Smith I, Biggs JC & Brooks PM (1999) . Rheumatology, 38(4), 321-324.
  • Snowden JA, Chan-Lam D, Thomas SE & Ng J-P (1999) . The Lancet, 353(9150), 411-411.
  • Moore J, Snowden J, Milliken S, Cannell P, Szer J, Joske D, Brooks P & Biggs J (1999) PBCST for rheumatoid arthritis - An Australian experience.. EXPERIMENTAL HEMATOLOGY, 27(7), 132-132.
  • Freeman AG (1999) . The Lancet, 353(9150), 410-411.
  • Snowden JA, Nink V, Cooley M, Zaunders J, Keir M, Wright L, Milliken ST, Brooks PM & Biggs JC (1998) . British Journal of Haematology, 103(3), 601-609.
  • Snowden JA, Biggs JC, Milliken ST, Fuller A, Staniforth D, Passuello F, Renwick J & Brooks PM (1998) . Bone Marrow Transplantation, 22(11), 1035-1041.
  • Snowden JA, Kearney P, Kearney A, Cooley HM, Grigg A, Jacobs P, Bergman J, Brooks PM & Biggs JC (1998) Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation. Arthritis and Rheumatism, 41(3), 453-459.
  • Snowden JA, Brooks PM, Milliken ST, Fuller A, Passuello F, Renwick J & Biggs JC (1998) Haemopoietic stem cell (HSC) mobilisation with filgrastim in severe active rheumatoid arthritis (RA). BONE MARROW TRANSPLANTATION, 21, S51-S51.
  • Snowden JA (1998) . GASTROENTEROLOGY, 115(4), 1035-1036.
  • Brooks PM, Snowden J, Biggs J & Millikin S (1998) A pilot dose escalation of high dose cyclophosphamide (CY) and autologous stem cell therapy (ASCT) in active rheumatoid arthritis (RA).. ARTHRITIS AND RHEUMATISM, 41(9), S132-S132.
  • Snowden JA, Milliken ST, Brooks PM & Biggs JC (1998) Autografting in severe active rheumatoid arthritis (RA) - Mobilisation and dose escalation studies. BRITISH JOURNAL OF HAEMATOLOGY, 101, 70-70.
  • Snowden JA, Milliken ST, Brooks PM & Biggs JC (1998) High dose cyclophosphamide (Cy) with autologous stem cell rescue in severe active rheumatoid arthritis (RA) - A dose escalation study. BONE MARROW TRANSPLANTATION, 21, S52-S52.
  • Snowden JA & Heaton DC (1997) . British Journal of Dermatology, 137(1), 130-132.
  • Cooley HM, Snowden JA, Grigg AP & Wicks IP (1997) . Arthritis & Rheumatism, 40(9), 1712-1715.
  • Snowden JA, Brooks PM & Biggs JC (1997) . British Journal of Haematology, 99(1), 9-22.
  • Snowden JA, Poole J, Bates AJ, Faulkner M, Day V, Booker D, Sokol RJ & Reilly JT (1997) . Clin Lab Haematol, 19(2), 143-148.
  • Reilly JT, Snowden JA, Spearing RL, Fitzgerald PM, Jones N, Watmore A & Potter A (1997) . British Journal of Haematology, 98(1), 96-102.
  • Biggs JC, Snowden JA, Milliken ST & Brooks P (1997) Haemopoietic stem cell transplantation (HSCT) for rheumatoid arthritis (RA). Experimental Hematology, 25(8), 902.
  • Snowden JA, Atkinson K, Kearney P, Brooks P & Biggs JC (1997) . Bone Marrow Transplantation, 20(1), 71-73.
  • Snowden JA, Patton WN, O'Donnell JL, Hannah EE & Hart DNJ (1997) . Bone Marrow Transplantation, 19(12), 1247-1250.
  • Biggs JC, Snowden JA, Milliken ST & Brooks P (1997) Haemopoietic stem cell transplantation (HSCT) for rheumatoid arthritis (RA). EXPERIMENTAL HEMATOLOGY, 25(8), 611-611.
  • Brooks P, Snowden JA, Fuller A, Milliken S, Biggs JC & Passuello F (1997) A randomised, blinded, placebo controlled, pilot phase 1 study of the tolerability of filgrastim in patients with severe active rheumatoid arthritis for the mobilisation of peripheral blood progenitor cells.. ARTHRITIS AND RHEUMATISM, 40(9), 131-131.
  • Snowden JA, Hutchings M, Spearing R & Patton WN (1997) . Pathology, 29(2), 221-223.
  • Snowden JA, Angel CA, Winfield DA, Pringle JH & West KP (1997) . Journal of Clinical Pathology, 50(1), 67-70.
  • Dapling RB, Snowden JA, West J, Talbot JF, Nelson ME & Greaves M (1996) The microvasculature in myeloproliferative disease. A study using retinal fluorescein angiography. Clinical and Laboratory Haematology, 18(4), 277-279.
  • Hill G, McClean D, Fraser R, Hart D, Crozier I, Snowden J & Gibbons S (1996) . Aust N Z J Med, 26(6), 852-853.
  • Snowden JA, Biggs JC & Brooks PM (1996) . Lancet, 348(9035), 1112-1113.
  • SNOWDEN JA & GREAVES M (1995) . Clinical Laboratory Haematology, 17(1), 95-96.
  • WEIR NU, SNOWDEN JA, GREAVES M & DAVIES‐JONES GAB (1995) . British Journal of Dermatology, 132(2), 283-285.
  • Wodziński MA, Snowden JA & Reilly JT (1994) . Postgraduate Medical Journal, 70(830), 921-923.
  • Snowden JA, Milford-Ward A & Reilly JT (1994) . Postgraduate Medical Journal, 70(830), 924-926.
  • SNOWDEN JA, LAIDLAW ST, CHAMPION AE & REILLY JT (1994) . LANCET, 344(8933), 1361-1361.
  • SNOWDEN JA, WRIGHT JG, PEEL J & WINFIELD DA (1994) . BRITISH MEDICAL JOURNAL, 309(6955), 671-671.
  • SNOWDEN JA, FORSTER DMC & MCKENDRICK MW (1994) . CLINICAL INFECTIOUS DISEASES, 19(3), 547-548.
  • Jones JW, Pether JVS, Frost RWP, Snowden JA & Ali-Wali WI (1994) . BMJ, 308(6928), 595-595.
  • SNOWDEN JA & ALIWALI WI (1994) HUMAN PARVOVIRUS B19 - VIRUS TRANSMISSIBLE IN BLOOD PRODUCTS. BRITISH MEDICAL JOURNAL, 308(6928), 595-595.
  • Snowden JA, Greaves M & Page K (1994) Reversal of diabetes associated with escape of myeloma: Evidence for inappropriate IGF-II secretion. British Journal of Haematology, 87(1), 202-204.
  • Snowden JA, Young MJ & Mc Kendrick MW (1994) . QJM, 87(1), 55-62.
  • Mcdonagh AJ, Snowden JA, Stierle C, Elliott K & Messenger AG (1993) . Br J Dermatol, 129(3), 250-256.
  • LAIDLAW ST, SNOWDEN JA & BROWN MJ (1993) APLASTIC-ANEMIA AND REMOXIPRIDE. LANCET, 342(8881), 1245-1245.
  • PHILPOTT N (1993) . The Lancet, 342(8881), 1244-1245.
  • Snowden JA, Milford-Ward A, Cookson LJ & McKendrick MW (1993) . Journal of Infection, 27(3), 285-289.
  • SNOWDEN JA & MCKENDRICK MW (1992) . BRITISH MEDICAL JOURNAL, 305(6848), 314-314.
  • Snowden JA, Harkin PJR, Thornton JG & Wells M (1989) . Maturitas, 11(4), 348-348.
  • Snowden JA, Bradbury K, Thornton JG & Wells M (1989) . J Pathol, 159(1), 59-65.
  • Snowden JA, Harkin PJ, Thornton JG & Wells M (1989) . Histopathology, 14(4), 369-379.
  • Basak G, Peczynski C, Koenecke C, Terwel S, Cabrerizo Y, Penack O, Moiseev I, Schoemans H, Fegueux N, Potter V , Zeerleder S et al () . HemaSphere, 6, 1327-1328.
  • Snowden JA, Styczyński J, Snarski E & Greco R () . Acta Haematologica Polonica, 52(4), 217-224.
  • Soto JR, Anthias C, Madrigal A & Snowden JA () . Frontiers in Immunology, 11.
  • Mankarious M, Matthews NC, Snowden JA & Alfred A () . Frontiers in Immunology, 11.
  • Joerg Henes , Maria Carolina Oliveira , Myriam Labopin , Manuela Badoglio , Hans Ulrich Scherer , Nicoletta Del Papa , Thomas Daikeler , Marc Schmalzing , Roland Schroers , Thierry Martin , Gregory Pugnet et al () . Haematologica, 106(2), 375-383.
  • Greco R, Labopin M, Badoglio M, Veys P, Furtado Silva JM, Abinun M, Gualandi F, Bornhauser M, Ciceri F, Saccardi R , Lankester A et al () . Frontiers in Immunology, 10.
  • Miller PDE, Forster AS, de Silva TI, Leonard H, Anthias C, Mayhew M, Klammer M, Paskar S, Hurst E, Peggs K , Madrigal A et al () . BMJ OPEN, 8(8).
  • Greenfield D, Blewitt A, Coleman R, Walsh J, Snowden J, Ross R & Han T () . Endocrine Abstracts.
  • Tridente A, Browett K, Hall J, Sorour Y, Snowden J & Webber S () . Critical Care, 18(S1).

Book chapters

  • Galvan ER, Snowden JA & Greenfield DM (2024) , The EBMT Handbook (pp. 495-500). Springer International Publishing
  • Alexander T, Sharrack B, Rovira M, Saccardi R, Farge D, Snowden JA & Greco R (2024) , The EBMT Handbook (pp. 825-836). Springer International Publishing
  • Saccardi R, Rintala T, McGrath E & Snowden JA (2024) , The EBMT Handbook (pp. 41-47). Springer International Publishing
  • Snowden J & Duarte RF (2022) , The EBMT/EHA CAR-T Cell Handbook (pp. 225-227). Springer International Publishing
  • Hayden P, Gagelmann N & Snowden J (2022) , The EBMT/EHA CAR-T Cell Handbook (pp. 183-187). Springer International Publishing
  • Ros-Soto J, Burt RK & Snowden JA (2021) , Hematopoietic Stem Cell Transplantation and Cellular Therapies for Autoimmune Diseases (pp. 300-309). CRC Press
  • Snowden JA, Greco R, Badoglio M, Labopin M, Alvelo OFD & Pasquini MC (2021) , Hematopoietic Stem Cell Transplantation and Cellular Therapies for Autoimmune Diseases (pp. 271-281). CRC Press
  • Salooja N, Burt RK & Snowden JA (2021) , Hematopoietic Stem Cell Transplantation and Cellular Therapies for Autoimmune Diseases (pp. 252-263). CRC Press
  • Snowden JA, Ismail A, Burt RK & Jessop H (2021) , Hematopoietic Stem Cell Transplantation and Cellular Therapies for Autoimmune Diseases (pp. 241-251). CRC Press
  • Burt RK, Farge D, Saccardi R, Quigley K, Han X & Snowden JA (2021) , Hematopoietic Stem Cell Transplantation and Cellular Therapies for Autoimmune Diseases (pp. 204-212). CRC Press
  • McGrath E, Schwartz J, Warkentin , Saccardi R & Snowden JA (2021) , Hematopoietic Stem Cell Transplantation and Cellular Therapies for Autoimmune Diseases (pp. 103-109). CRC Press
  • Penglase R, Sandler RD, Moore J & Snowden JA (2021) , Hematopoietic Stem Cell Transplantation and Cellular Therapies for Autoimmune Diseases (pp. 547-556). CRC Press
  • Aljurf M, Snowden JA, Hayden P, Orchard KH & McGrath E (2021) , Quality Management and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular Therapy (pp. C1-C2). Springer International Publishing
  • Saccardi R, McGrath E & Snowden JA (2019) , The EBMT Handbook (pp. 35-40). Springer International Publishing
  • Greenfield DM & Snowden JA (2019) , The EBMT Handbook (pp. 415-420). Springer International Publishing
  • Snowden JA & Webber S (2014) Haematopoietic Stem Cell Transplantation In Thachil J & Hill Q (Ed.), Haematology in Critical Care- a Practical Handbook Wiley-Blackwell
  • Snowden JA, Saccardi R & Farge D (2012) Autoimmune Diseases In Apperley J (Ed.), EBMT Handbook European School of Haematology
  • Snowden JA, Moore J, Pavletic S, Bingham S & Burt R (2004) Haemopoietic stem cell transplantation in severe rheumatoid arthritis – world results In Burt RK & Marmont AM (Ed.), Stem Cell Therapy for Autoimmune Disease
  • Snowden JA, Steward W, Hunter A & O'Bryne K (2001) Acute intestinal failure – malignancy, chemotherapy and haemopoietic stem cell transplantation, Intestinal failure Wisepress
  • Snowden JA, Bingham S, Morgan G & Emery P (1999) High dose therapy and blood stem cell transplantation for rheumatoid arthritis. In Emery P (Ed.), Rheumatology Highlights 1998-99 (pp. 42-50). Oxford: Health Press.
  • Snowden JA & Brooks P (1997) High dose therapy and blood stem cell transplantation for autoimmune diseases. In Emery P (Ed.), Rheumatology Highlights 1997

Conference proceedings

  • Aspa-Cilleruelo J, Roldan-Galvan E, Fairley V, Chantry A, Nield A, Ezaydi Y, Keat S, Greenfield D & Snowden J (2025) Long-term outcomes of intensively-treated multiple myeloma: Service evaluation per BSH Guidelines. BRITISH JOURNAL OF HAEMATOLOGY, Vol. 206
  • Russell NH, Wilhelm-Benartzi C, Othman J, Dillon R, Knapper S, Batten LM, Canham J, Hinson EL, Betteridge S, Overgaard UM , Gilkes A et al (2024) . Journal of Clinical Oncology, Vol. 42(10) (pp 1158-1168)
  • Parrish C, Welsh A, Ashcroft J, Olivier C, Hockaday A, Cavenagh J, Snowden J, Drayson M, De Tute R, Owen R , Yong K et al (2024) Proteasome Inhibitor-Augmented Salvage Autologous Stem Cell Transplantation for First Relapse Management in Relapsed Multiple Myeloma. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, Vol. 24 (pp S37-S38)
  • Muraro P, Kazmi M, De Matteis E, Brittain G, Nicholas R, Silber E, Mehra V, Gabriel I, Lee J, Pearce R , Malladi R et al (2024) Real-world Effectiveness and Safety of Autologous Haematopoietic Stem Cell Transplantation in MS: the UK Experience in 363 patients treated during 2002-2023. MULTIPLE SCLEROSIS JOURNAL, Vol. 30(3) (pp 20-21)
  • Brittain G, Ismail A, Hoyle N, Roldan E, Snowden J & Sharrack B (2024) The impact of disease modifying treatment washout periods prior to autologous stem cell transplantation for multiple sclerosis: real-world experience at a large centre. MULTIPLE SCLEROSIS JOURNAL, Vol. 30(3) (pp 1073-1074)
  • Kalincik T, Sharmin S, Roos I, Freedman MS, Atkins H, Massey J, Sutton I, Withers B, Burman J, Torkildsen O , Bo L et al (2024) Effectiveness of autologous haematopoietic stem cell transplantation in comparison with immune-reconstitution therapies in relapsing-remitting MS. MULTIPLE SCLEROSIS JOURNAL, Vol. 30(3) (pp 1193-1196)
  • McIntyre A, Cuadrado M, Hughes J, O'Neill A, Wilson W, Edwards D, Mak KM, Hunt J, Clifton-Hadley L, Bloor A , Clark A et al (2024) LIN VIVO TRANSFER OF CD4+ T CELLS RESHAPES CD8+ T CELL DIFFERENTIATION TRAJECTORY IN HUMANS. BONE MARROW TRANSPLANTATION, Vol. 59 (pp 53-54)
  • Serpenti F, Ben C, Snowden J, Roldangalvan E, Kesse-Adu R, Tholouli E, Samuelson C, Chakravorty S & Potter V (2024) NON-MYELOABLATIVE HAEMATOPOIETIC STEM CELL TRANSPLANT FROM MATCHED RELATED DONORS IN ADULT PATIENTS WITH SEVERE SICKLE CELL DISEASE: THE UK REALLIFE EXPERIENCE. BONE MARROW TRANSPLANTATION, Vol. 59 (pp 87-88)
  • Cilleruelo JA, Bourlon C, Galvan ER, Benjamin R, Cuthill K, Gunawan A, Kazmi M, Krishnamurthy P, Potter V, Sanderson R , Kenyon M et al (2024) REAL-WORLD MOBILIZATION AND HARVEST OUTCOMES IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING D-VTD: UK EXPERIENCE. BONE MARROW TRANSPLANTATION, Vol. 59 (pp 642-643)
  • Kazmi M, Muraro P, Mehra V, Gabriel I, De Matteis E, Brittain G, Nicholas R, Silber E, Lee J, Pearce R , Paul R et al (2024) AUTOLOGOUS HSCT IN MULTIPLE SCLEROSIS: THE UK EXPERIENCE 2002-2023 (ON BEHALF OF THE BSBMT CTC GROUP). BONE MARROW TRANSPLANTATION, Vol. 59 (pp 39-40)
  • Ismail A, Nitti R, Sharrack B, Badoglio M, Ambron P, Labopin M, Alexander T, Snowden J & Raffaella G (2024) ATG AND OTHER SEROTHERAPY IN CONDITIONING REGIMENS FOR ASCT IN AUTOIMMUNE DISEASES: A SURVEY OF THE EBMT AUTOIMMUNE DISEASES WORKING PARTY (ADWP). BONE MARROW TRANSPLANTATION, Vol. 59 (pp 194-195)
  • Perruccio K, Tridello G, Knelange N, Carotti A, Labussiere-Wallet H, Locatelli F, Galaverna F, Itala-Remes M, Collin M, Sobczyk-Kruszelnicka M , Rambaldi A et al (2024) INCIDENCE AND OUTCOME OF HHV-6 ENCEPHALITIS IN HLAHAPLOIDENTICAL STEM CELL TRANSPLANT RECIPIENTS: A PROSPECTIVE ANALYSIS OF THE IDWP-EBMT. BONE MARROW TRANSPLANTATION, Vol. 59 (pp 102-103)
  • Stamouli M, Snowden J, Xhaard A, AlAnazi A, Perez Martinez A, Yeshurun M, Kroeger N, Kuball J, Kontos F, Passweg J , Mielke S et al (2024) NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS AMONG HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: A MULTICENTER EUROPEAN CASE-CONTROL STUDY BY THE INFECTIOUS DISEASES WORKING PARTY OF EBMT. BONE MARROW TRANSPLANTATION, Vol. 59 (pp 427-428)
  • von Asmuth EGJ, de Wreede LC, Halkes CJM, Eikema D-JA, Saccardi R, Hazenberg MD, Busto MP, Snowden JA, Sureda A, Lankester AC & Putter H (2024) A CASEMIX OUTCOME STRATIFICATION MODEL FOR SCT USING MACHINE LEARNING (COSMOS). BONE MARROW TRANSPLANTATION, Vol. 59 (pp 29-30)
  • Garderet L, Gras L, Koster L, Montserrat R, Vincent L, Kobbe G, Pillai S, Deeren D, Kaufmann M, Kuball J , Ozdogu H et al (2023) . Bone Marrow Transplant, Vol. 58(Supp 1) (pp 478-478). Paris Hybrid Meeting, 23 April 2023 - 23 April 2023.
  • Garderet L, Gras L, Koster L, Dsouza A, Parameswaran H, Merly NE, Saber W, Cowan A, Iida M, Okamoto S , Takamatsu H et al (2023) WORLDWIDE NETWORK FOR BLOOD AND MARROW TRANSPLANTATION GLOBAL STUDY ON BASELINE CHARACTERISTICS/CLINICAL OUTCOMES IN MULTIPLE MYELOMA PATIENTS UNDERGOING ASCT, A STUDY OFF 61,725 PATIENTS. BONE MARROW TRANSPLANTATION, Vol. 58(SUPP1) (pp 479-480)
  • Barkauskiene R, Pryce A, Pearce R, Snowden JA, Malladi R, Potter V, Lee J, Wilson M, Paglucia A, Anthias C , Pawson R et al (2023) GRAFT CRYOPRESERVATION EFFECTS ON THE OUTCOMES OF ALLOGENEIC HAEMATOPOIETIC CELL TRANSPLANTS IN PAEDIATRIC POPULATION: A MULTICENTRE UK STUDY. BONE MARROW TRANSPLANTATION, Vol. 58(SUPP1) (pp 569-570)
  • Moore J, Milliken S, Withers B, Massey J, Sutton I, Penglase R, Englert H, Laila G, Handel M, Brooks P , Jabbour A et al (2023) AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AUTOIMMUNE DISEASES AT ST VINCENTS HOSPITAL, SYDNEY-25 YEARS AND 159 PATIENTS: AN ANALYSIS OF DISEASE SPECIFIC OUTCOMES AND SAFETY. BONE MARROW TRANSPLANTATION, Vol. 58(SUPP1) (pp 37-38)
  • von Asmuth EGJ, Putter H, Mohseny AB, Schilham MW, Snowden JA, Saccardi R & Lankester AC (2023) AUTOMATING OUTCOME ANALYSIS FOR SCT PATIENTS: THE YEARLY OUTCOME REVIEW TOOL. BONE MARROW TRANSPLANTATION, Vol. 58(SUPP1) (pp 666-667)
  • von Asmuth EGJ, Putter H, Mohseny AB, Schilham MW, Snowden JA, Saccardi R & Lankester AC (2023) AUTOMATING OUTCOME ANALYSIS FOR SCT PATIENTS: THE YEARLY OUTCOME REVIEW TOOL. BONE MARROW TRANSPLANTATION, Vol. 58(SUPP1) (pp 688-688)
  • Bruno A, Gurnari C, Greco R, Alexander T & Snowden J (2023) TOWARD A CLINICAL PHENOTYPE INSPIRED DIAGNOSIS OF AUTOIMMUNE MANIFESTATIONS IN VEXAS SYNDROME: A GUIDE TO UBA1-TESTING FOR THE GENERALIST. BONE MARROW TRANSPLANTATION, Vol. 58(SUPP1) (pp 344-345)
  • Mayor NP, Szydlo RM, Sheikh Y, Lee J, Pearce RM, Farrow C, Agapiou M, Rao K, Orchard K, Olavarria E , Marsh SGE et al (2023) THE IMPACT OF PATIENT-REPORTED ETHNICITY ON HAEMATOPOIETIC CELL TRANSPLANT OUTCOME: THE UK EXPERIENCE. BONE MARROW TRANSPLANTATION, Vol. 58(SUPP1) (pp 34-34)
  • Bug G, Labopin M, Byrne JL, Mielke S, Orchard K, Burns D, Potter V, Blaise D, Robinson S, Snowden J , Yakoub-Agha I et al (2023) ANTITHYMOCYTE GLOBULIN - OR ALEMTUZUMAB-BASED GVHD PROPHYLAXIS IN REDUCED- INTENSITY CONDITIONING ALLO-HCT FOR ACUTE LYMPHOBLASTIC LEUKEMIA IN CR1: A STUDY FROM THE ACUTE LEUKEMIA WORKING PARTY. BONE MARROW TRANSPLANTATION, Vol. 58(SUPP1) (pp 58-59)
  • Kanellopoulos A, Labopin M, Spyridonidis A, Nikolousis E, Platzbecker U, Blaise D, Sengeloev H, Burns D, Schroeder T, Choi G , Tholouli E et al (2023) NON MYELOABLATIVE VERSUS REDUCED INTENSITY CONDITIONING FOR ALLO-HCT FROM SIBLING OR UNRELATED DONORS IN PATIENTS WITH AML=65YEARS. A STUDY FROM THE EBMT ALWP. BONE MARROW TRANSPLANTATION, Vol. 58(SUPP1) (pp 155-156)
  • Greco R, Snowden JA, Knelange NS, Tridello G, Cacciatore C, Xhaard A, Ciceri F, Collin M, Ferra C, De Becker A , Averbuch D et al (2023) OUTCOME OF SARS-COV2 INFECTION IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS FOR AUTOIMMUNE DISEASES. BONE MARROW TRANSPLANTATION, Vol. 58(SUPP1) (pp 38-39)
  • Garderet L, Gras L, Koster L, Dsouza A, Merly NE, Parameswaran H, Saber W, Cowan A, Iida M, Okamoto S , Takamatsu H et al (2023) INTERNATIONAL DIFFERENCES IN BASELINE CHARACTERISTICS AND PRACTICE PATTERNS IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA UNDERGOING UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION. BONE MARROW TRANSPLANTATION, Vol. 58(SUPP1) (pp 479-479)
  • Pagliuca S, Kulasekararaj A, Eikema D-J, Piepenbroek B, Iftikhar R, Satti TM, Griffin M, Laurino M, Kupesiz A, Bertrand Y , Fattizzo B et al (2023) CURRENT USE OF ANDROGENS IN BONE MARROW FAILURE DISORDERS: A REPORT FROM THE SEVERE APLASTIC ANEMIA WORKING PARTY (SAAWP) OF THE EBMT. BONE MARROW TRANSPLANTATION, Vol. 58(SUPP1) (pp 36-37)
  • Hayden P, Eikema D-J, Koster L, Snowden J, Caillot D, van Gorkom G, Griskevicius L, Arcese W, Crawley C, Musso M , Bulabois CE et al (2023) AUTOLOGOUS PERIPHERAL BLOOD STEM CELL MOBILISATION TECHNIQUES, CELL YIELDS AND PRACTICE VARIATION-BYCOUNTRY IN MYELOMA PATIENTS UNDERGOING FIRST AUTOLOGOUS STEM CELL TRANSPLANTS IN EBMT CENTRES (2012-2021). BONE MARROW TRANSPLANTATION, Vol. 58(SUPP1) (pp 602-603)
  • Hewerdine S, Judge G, Lee J, Braund H, Allen H, Snowden JA, Carpenter B, Potter V, Marsh SGE & Mayor NP (2023) COMPLETION OF THE PILOT PROJECT EVALUATING THE BENEFIT OF ADDITIONAL SUPPORT IN HCT RESEARCH DATA MANAGEMENT ON BEHALF OF ANTHONY NOLAN AND BSBMTCT. BONE MARROW TRANSPLANTATION, Vol. 58(SUPP1) (pp 682-683)
  • Riva E, Kastritis E, Gras L, Koster L, Caillot D, Tucci A, Lanza F, Musso M, Sirvent A, Illes A , Ram R et al (2023) NO EVIDENCE FOR IMPROVED OVERALL SURVIVAL OR PROGRESSION-FREE SURVIVAL IN MULTIPLE MYELOMA PATIENTS AGED 70-75 UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION COMPARED TO A NON-TRANSPLANT STRATEGY. BONE MARROW TRANSPLANTATION, Vol. 58(SUPP1) (pp 366-367)
  • Alexander T, Badglio M, Labopin M, Daikeler T, Farge D, Kazmi M, Rovira M, Saccardi R, Snowden J & Greco R (2023) MONITORING AND MANAGEMENT OF CMV AND EBV AFTER AUTOLOGOUS HAEMATOPOIETIC CELL TRANSPLANTATION FOR AUTOIMMUNE DISEASES: A SURVEY OF THE EBMT AUTOIMMUNE DISEASES WORKING PARTY (ADWP). BONE MARROW TRANSPLANTATION, Vol. 58(SUPP1) (pp 418-419)
  • Garderet L, Gras L, Koster L, D'Souza A, Estrada-Merly N, Hari P, Saber W, Cowan AJ, Iida M, Okamoto S , Takamatsu H et al (2022) . Blood, Vol. 140(Supplement 1) (pp 5225-5227)
  • Pagliuca S, Kulasekararaj A, Eikema D-J, Piepenbroek B, Iftikhar R, Satti TM, Griffin M, Laurino M, Kupesiz OA, Bertrand Y , Fattizzo B et al (2022) . Blood, Vol. 140(Supplement 1) (pp 5799-5800)
  • Oporto Espuelas M, Burridge S, Bonney D, Watts K, Roddie C, O'Reilly MA, Shenton G, Snowden JA, Furness C, Jalowiec KAA , Neill L et al (2022) . Blood, Vol. 140(Supplement 1) (pp 2408-2410)
  • Garderet L, Gras L, Koster L, D'Souza A, Estrada-Merly N, Hari P, Saber W, Cowan AJ, Iida M, Okamoto S , Takamatsu H et al (2022) . Blood, Vol. 140(Supplement 1) (pp 4839-4842)
  • Maniusyte R, Pryce A, Pearce R, Snowden JA, Malladi R, Potter V, Lee J, Wilson M, Pagliuca A, Olavarria E , Palanicawandar R et al (2022) . Blood, Vol. 140(Supplement 1) (pp 7552-7554)
  • Abamba C, Lee J, Pearce RM, Wilson MC, Paul RE & Snowden JA (2022) Observational trends in GvHD data submissions: Do centres have a data collection process and is this responsible for submission improvements?. BONE MARROW TRANSPLANTATION, Vol. 57(SUPPL 1) (pp 460-461)
  • Kirgizov K, Greco R, Badoglio M, Labopin M, Saccardi R, Rovira M, Farge D, Schaap N, Moore J, Polushin A , Finke J et al (2022) Late complications after autologous HSCT for autoimmune diseases: a retrospective study from the EBMT autoimmune. BONE MARROW TRANSPLANTATION, Vol. 57(SUPPL 1) (pp 25-26)
  • Garderet L, Grass L, Koster L, D'Souza A, Estrada N, Parameswaran H, Saber W, Cowan A, Iida M, Shin O , Takamatsu H et al (2022) International differences in baseline characteristics and practice patterns in newly diagnosed multiple myeloma (MM) patients undergoing upfront autologous stem cell transplantation. BONE MARROW TRANSPLANTATION, Vol. 57(SUPPL 1) (pp 44-45)
  • Murrell J, Hill T, State A, Francis S, Pickersgill L, Raza M & Snowden JA (2022) Impact of societal and healthcare infection control measures on incidence of non-sars-2-cov respiratory viral infections in HSCT in-patient admissions; a single uk centre experience. BONE MARROW TRANSPLANTATION, Vol. 57(SUPPL 1) (pp 272-273)
  • Maniusyte R, Pryce A, Pearce R, Snowden JA, Malladi R, Potter V, Lee J, Wilson M, Pawson R & Danby R (2022) Does graft cryopreservation affect the outcomes of allogeneic haematopoietic cell transplants? A UK multicentre case control study during COVID19 pandemic. BONE MARROW TRANSPLANTATION, Vol. 57(SUPPL 1) (pp 97-97)
  • Ros-Soto J, Matthews NC, Burton C, Szydlo R, Alfred A, Andrews R, Anthias C, Mehra V, Potter V, Madrigal A & Snowden JA (2022) Association between vitamin d and GVHD biomarkers with response to immunosuppression and survival in acute GVHD: An exploratory study. BONE MARROW TRANSPLANTATION, Vol. 57(SUPPL 1) (pp 216-216)
  • Kalincik T, Sharmin S, Roos I, Massey J, Sutton I, Withers B, Freedman M, Atkins H, Horakova D, Havrdova EK , Krasulova E et al (2022) Effectiveness of autologous haematopoietic stem cell transplantation in comparison with natalizumab in progressive MS. MULTIPLE SCLEROSIS JOURNAL, Vol. 28(3_SUPPL) (pp 953-954)
  • Kalincik T, Sharmin S, Roos I, Freedman MS, Atkins H, Burman J, Massey J, Sutton I, Withers B, Macdonell R , Grigg A et al (2022) Comparative effectiveness of autologous haematopoietic stem cell transplantation with immune reconstitution therapies in relapsing-remitting MS. MULTIPLE SCLEROSIS JOURNAL, Vol. 28(3_SUPPL) (pp 619-621)
  • Kalincik T, Sharman S, Roos I, Freedman M, Atkins H, Burman J, Massey J, Sutton I, Withers B, Macdonell R , Grigg A et al (2022) Comparative effectiveness of autologous haematopoietic stem cell transplantation vs. fingolimod, ocrelizumab and natalizumab in relapsing-remitting MS. MULTIPLE SCLEROSIS JOURNAL, Vol. 28(3_SUPPL) (pp 11-14)
  • Brittain G, Glover R, Roldan E, Papaioannou D, Cooper C, Muraro P, Snowden J & Sharrack B (2022) A changing target - adapting ongoing autologous haematopoietic stem cell transplantation clinical trials to evolving clinical practice in the treatment of highly active relapsing remitting multiple sclerosis. MULTIPLE SCLEROSIS JOURNAL, Vol. 28(3_SUPPL) (pp 843-843)
  • Lindsay J, Din S, Hawkey C, Hind D, Irving P, Lobo A, Mahida Y, Moran G, Parkes M, Satsangi J , Subramanian S et al (2021) . Gut, Vol. 70(Suppl 4) (pp a4-a4). Virtual conference, 8 November 2021 - 8 November 2021.
  • Cesaro S, Tridello G, Knelange NS, Blijlevens N, Martin M, Snowden JA, Malladi R, Ljungman P, Deconinck E, Gedde-Dahl T , Byrne J et al (2021) . Bone Marrow Transplantation, Vol. 56(7) (pp 1563-1572)
  • Dillon J, Hayden PJ, Eikema D-J, Koster L, Blaise D, Nicholson E, Potter V, Rabin N, Byrne J, Cornelissen J , Chevallier P et al (2021) Trends in Autologous Stem Cell Mobilisation Practices in Myeloma Patients in Ebmt Centers Between 2008 And 2017. BONE MARROW TRANSPLANTATION, Vol. 56(SUPPL 1) (pp 327-328)
  • Scheid C, Eikema D-J, Niittyvuopio R, Maertens J, Passweg J, Blaise D, Byrne J, Kroeger N, Bornhaeuser M, Chevallier P , Bourhis J-H et al (2021) Change In IPSS-R Between Diagnosis And Transplant And Transplant Outcome in Patients With MDS. A Retrospective Analysis From The Chronic Malignancies Working Party. BONE MARROW TRANSPLANTATION, Vol. 56(SUPPL 1) (pp 141-142)
  • Drozd-Sokolowska J, Gras L, Zinger N, Snowden JA, Arat M, Basak G, Pouli A, Crawley C, Wilson KMO, Tilly H , Byrne J et al (2021) Autologous Hematopoietic Cell Transplantation For Relapsed Multiple Myeloma Performed With Stem Cells Re-Mobilised Following A Prior AUTO-HCT - A Retrospective Study on Behalf of EBMT CMWP. BONE MARROW TRANSPLANTATION, Vol. 56(SUPPL 1) (pp 133-134)
  • Schoemans H, Verhoeven B, Bolanos N, Lewis C, Liptrott SJ, Scholl I, Barata A, Johnson P, Buk D, Pretzel D , Van Biezen A et al (2021) One Thousand Voices Address Patient Engagement in Hematopoietic Stem Cell Transplantation And Cell Therapy: Results of A Survey From The EBMT. BONE MARROW TRANSPLANTATION, Vol. 56(SUPPL 1) (pp 160-162)
  • Chabannon C, Terwel S, Hoogenboom JD, Basak G, Corbacioglu S, de la Camara R, Dolstra H, Glass B, Greco R, Lankester A , Mohty M et al (2021) Building of The G0-CAR-T Initiative to Promote Use of Data Collected from Patients Treated With CAR-T Cells AT EU OR EBMT Affiliated Programs. BONE MARROW TRANSPLANTATION, Vol. 56(SUPPL 1) (pp 43-44)
  • Drozd-Sokołowska J, Tridello G, Verheggen I, Karakukcu M, Ben Abdeljelil N, Colita A, Aljurf M, Kröger N, Ozturk G, Passweg J , Gambella M et al (2020) . Bone Marrow Transplantation, Vol. 55(SUPPL 1) (pp 110-112). Virtual, 29 August 2020 - 29 August 2020.
  • Creasey T, Barretta E, Kirkwood A, Schwab C, Patrick P, Clifton-Hadley L, Patel B, Menne T, McMillan A, Morley N , Snowden J et al (2020) Genetic and genomic characterisation of older adults with acute lymphoblastic leukemia treated on the UKALL14 and UKALL60+clinical trials. BRITISH JOURNAL OF HAEMATOLOGY, Vol. 189 (pp 58-58)
  • Jones G, Darby F, Moss R, Vogt K, Skull J, Velikova G, Greenfield D, Bekker H, Mahmoodi N, Snowden J , Yeomanson D et al (2020) Cancer, fertility and me: a NEW fertility preservation patient decision aid to support YOUNG women with breast cancer. BREAST CANCER RESEARCH AND TREATMENT, Vol. 180(2) (pp 578-578)
  • Styczynski J, Tridello G, Knelange N, Veelken JH, Socie G, Mielke S, Neven B, Snowden JA, Dalle J-H, Rubio MT , Crawley C et al (2020) Adenovirus Infections after HCT: Infectious Diseases Working Party Retrospective EBMT Registry Study. BONE MARROW TRANSPLANTATION, Vol. 55(SUPPL 1) (pp 467-468)
  • Das J, Gill A, Lo C, Chan-Lam N, Price S, Wharton S, Jessop H, Sharrack B & Snowden J (2020) Multiple sclerosis-like CNS inflammation following allogeneic haematopoietic stem cell transplantation treated with a 'domino' autologous haematopoietic stem cell transplantation. NEUROLOGY, Vol. 94(15)
  • Morris E, Bigley V, Burns SO, Patel S, Lowe D, Laurence A, Elcombe S, Baxendale H, Uttenthal B, Huissoon A , Sargur R et al (2020) National Health Service England (NHSE) Program for Selection of Adult Primary Immunodeficiency Patients For Allogeneic Haematopoietic Stem Cell Transplantation. BONE MARROW TRANSPLANTATION, Vol. 55(SUPPL 1) (pp 104-105)
  • Bell S, Jessop H, Chantry A, Sharrack B & Snowden J (2020) The use of Autologous Haemopoetic Stem Cell Transplantation (aHSCT) in Multiple Sclerosis after Alemtuzumab Treatment Failure: A Case Series. BONE MARROW TRANSPLANTATION, Vol. 55(SUPPL 1) (pp 227-227)
  • Saccardi R, Badoglio M, Burman J, Helbig G, Innocenti C, Kazmi M, Mancardi GL, Moore J, Muraro P, Sharrack B , Smilowski M et al (2020) Beam vs Cyclophosphamide-Based Conditioning Regimen in Aggressive Multiple Sclerosis: A Retrospective Analysis of European Blood and Marrow Transplantation Society. BONE MARROW TRANSPLANTATION, Vol. 55(SUPPL 1) (pp 37-38)
  • Sharrack B, Snowden J & Muraro P (2020) Autologous stem cell transplantation versus alemtuzumab or ocrelizumab in relapsing remitting multiple sclerosis (starms). MULTIPLE SCLEROSIS JOURNAL, Vol. 26(3_SUPPL) (pp 209-210)
  • Sharrack B, Saccardi R, Alexander T, Manuela B, Burman J, Farge D, Greco R, Jessop H, Kazmi M, Kirgizov K , Labopin M et al (2020) Autologous haematopoietic stem cell transplantation in multiple sclerosis and other immune-mediated neurological diseases: guidelines and recommendations of the European Society for Blood and Marrow Transplantation and the Joint Accreditation Committee of the International Society for Cellular Therapy. NEUROLOGY, Vol. 94(15)
  • Bell S, Snowden J, Jessop H, Das J, Ismail A & Sharrack B (2020) The use of Autologous Haemopoetic Stem Cell Transplantation (AHSCT) in Multiple Sclerosis after Alemtuzumab treatment failure: a case series. NEUROLOGY, Vol. 94(15)
  • Smith R, Snowden J & Akil M (2020) HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN SYSTEMIC SCLEROSIS: SHEFFIELD TEACHING HOSPITALS' EXPERIENCE. RHEUMATOLOGY, Vol. 59
  • Furness CL, Hough R, Cummins M, Murphy G, Ghorashian S, Amrolia P, Roddie C, O'Reilly M, Wynn R, Bonney D , Marks D et al (2020) National Implementation of the use of Tisagenlecleucel in Paediatric and Young Adult Patients with Acute Lymphoblastic Leukaemia (ALL) in National Health Service England (NHSE). BONE MARROW TRANSPLANTATION, Vol. 55(SUPPL 1) (pp 228-229)
  • Sandler RD, Tattersall RS, Schoemans H, Greco R, Badoglio M, Labopin M, Alexander T, Kirgizov K, Rovira M, Saif M , Saccardi R et al (2020) Diagnosis and Management of Secondary HLH/MAS following HSCT and CAR-t Cell Therapy in Adults; An EBMT-wide Survey on Behalf of the ADWP and TCWP. BONE MARROW TRANSPLANTATION, Vol. 55(SUPPL 1) (pp 582-583)
  • Puyade M, Patel A, Lim YL, Blank N, Badoglio M, Gualandi F, Ma D, Maximova N, Alexander T & Snowden J (2020) Autologous Stem Cell Transplantation in Behcet′s Disease: A Retrospective Study. BONE MARROW TRANSPLANTATION, Vol. 55(SUPPL 1) (pp 224-225)
  • Devillier R, Eikema D-J, Bosman P, Dufour C, Aljurf M, Wu D, Maschan A, Afanasyev B, Veelken JH, Collin M , Snowden J et al (2020) GVHD and Relapse Free Survival (GRFS) After Allogeneic Transplantation for Idiopathic Severe Aplastic Anemia: An Analysis from the Saawp Data Quality Initiative Program of EBMT. BONE MARROW TRANSPLANTATION, Vol. 55(SUPPL 1) (pp 34-35)
  • Laurent C, Marjanovic Z, Ricard L, Henes J, Dulery R, Badoglio M, Farge D, Snowden J, Moraes D, Dias J , Mohty M et al (2020) Outcome of Autologous Hematopoietic Stem Cell Transplantation for Refractory Takayasu Arteritis, A Retrospective Survey from the Autoimmune Diseases Working Party (ADWP) of the Ebmt. BONE MARROW TRANSPLANTATION, Vol. 55(SUPPL 1) (pp 226-227)
  • Lum SH, Samarasinghe S, Wynn R, Eikeman D-J, Bosman P, Aksoylar S, Ghavamzadeh A, Bierings M, Bertrand Y, Kitra-Roussou V , Smiers F et al (2020) Outcome of Haematopoietic Cell Transplantation in Children with Fanconi Anaemia: A Study on Behalf of the EBMT SAAWP and PDWP. BONE MARROW TRANSPLANTATION, Vol. 55(SUPPL 1) (pp 35-36)
  • Soto JR, Snowden JA, Szydlo R, Nicholson E, Madrigal A, Easdale S, Ethell M, Potter M & Anthias C (2020) Donor Factors Influence Outcomes of Patients Receiving Donor Lymphocyte Infusion for Mixed Chimerism after Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation. BONE MARROW TRANSPLANTATION, Vol. 55(SUPPL 1) (pp 551-551)
  • Dignan F, Hamblin A, Chong A, Perry J, Kenyon M, Miller P, Gilleece M, Hunter H & Snowden J (2020) Survivorship Care for Allogeneic Transplant Patients in The UK: Current Service Provision and Barriers to Implementation. BONE MARROW TRANSPLANTATION, Vol. 55(SUPPL 1) (pp 618-619)
  • Puyade M, Amit P, Lim YJ, Blank N, Badoglio M, Gualandi F, Ma DD, Greco A, Maximova N, Alexander T & Snowden JA (2020) Autologous Hematopoietic Stem Cell Transplantation for Behcet's Disease: A Retrospective Survey of Patients Treated in Europe, on the Behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Bone Marrow Transplantation. ARTHRITIS & RHEUMATOLOGY, Vol. 72
  • Sanichar M, Claire M, Collins N, Roche L, Snowden J, Whittle R & Key T (2020) THE CLINICAL IMPACT OF PERMISSIVE AND NON-PERMISSIVE HLA-DPB1 MISMATCHES IN HAEMOPOIETIC STEM CELL TRANSPLANTATION, A RETROSPECTIVE STUDY. HLA, Vol. 95(4) (pp 394-394)
  • Thorpe A, Kass-Iliyya L, Jessop H, Chantry A, Hadjivassiliou M, Snowden J & Sharrack B (2019) . Neurology, Vol. 92(15_supplement)
  • Styczynski J, Tridello G, Gil L, Ljungman P, Mikulska M, van der Werf S, Knelange N, Averbuch D, Socie G, Veelken H , Dalle J-H et al (2019) Donor EBV-positive serostatus increases the risk of chronic GVHD in patients with non-malignant hematological disorders: Infectious diseases working party EBMT study. BONE MARROW TRANSPLANTATION, Vol. 54 (pp 400-401)
  • Greco R, Labopin M, Badoglio M, Veys P, Silva J, Abinun M, Gualandi F, Bornhauser M, Ciceri F, Saccardi R , Lankester A et al (2019) Allogeneic hsct for autoimmune diseases: A retrospective study from the ebmt autoimmune diseases, inborn errors and paediatric working parties. BONE MARROW TRANSPLANTATION, Vol. 54 (pp 33-34)
  • Shouval R, Fein JA, Labopin M, Duarte RF, Corbacioglu S, Bader P, Chabannon C, Kuball J, Basak G, de Latour RP , Lankeste A et al (2019) Young HLA-matched unrelated donors are comparable to matched sibling donors in elderly patients receiving reduced-intensity conditioning: an analysis on behalf of the EBMT scientific council. BONE MARROW TRANSPLANTATION, Vol. 54 (pp 602-603)
  • Burt R, Balabanov R, Snowden J, Sharrack B, Oliveira MC, Nelson F & Burman J (2019) HSCT treatment for multiple sclerosis: Results from the MIST trial. EUROPEAN JOURNAL OF NEUROLOGY, Vol. 26 (pp 978-978)
  • Sharrack B & Snowden J (2019) Autologous haematopoietic stem cell transplantation for severe treatment resistant autoimmune diseases. HUMAN GENE THERAPY, Vol. 30(8) (pp A5-A5)
  • Henes J, Oliveira MC, Labopin M, Badoglio M, Scherer HU, Del Papa N, Daikeler T, Schmalzing M, Schroers R, Martin T , Pugnet G et al (2019) Baseline Skin Score, Older Age and CD34-selection Influence the Outcome of Autologous Stem Cell Transplantation for Systemic Sclerosis - Results of a Prospective Non-interventional Study from the European Society for Blood & Marrow Transplantation (EBMT). ARTHRITIS & RHEUMATOLOGY, Vol. 71
  • Greenfield DM, Salooja N, Peczynski C, van der Werf S, Schoemans H, Hill K, Cortelezzi A, Lupo Stanghellini MT, Ozkurt ZN, Arat M , Metzner B et al (2018) . Blood, Vol. 132(Supplement 1) (pp 251-251)
  • Cook G, Parrish C, Yong K, Cavenagh J, Snowden JA, Drayson MT, Garg M, Cairns D, Ashcroft J, Striha A , Hockaday A et al (2018) . Blood, Vol. 132(Supplement 1) (pp 255-255)
  • Farge D, Snowden JA, Badoglio M, Labopin M, Scherer HU, Del Papa N, Kanz L, Schmalzing M, Martin T, Rovira M , Daikeler T et al (2018) . Blood, Vol. 132(Supplement 1) (pp 3431-3431)
  • Lawless S, Iacobelli S, Knelange N, Chevallier P, Blaise D, Milpied N-J, Foà R, Cornelissen JJ, Lioure B, Potter V , Poire X et al (2018) . Blood, Vol. 132(Supplement 1) (pp 3425-3425)
  • Alexander T, Samuelson C, Daikeler T, Henes J, Skagerlind L, Akil M, Ehninger G, Jantunen E, Farge D & Snowden J (2018) . Annals of the Rheumatic Diseases, Vol. 77 (pp 1128-1128)
  • Das J, Snowden J, Mistry S, Jessop H, Bell S & Sharrack B (2018) . Neurology, Vol. 90(15_supplement)
  • Burt RK, Balabanov R, Snowden JA, Sharrack B, Oliveira MC & Burman J (2018) . Neurology, Vol. 90(15_supplement)
  • Styczynski J, Tridello G, Koster L, Iacobelli S, van Biezen A, van der Werf S, Mikulska M, Gil L, Cordonnier C, Ljungman P , Averbuch D et al (2018) Lethal infectious complications after hematopoietic stem cell transplantation: progress and challenges in Infectious Diseases Working Party study. BONE MARROW TRANSPLANTATION, Vol. 53 (pp 94-95)
  • Morley N, Snowden J, Pearce R, Perry J, Paul R, Kirkland K, Lambert J, Malladi R & Peniket A (2018) BEAM versus LEAM conditioning chemotherapy for autologous transplantation in lymphoma. A retrospective study from the BSBMT. BONE MARROW TRANSPLANTATION, Vol. 53 (pp 258-258)
  • Raj K, Protheroe R, Smith M, Gilleece M, Snowden JA, Uttenthal B, Irvine D, Collin M, Paneesha S, Salim R , Tholouli E et al (2018) Peripheral blood stem cell RIC haploidentical transplantation low incidence of GVHD and non relapse mortality: Preliminary results from the prospective phase II UK Haplo study. BONE MARROW TRANSPLANTATION, Vol. 53 (pp 752-754)
  • Shouval R, Fein J, Labopin M, Kroger N, Duarte RF, Bader P, Bonini C, Kuball J, Basak G, Dufour C , Lankester A et al (2018) Should Donor Selection be Driven by Disease Risk? A Retrospective Analysis of the EBMT Registry on Behalf of the Acute Leukemia Working Party. BONE MARROW TRANSPLANTATION, Vol. 53 (pp 135-136)
  • Chalandon Y, Sbianchi G, Hoek J, Apperley J, Itala-Remes M, Markiewicz M, Byrne J, Sengeloev H, Chaudri N, Malladi R , Remenyi P et al (2018) Allogeneic stem cell transplantation in patients with CML-CP in the era of third generation tyrosine kinase inhibitors: a study by the CMWP of the EBMT. BONE MARROW TRANSPLANTATION, Vol. 53 (pp 45-46)
  • Samuelson C, Alexander T, Daikeler T, Badoglio M, Henes J, Akil M, Skagerlind L, Ehninger G, Jantunen E, Farge D & Snowden JA (2018) Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Anti-Neutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis (AAV): Results of a EBMT Retrospective Survey. BONE MARROW TRANSPLANTATION, Vol. 53 (pp 203-204)
  • Das J, Snowden J, Mistry S, Jessop H, Bowman M, Ismail A, Bell S, Freedman M, Atkins H, Burman J & Sharrack B (2018) The use of Autologous Haematopoietic Stem Cell Transplantation in treatment naive patients with severe multiple sclerosis. BONE MARROW TRANSPLANTATION, Vol. 53 (pp 38-39)
  • Henes J, Oliveira MC, Labopin M, Badoglio M, Scherer HU, Del Papa N, Daikeler T, Schmalzing M, Schroers R, Martin T , Pugnet G et al (2018) Autologous Stem cell transplantation for progressive systemic sclerosis: an EBMT Autoimmune Disease Working Party prospective non-interventional approach. BONE MARROW TRANSPLANTATION, Vol. 53 (pp 37-38)
  • Ward KN, Ljungman P, Hoek J, Finke J, Niederwieser D, Einsele H, Fegueux N, Angel Diaz M, Maria Fernandez J, Menard A-L , Collin M et al (2018) Infectious Diseases Working Party Retrospective Study on HHV-6 encephalitis: clinical characteristics and outcome after allogeneic HSCT. BONE MARROW TRANSPLANTATION, Vol. 53 (pp 565-566)
  • Snowden J, Keen C, Smith L, Skilbeck J, Ross H, Collins K, Simpson S, Dixey J, Walters S, Greenfield D & Mawson S (2018) Is it feasible to conduct a randomised controlled trial of pre-habilitation in multiple myeloma (MM) patients awaiting autologous haematopoietic stem-cell transplantation (AHSCT)? The PREeMPT study. BONE MARROW TRANSPLANTATION, Vol. 53 (pp 343-344)
  • Greenfield D, Snowden J, Morley N, Wright J, Evans C & DeSilva T (2018) Vaccine preventable diseases: a clinical evaluation of antibody reconstitution after autologous HCT. BONE MARROW TRANSPLANTATION, Vol. 53 (pp 381-382)
  • Das J, Snowden J, Burman J, Freedman M, Atkins H, Bowman M, Burt R, Sarccardi R, Innocenti C, Mistry S , Bell S et al (2018) The use of autologous haematopoietic stem cell transplantation as a first line disease modifying therapy in patients with 'aggressive' multiple sclerosis.. MULTIPLE SCLEROSIS JOURNAL, Vol. 24 (pp 87-88)
  • Jones GL, Vogt K, Darby F, Mahmoodi N, Hughes J, Greenfield D, Skull J, Lane S, Brauten-Smith G, Yeomanson D , Baskind NE et al (2018) Experience of developing and evaluating a fertility preservation patient decision aid for teenage and adult women with cancer for use in oncology settings, UK (The Cancer, Fertility and Me study). PSYCHO-ONCOLOGY, Vol. 27 (pp 45-45)
  • Chalandon Y, Sbianchi G, Hoek J, Apperley J, Itala-Remes M, Markiewicz M, Byrne J, Sengeloev H, Chaudri N, Malladi R , Remenyi P et al (2018) Allogeneic stem cell transplantation in patients with CML-CP in the era of third generation tyrosine kinase inhibitors: a study by the CMWP of the EBMT. SWISS MEDICAL WEEKLY, Vol. 148 (pp 4S-4S)
  • Raj K, Protheroe R, Smith M, Gilleece M, Snowden J, Uttenthal B, Irvine D, Collin M, Paneesha S, Salim R , Tholouli E et al (2018) Peripheral blood stem cell RIC haploidentical stem cell transplantation low TRM, low rates of GVHD: Preliminary results from the prospective Phase II single arm UK Haplo study (Bloodwise: 11034). BRITISH JOURNAL OF HAEMATOLOGY, Vol. 181 (pp 13-13)
  • Brierley C, Castilla-Llorente C, Labopin M, Badoglio M, Rovira M, Ricart E, Dierickx D, Vermeire S, Hasselblatt P, Finke J , Onida F et al (2018) Autologous haematopoietic stem cell transplantation for Crohn's disease: a retrospective study from the European Society for Blood & Marrow Transplantation (EBMT) Autoimmune Diseases Working Party. JOURNAL OF CROHNS & COLITIS, Vol. 12 (pp S14-S15)
  • Snowden J, Panes J, Alexander T, Allez M, Ardizzone S, Dierickx D, Finke J, Hasselblatt P, Hawkey C, Kazmi M , Lindsay J et al (2018) ECCO-EBMT joint paper: autologous haematopoietic stem cell transplantation (AHSCT) in severe Crohn's disease: Summary of the ECCO-EBMT joint review. JOURNAL OF CROHNS & COLITIS, Vol. 12 (pp S70-S71)
  • Miller PDE, de Silva T, Leonard H, Goddard K, Anthias C, Hoschler K, Peggs K, Madrigal A & Snowden JA (2017) . Bone Marrow Transplantation, Vol. 52(Suppl 1) (pp S269-S270). Marseille, France, 26 March 2017 - 26 March 2017.
  • Ismail A, Hickman S, Paling D, Phelan J, Havercroft J, Webster S, Alexander HJ, Snowden J & Sharrack B (2017) . Neurology, Vol. 88(16_supplement)
  • Passweg JR, Baldomero H, Bader P, Bonini C, Duarte RF, Dufour C, Gennery A, Kroeger N, Kuball J, Lanza F , Montoto S et al (2017) Use of haploidentical stem cell transplantation continues to increase, the 2015 European society for blood and marrow transplant activity survey report. BONE MARROW TRANSPLANTATION, Vol. 52 (pp S191-S192)
  • Brierley C, Castilla-Llorente C, Labopin M, Badoglio M, Rovira M, Ricart E, Dierickx D, Vermeire S, Hasselblatt P, Finke J , Onida F et al (2017) Autologous haematopoietic stem cell transplantation (AHSCT) for Crohn's disease (CD): A retrospective study of outcomes from the EBMT autoimmune diseases working party (ADWP). BONE MARROW TRANSPLANTATION, Vol. 52 (pp S418-S418)
  • Domingo-Domenech E, Boumendil A, Climent F, Sengeloev H, Ljungman P, Wattad M, Arat M, Finel H, Schaap M, Ganser A , Yeshurun M et al (2017) Autologous stem cell transplantation for systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT. BONE MARROW TRANSPLANTATION, Vol. 52 (pp S440-S440)
  • Shouval R, Fein J, Labopin M, Kroger N, Duarte RF, Bader P, Bonini C, Dreger P, DuFour C, Gennery A , Kuball J et al (2017) Application of the disease risk index for risk stratification of allogeneic hematopoietic stem cell transplantation in a large cohort of the European Society for Blood and Marrow Transplantation (EBMT). BONE MARROW TRANSPLANTATION, Vol. 52 (pp S12-S13)
  • Kuehl J-S, Snowden J, Aubourg P, Koehler W & Arnold R (2017) HSCT for adult cerebral adrenoleukodystrophy. BONE MARROW TRANSPLANTATION, Vol. 52 (pp S120-S120)
  • Mapplebeck C, Sharrack B, Kaur H, Ezaydi Y, Jessop H, Pickersgill L, Scott L, Raza M & Snowden JA (2017) EBV and CMV reactivation following autologous haematopoietic stem cell transplantation (HSCT) for autoimmune neurological diseases resolves spontaneously and rarely requires treatment. BONE MARROW TRANSPLANTATION, Vol. 52 (pp S419-S419)
  • Greco R, Labopin M, Badoglio M, Veys P, Silva J, Abinun M, Gualandi F, Bornhauser M, Ciceri F, Tobias A , Gennery A et al (2017) Allogeneic HSCT for autoimmune diseases: a retrospective study from the EBMT autoimmune diseases, inborn errors and paediatric working parties. BONE MARROW TRANSPLANTATION, Vol. 52 (pp S42-S42)
  • Tappenden P, Wang Y, Burman J, Kazmi M, Saccardi R, Bermejo I, Harvey R, Badoglio M, Farge D, Sharrack B & Snowden J (2017) Evaluating the cost-effectiveness of autologous haematopoietic stem cell transplantation (aHSCT) versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison (MAIC). BONE MARROW TRANSPLANTATION, Vol. 52 (pp S41-S41)
  • Morley N, Kirkwood A, Moorman A, Clifton-Hadley L, Rowntree C, Wrench B, Marwood E, Patrick P, Snowden J, Rijneveld A , Marks D et al (2017) RESULTS FROM UKALL60+, A UK/HOVON COLLABORATIVE PHASE 2 STUDY IN ELDERLY PATIENTS WITH UNTREATED ACUTE LYMPHOBLASTIC LEUKAEMIA. HAEMATOLOGICA, Vol. 102 (pp 31-32)
  • Galleu A, Deplano S, Szydlo R, Milojkovic D, Bradshaw A, Wynn R, Marks D, Richardson D, Orchard K, Kanfer E , Tholouli E et al (2017) MESENCHYMAL STROMAL CELLS FOR THE TREATMENT OF STEROID-RESISTANT ACUTE GRAFT VERSUS HOST DISEASE: FACTORS INFLUENCING CLINICAL RESPONSES. HAEMATOLOGICA, Vol. 102 (pp 336-337)
  • Ismail A, Hickman S, Paling D, Phelan J, Havercroft J, Webster S, Alexander HJ, Snowden J & Sharrack B (2017) The impact of the BBC Panorama television programme on public awareness of autologous haematopoietic stem cell transplantation (AHSCT) for patients with multiple sclerosis. NEUROLOGY, Vol. 88
  • Shouval R, Fein J, Labopin M, Kroger N, Duarte RF, Bader P, Bonini C, Dreger P, DuFour C, Gennery A , Kuball J et al (2016) . Blood, Vol. 128(22) (pp 988-988)
  • Olavarria E, Schleuning M, Iacobelli S, Hoek J, Blok H-J, Aljurf M, Afanasyev BV, Volin L, Sengeloev H, Masszi T , Passweg J et al (2016) . Blood, Vol. 128(22) (pp 628-628)
  • Lawless S, Simona I, van Biezen A, Koster L, Chevallier P, Blaise D, Foà R, Tabrizi R, Schaap NPM, Lenhoff S , Russell NH et al (2016) . Blood, Vol. 128(22) (pp 2293-2293)
  • Cook G, Carter CR, Brock K, McQuaker G, Snowden JA, Crawley C, Hunter H, Cavenagh JD, Lobb M, Cullen K , Hodgkinson A et al (2016) . Blood, Vol. 128(22) (pp 4585-4585)
  • Gagelmann N, Iacobelli S, Koster L, Nahi H, Stoppa A-M, Masszi T, Caillot D, Lenhoff S, Udvardy M, Crawley C , Arcese W et al (2016) . Blood, Vol. 128(22) (pp 2266-2266)
  • Bell S, Kelsey P, Jessop H, Snowden J & Sharrack B (2016) The Use of Autologous Haemopoietic Stem Cell Transplantation in Treating Patients with Rapidly Evolving Severe Multiple Sclerosis. NEUROLOGY, Vol. 86
  • Bell S, Kelsey P, Jessop H, Snowden J & Sharrack B (2016) . Neurology, Vol. 86(16_supplement)
  • Veys P, Danby R, Vora A, Slatter M, Wynn R, Lawson S, Steward C, Gibson B, Potter M, de la Fuente J , Shenton G et al (2016) . British Journal of Haematology, Vol. 172(3) (pp 482-486)
  • Morley N, Kirkwood A, Moorman A, Smith P, Rowntree C, Wrench B, Marwood E, Patrick P, Snowden J, Rijneveld A , Marks D et al (2016) INITIAL RESULTS FROM UKALL60+, A UK/HOVON COLLABORATIVE PHASE 2 STUDY IN ELDERLY PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA. HAEMATOLOGICA, Vol. 101 (pp 34-34)
  • Mohammed MK, Snowden J, Rosario DJ & Munir M (2016) High dose melphalan and autologous stem cell transplantation following urinary bladder reconstruction with ileum: Measures to minimise mucositis. BRITISH JOURNAL OF HAEMATOLOGY, Vol. 173 (pp 178-178)
  • Cook G, Williams C, Cairns DA, Hockaday A, Cavenagh JD, Snowden JA, Parrish C, Yong K, Cavet J, Hunter H , Bird JM et al (2016) A salvage autologous stem cell transplant (ASCT2) induces superior overall survival following bortezomib-containing re-induction therapy for relapsed multiple myeloma (MM): Results from the Myeloma X (Intensive) Trial. BRITISH JOURNAL OF HAEMATOLOGY, Vol. 173 (pp 5-6)
  • Samuelson CV, Griffin M, Welch E, Went R, Kaul S, Ng JP, Barker H & Snowden JA (2016) Mortality within 30 days of systemic anticancer therapy (SACT) - results of a multi-site audit following the NCEPOD model in the South Yorkshire region. BRITISH JOURNAL OF HAEMATOLOGY, Vol. 173 (pp 34-34)
  • Ahmedzai SH, Snowden JA, Cox A, Cairns DA, Williams C, Hockaday A, Cavenagh JD, Parrish C, Yong K, Cavet J , Hunter H et al (2016) Balancing therapeutic impact of treatment strategies with quality of life and pain experience in multiple myeloma: New insights into influence of genetic variants. BRITISH JOURNAL OF HAEMATOLOGY, Vol. 173 (pp 132-133)
  • Ashcroft AJ, Cairns DA, Williams C, Hockaday A, Cavanagh JD, Snowden JA, Parrish C, Yong K, Cavet J, Hunter H , Bird JH et al (2016) Outcomes following salvage autologous stem cell transplant (ASCT2) vs low dose alkylating consolidation (non-transplant consolidation NTC) therapy following bortezomib-containing re-induction for relapsed multiple myeloma (MM) may be dependent on age and symptomatic status initiation of re-induction: Results from the Myeloma X (Intensive) Trial. BRITISH JOURNAL OF HAEMATOLOGY, Vol. 173 (pp 165-165)
  • Miller PDE, de Silva T, Skinner R, Gilleece M, Peniket A, Hamblin A, Greenfield D, Anthias C, Peggs K, Madrigal A & Snowden JA (2016) Routine Vaccination Programme (RVP) Practice after Adult and Paediatric Allogeneic Haematopoietic Stem Cell Transplant (HSCT): A British Society of Blood and Marrow Transplantation (BSBMT) Survey of UK NHS-Based Programmes. BONE MARROW TRANSPLANTATION, Vol. 51 (pp S400-S401)
  • Holbro A, Baldomero H, Buser A, Chabannon C, Lanza F, Snowden J, Worel N, Sureda A, Badoglio M, Passweg J & Bonini C (2016) Graft storage and disposal policies in a large group of european centers: a survey by the cellular therapy and immunobiology working party (CTIWP) of the European Group For Blood And Marrow Transplantation (EBMT). BONE MARROW TRANSPLANTATION, Vol. 51 (pp S50-S51)
  • Lawless S, Iacobelli S, van Biezen A, Koster L, Chevallier P, Blaise D, Foa R, Tabriz R, Schaap N, Lenhoff S , Russell N et al (2016) Comparison of Haematopoietic Stem Cell Transplantation Approaches in Primary Plasma Cell Leukaemia. BONE MARROW TRANSPLANTATION, Vol. 51 (pp S18-S19)
  • Samarasinghe S, Iacobelli S, Knol C, Hamladji R-M, Socie G, Aljurf M, Koh M, Sengeloev H, Dalle J-H, Robinson S , Bacigalupo A et al (2015) . Blood, Vol. 126(23) (pp 1210-1210)
  • Guillaume-Jugnot P, Marjanovic Z, Labopin M, Terriou L, Deligny C, Lioure B, Martin T, Leblond V, Pugnet G, Blaise D , Peffault de Latour R et al (2015) . Blood, Vol. 126(23) (pp 1985-1985)
  • Ashcroft J, Cairns DA, Williams C, Hockaday A, Cavenagh JD, Snowden JA, Parrish C, Yong KL, Cavet J, Hunter H , Bird J et al (2015) . Blood, Vol. 126(23) (pp 1981-1981)
  • Ahmedzai SH, Snowden JA, Cox A, Cairns DA, Williams CD, Hockaday A, Cavenagh J, Parrish C, Yong KL, Cavet J , Hunter H et al (2015) . Blood, Vol. 126(23) (pp 3180-3180)
  • Kelsey P, Bell SM, Jessop H, Snowden JA & Sharrack B (2015) . Journal of Neurology, Neurosurgery & Psychiatry, Vol. 86(11) (pp e4.116-e4)
  • Cook G, Williams C, Cairns DA, Hockaday A, Cavenagh J, Snowden JA, Parrish C, Yong KL, Cavet J, Hunter H , Bird J et al (2015) ASCT2A Salvage Autologous Stem Cell Transplant (ASCT2) Induces Superior Overall Survival Following Bortezomib-Containing Re-Induction Therapy for Relapsed Multiple Myeloma (MM): Results from the Myeloma X (Intensive) Trial. BLOOD, Vol. 126(23)
  • Snowden J, Badoglio M & Farge D (2015) EBMT Autoimmune Diseases Working Party (ADWP) Database: Activity 1994-2014. BONE MARROW TRANSPLANTATION, Vol. 50 (pp S112-S112)
  • Greenfield D, Snowden J, Schoemans H, Hill K, Annaloro C, Lupo-Stanghellini MT, Aki Z, Arat M, Metzner B, Turlure P , Han T et al (2015) Metabolic syndrome is common following haematopoietic cell transplantation (HCT) and is associated with increased cardiovascular disease: an EBMT cross-sectional non-interventional study. BONE MARROW TRANSPLANTATION, Vol. 50 (pp S89-S90)
  • Cesaro S, Tridello G, Volin L, Craddock C, Michallet M, Schaap N, Cornelissen J, Ljungman P, Hunter A, Maertens J , Russell N et al (2015) A retrospective IDWP-ALWP study on Candida infections in allogeneic haematopoietic stem cell transplant patients. BONE MARROW TRANSPLANTATION, Vol. 50 (pp S32-S33)
  • Collins N, Whittle R, Robertson K, Lunn R, Sills K, Bloor A, Snowden J & Key T (2015) CD34+count and not total nucleated cell count has impact on OS in adult dUCBT. BONE MARROW TRANSPLANTATION, Vol. 50 (pp 5566-5567)
  • Clay J, Kelsey P, Bell S, Lim C, Helen J, Nicholas R, Silber E, Malik O, Brex P, Muraro P , Sharrack B et al (2015) Autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a UK cohort from two centres. BONE MARROW TRANSPLANTATION, Vol. 50 (pp S61-S61)
  • Meiring J, De Silva T & Snowden J (2015) A study of adherence to a vaccination schedule following adult allogenic haematopoietic stem cell transplants in UK transplant centre. BONE MARROW TRANSPLANTATION, Vol. 50 (pp S203-S204)
  • Greenfield D, Shanklin V & Snowden J (2015) Implementing International HCT Late Effects Screening Guidelines in Clinical Practice: Outcomes. BONE MARROW TRANSPLANTATION, Vol. 50 (pp S210-S210)
  • Hamblin A, Greenfield D, Gilleece M, Salooja N, Kenyon M, Morris E, Glover N, Miller P, Braund H, Peniket A , Shaw B et al (2015) Provision of Long-term Monitoring and Late Effects Services Following Allogeneic HSCT in Adults: A British Society of Blood and Marrow Transplantation (BSBMT) Survey of UK NHS-Based Programmes. BONE MARROW TRANSPLANTATION, Vol. 50 (pp S91-S92)
  • Thomas SJ, Fisher K, Brown S, Snowden JA, Danson S & Zeidler M (2014) . Blood, Vol. 124(21) (pp 4577-4577)
  • Oliveira MC, Labopin M, Henes J, Moore J, Del Papa N, Stanciu R, Sakellari I, Schroers R, Scherer HU, Kyrcz-Krzemien S , Daikeler T et al (2014) . Blood, Vol. 124(21) (pp 2517-2517)
  • Veys P, Danby R, Vora A, Slatter M, Wynn R, Lawson S, Steward C, Gibson B, Potter M, de la Fuente J , Shenton G et al (2014) UK EXPERIENCE OF UNRELATED CORD BLOOD TRANSPLANTATION IN PAEDIATRIC PATIENTS. BONE MARROW TRANSPLANTATION, Vol. 49 (pp S359-S359)
  • Snowden J, Marjanovic Z, Badoglio M, Saccardi R & Farge D (2014) EVOLUTION, TRENDS AND LONG TERM OUTCOMES IN HAEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) IN AUTOIMMUNE DISEASES (ADS): A RETROSPECTIVE STUDY FROM THE AUTOIMMUNE DISEASES WORKING PARTY (ADWP) OF THE EBMT 1996-2013. BONE MARROW TRANSPLANTATION, Vol. 49 (pp S43-S43)
  • Snowden J, Danby R, Ruggeri A, Marks D, Hough R, Pagliuca A, Potter M, Russell N, Craddock C, Clark A , Miller P et al (2014) UK EXPERIENCE OF UNRELATED CORD BLOOD TRANSPLANTATION (UCBT) IN ADULTS: A RETROSPECTIVE ANALYSIS ON BEHALF OF EUROCORD AND THE BRITISH SOCIETY OF BLOOD AND MARROW TRANSPLANTATION (BSBMT). BONE MARROW TRANSPLANTATION, Vol. 49 (pp S233-S234)
  • Parrish C, Morris T, Williams C, Cairns D, Cavenagh J, Snowden JA, Ashcroft J, Cavet J, Hunter H, Bird JM , Chalmers A et al (2014) STEM CELL HARVESTING AFTER RE-INDUCTION WITH A BORTEZOMIB-BASED REGIMEN FOR MULTIPLE MYELOMA RELAPSING AFTER AUTOLOGOUS STEM CELL TRANSPLANT IS FEASIBLE, SAFE AND EFFECTIVE: RESULTS FROM THE BSBMT/UKMF MYELOMA X (INTENSIVE) TRIAL. BONE MARROW TRANSPLANTATION, Vol. 49 (pp S73-S74)
  • Snowden J, Badoglio M & Farge D (2014) UPDATE OF THE ACTIVITY OF THE EBMT AUTOIMMUNE DISEASES WORKING PARTY (ADWP). BONE MARROW TRANSPLANTATION, Vol. 49 (pp S95-S96)
  • Cook G, Williams C, Cairns DA, Chalmers A, Cavenagh J, Snowden J, Parrish C, Ashcroft J, Yong K, Cavet J , Hunter H et al (2014) SUPERIOR DURABILITY OF RESPONSE WHEN A SECOND AUTOLOGOUS STEM CELL TRANSPLANT CONSOLIDATES BORTEZOMIB-CONTAINING RE-INDUCTION THERAPY FOR RELAPSED MULTIPLE MYELOMA (MM): FINAL RESULTS FROM THE BSBMT/UKMF MYELOMA X (INTENSIVE) TRIAL. BONE MARROW TRANSPLANTATION, Vol. 49 (pp S72-S72)
  • Ashcroft J, De Tute RM, Cairns DA, Fletcher M, Owen RG, Williams C, Cavanagh JD, Snowden JA, Rawstron AC, Parrish C , Morris TCM et al (2014) MINIMAL RESIDUAL DISEASE (MRD) ASSESSMENT IN POST-FIRST RELAPSE RE-INDUCTION IS PREDICTIVE FOR TIME TO PROGRESSION (TTP): RESULTS FROM THE BSBMT/UKMF MULTIPLE MYELOMA (MM) X INTENSIVE TRIAL. BONE MARROW TRANSPLANTATION, Vol. 49 (pp S79-S80)
  • Sezer O, Beksac M, Hajek R, Sucak G, Cagirgan S, Linkesch W, Akay OM, Armbrecht G, Plesner T, Snowden JA , Nahi H et al (2014) EFFECTS OF SINGLE-AGENT BORTEZOMIB (BTZ) AS POST-TRANSPLANT CONSOLIDATION ON MULTIPLE MYELOMA (MM)-RELATED BONE DISEASE: FIRST RESULTS FROM A MULTICENTER, RANDOMIZED PHASE 2 STUDY. HAEMATOLOGICA, Vol. 99 (pp 362-362)
  • Parrish C, Morris TCM, Williams C, Cairns DA, Cavenagh J, Snowden JA, Ashcroft J, Cavet J, Hunter H, Bird JM , Chalmers A et al (2014) Stem cells harvested after bortezomib-based re-induction for multiple myeloma relapsing after autologous stem cell transplant (ASCT) and those stored from first induction yield equal outcomes: results from the BSBMT/UKMF Myeloma X (Intensive) Trial. BRITISH JOURNAL OF HAEMATOLOGY, Vol. 165 (pp 62-63)
  • Owen RG, DeTute DM, Ashcroft AJ, Cairns DA, Fletcher M, Williams C, Cavenagh JD, Snowden JA, Rawstron AC, Parrish C , Morris TC et al (2014) The utility of minimal residual disease (MRD) assessment in post-first relapse re-induction: results from the BSBMT/UKMF Myeloma X (intensive) Trial. BRITISH JOURNAL OF HAEMATOLOGY, Vol. 165 (pp 65-66)
  • Morris TCM, Williams C, Bell S, Flrtcher M, Szubert A, Yong K, Cavet J, Cavenagh J, Snowden J, Ashcroft J , Brown J et al (2013) BSBMT/UKMF Myeloma X Relapse (intensive) Trial - challenges in recruitment and randomisation. BRITISH JOURNAL OF HAEMATOLOGY, Vol. 161 (pp 52-52)
  • Cook G, Williams C, Szubert A, Yong K, Cavet J, Hunter H, Bird J, Bell S, O'Connor S, Cavenagh J , Snowden J et al (2013) A second autologous stem cell transplant induces superior response durability following bortezomib-containing re-induction therapy for relapsed multiple myeloma: results from the BSBMT/UKMF myeloma x (intensive) trial. BONE MARROW TRANSPLANTATION, Vol. 48 (pp S17-S17)
  • Morris C, Williams C, Bell S, Fletcher M, Szubert A, Yong K, Covet J, Cavenagh J, Snowden J, Ashcroft J , Brown J et al (2013) BSBMT/UKMF myeloma X relapse (intensive) trial: barriers to recruitment and randomization. BONE MARROW TRANSPLANTATION, Vol. 48 (pp S210-S211)
  • Browett K, Tridente A, Hall J, Sorour Y, Snowden J, Mills GH & Webber S (2013) Mortality predictors in patients with haematological malignancies admitted to critical care. BRITISH JOURNAL OF ANAESTHESIA, Vol. 110(5) (pp 862-863)
  • Douglas KW, Hayden P, Hunter H, Johnson P, Malladi R, Paneesha S, Pawson R, Quinn M, Raj K, Richardson D , Robinson S et al (2013) Use of plerixafor to rescue absolute and predicted mobilization failures: a UK and Ireland consensus. BONE MARROW TRANSPLANTATION, Vol. 48 (pp S112-S113)
  • Stradwick S, Freemantle N, Snowden J, Rodrigues F & Brereton N (2012) Comparative Effectiveness of Lenalidomide Plus Dexamethasone for the Treatment of Refractory/Relapsed Multiple Myeloma: A Systematic Review and Mixed Treatment Comparison. BLOOD, Vol. 120(21)
  • Alix J, Blackburn D, Sokhi D, Dalley C, Jessop H, Sharrack B & Snowden J (2012) Pulse high-dose cyclophosphamide in malignant multiple sclerosis may result in successful functional recovery and stem cell mobilisation to enable safe delivery of AHSCT. BONE MARROW TRANSPLANTATION, Vol. 47 (pp S227-S228)
  • Hummel S, Snowden J, Nield A, McGoldrick R, Harrison S, Swanborough F, Davis J, Goddard Y, Ward S, Ezaydi Y , Morley N et al (2012) Predicting increases in bed capacity for haematopoietic stem cell transplantation or intensive chemotherapy through simulation modelling of ambulatory care. BONE MARROW TRANSPLANTATION, Vol. 47 (pp S278-S278)
  • Samuelson C, Ezaydi Y, Cachia E, Greenfield D, Ahmedzai S, O'Toole L & Snowden J (2012) A STUDY OF THE CARDIORESPIRATORY LATE EFFECTS IN PATIENTS WITH ADVANCED INTENSIVELY TREATED MULTIPLE MYELOMA. HAEMATOLOGICA, Vol. 97 (pp 623-623)
  • Craddock C, Jilani N, Siddique S, Vyas P, Goodyear O, Dennis M, Yin J, Russell N, Snowden J & Crawley C (2012) AZACITIDINE IS WELL TOLERATED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION AND ITS ADMINISTRATION IS ASSOCIATED WITH A REDUCED RISK OF ACUTE GRAFT-VERSUS-HOST DISEASE. HAEMATOLOGICA, Vol. 97 (pp 21-22)
  • Dharmagunawardena RT, Pearce RM, Lee J, Apperley JF, Littlewood T, Wilson KM, Orchard K, Jackson G, Snowden JA, Kirkland K , Cook G et al (2011) . THORAX, Vol. 66 (pp A62-A62)
  • Tailor IK, Walker R, Dalley CD, Vora AJ, Collins N & Snowden JA (2011) Umbilical cord blood transplantation (UCBT) in teenagers and adults: Sheffield experience 2005-2010. BRITISH JOURNAL OF HAEMATOLOGY, Vol. 153 (pp 68-69)
  • Greenfield DM, Ezaydi Y, Cachia E & Snowden J (2011) Endocrine, bone and nutritional 'late effects' in patients with advanced stage multiple myeloma following HSCT and other intensive treatment. BONE MARROW TRANSPLANTATION, Vol. 46 (pp S186-S186)
  • Daikeler T, Labopin M, Di Gioia M, Abinun M, Alexander T, Miniati I, Gualandi F, Fassas A, Martin T, Schwarze C-P , Wulffraat N et al (2011) Diagnosis of Lupus, age at HSCT and CD34+graft selection are the main risk factors for secondary autoimmune diseases occurring after HSCT for autoimmune diseases: a retrospective study of the EBMT Autoimmune Disease Working Party. BONE MARROW TRANSPLANTATION, Vol. 46 (pp S84-S85)
  • Dennis M, Goodyear O, Loke J, Jilani N, Siddique S, Ryan G, Khanum R, Snowden J, Griffiths M, Russell NH , Yin J et al (2011) Azacitidine Induces Expansion of Regulatory T Cells and Tumour Specific CD8+T Lymphocytes After Allogeneic Stem Cell Transplantation: A Strategy for Epigenetic Manipulation of a Graft-Versus-Leukemia Response. BLOOD, Vol. 118(21) (pp 152-152)
  • Marsh JCW, Pearce RM, Koh MB, Tang D, Lim Z, Pagliuca A, Mufti GJ, Snowden J, Vora AJ, Gibson B , Gilleece MH et al (2011) National, Retrospective, Multi-Centre Comparison of Alemtuzumab- Versus ATG-Based Conditioning Regimens in Hematopoietic Stem Cell Transplantation for Aplastic Anemia: A Study From the British Society for Blood and Marrow Transplantation (BSBMT) (CTCR 09-03). BLOOD, Vol. 118(21) (pp 26-26)
  • Cachia E, Eiser C, Beeken R, McAtamney K, Greenfield D, Ezaydi Y, Walmsley S, Ross RJ, Coleman R, Ahmedzai SH & Snowden J (2010) A study of pain, peripheral neuropathy and psychosocial late effects in patients with intensively treated advanced multiple myeloma. BONE MARROW TRANSPLANTATION, Vol. 45 (pp S396-S396)
  • Cachia E, Greenfield D, Ezaydi Y, Baxter L, Ahmedzai SH, Eiser C, Coleman R, Ross R & Snowden J (2010) A study of the endocrine, metabolic and nutritional late effects in patients with advanced intensively treated multiple myeloma. BONE MARROW TRANSPLANTATION, Vol. 45 (pp S396-S397)
  • Martinez C, Canals C, Alessandrino EP, Karakasis D, Pulsoni A, Leone G, Trneny M, Snowden J, Apperley J, Milpied N , Bossi A et al (2010) RELAPSE OF HODGKIN'S LYMPHOMA AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): IDENTIFICATION OF PROGNOSTIC FACTORS PREDICTING OUTCOME. HAEMATOLOGICA, Vol. 95 (pp S26-S26)
  • Snowden JA (2010) CHOICE OF CONDITIONING REGIMEN. BONE MARROW TRANSPLANTATION, Vol. 45 (pp S3-S3)
  • Daikeler T, Labopin M, di Gioia M, Abinun M, Alexander T, Miniati I, Gualandi F, Fassas A, Martin T, Schwarze C-P , Wulffraat N et al (2010) Incidence and Risk Factors for Secondary Autoimmune Diseases (AD) After Hematopoietic Stem Cell Transplantation (HSCT) for a Severe Autoimmune Disease-A Retrospective EBMT WP AD Study. BLOOD, Vol. 116(21) (pp 959-960)
  • Oo N, Jones DA, Snowden J & El-Ghariani K (2010) Autologous peripheral progenitor cell harvesting in haematology patients: One centre experience. BRITISH JOURNAL OF HAEMATOLOGY, Vol. 149 (pp 67-67)
  • Nield A, Charley C, Dalley C, Davis J, Goddard Y, Salt M, Snowden J, Sprigens N & Ward S (2009) High-dose melphalan with stem cell rescue in the ambulatory care setting: the process to enable the concept to become a realistic treatment option. BONE MARROW TRANSPLANTATION, Vol. 43 (pp S319-S319)
  • Fredrick L, Beeken R, Taylor N, Eiser C, Wright J, Snowden J & Dalley C (2009) Quality of life in adult survivors of blood and marrow transplantation correlates strongly with physical and psychological late effects of treatment: a mixed methods approach. BONE MARROW TRANSPLANTATION, Vol. 43 (pp S180-S180)
  • Kuhl JS, Kohler W, Bandmann O, Buchholz S, Hemmati P, Snowden J, Sokolowski P, Stadler M, Terwey T & Arnold R (2009) Bone marrow transplantation in adult cerebral X-linked adrenoleukodystrophy: an update. BONE MARROW TRANSPLANTATION, Vol. 43 (pp S182-S183)
  • Alfred A, Mahmood S, Jones DA, Hess D, Wright J, Snowden JA & Mijovic A (2009) High-dose G-CSF is safe and effective for mobilisation of haemopoietic cells for autologous stem cell transplantation with clinical utility in the majority of sub-optimal mobilisers. BONE MARROW TRANSPLANTATION, Vol. 43 (pp S114-S115)
  • Craddock C, Tauro S, Buckley L, Kottaridis P, Thelouli E, Thomson K, Milligan D, Liakopoulou E, Snowden J, Marsh J , Hunter A et al (2008) PATIENT AND DONOR CHARACTERISTICS DETERMINE OUTCOME AFTER REDUCED INTENSITY ALLOGENEIC STEM CELL TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, Vol. 93 (pp 354-354)
  • Craddock CF, Tauro S, Gregory JE, Buckley L, Ward J, Kottaridis P, Thelouli E, Thomson K, Milligan D, Das-Gupta E , Liakpopoulou E et al (2007) . BLOOD, Vol. 110(11) (pp 103A-103A)
  • Alfred A, Throssell D, Ezaydi Y, Jones B, Reilly JT & Snowden JA (2006) Successful myeloablative allogeneic haemopoietic stem cell transplantation in a patient with end-stage renal failure on haemodialysis. BONE MARROW TRANSPLANTATION, Vol. 37 (pp S350-S350)
  • Chantry AD, Snowden JA, Craddock C & Marks DM (2006) Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukaemia in second remission: a British Society of Bood and Marrow Transplantation Registry study. BONE MARROW TRANSPLANTATION, Vol. 37 (pp S9-S10)
  • Sorour Y, Robinson K, Hurlstone P, Ei-Ghariani K, Lobo A & Snowden JA (2006) High-dose immune immunoablative therapy and autologous stem cell transplantation in severe resistant Crohn's disease: profound response for 18 months followed by treatable relapse. BONE MARROW TRANSPLANTATION, Vol. 37 (pp S341-S341)
  • Feyler S, Rawstron A, Jackson G, Snowden J, Hawkins K & Johnson RJ (2005) Thalidomide maintenance following high dose therapy in multiple myeloma: A UK myeloma forum phase 2 study.. BLOOD, Vol. 106(11) (pp 190A-190A)
  • Feyler S, Jackson G, Rawstron A, El-Sherbiny YM, Snowden JA & Johnson RJ (2003) Thalidomide maintenance following high dose therapy in multiple myeloma: A UK myeloma forum phase 2 study.. BLOOD, Vol. 102(11) (pp 691A-691A)
  • Ponchel F, Papadaki H, Bingham S, Verburg R, Moore J, Protheroe A, McGonagle D, Snowden J, Van-Laar J, Markham AF , Emery P et al (2003) Il-7 and therapy-induced lymphopenia in RA. ANNALS OF THE RHEUMATIC DISEASES, Vol. 62 (pp 164-164)
  • Frost L, Wilson G, Goodeve A, Gerrard M, Snowden J, Peake I & Vora A (1999) Relapsing precursor B-ALL presenting as CD-10 positive isolated extramedullary lymphoma.. BLOOD, Vol. 94(10) (pp 219B-219B)
  • Greco R, Saccardi R, Ponzano M, Badoglio M, Helbig G, Smilowski M, Mariottini A, Burman J, Carlson K, Kazmi M , Muraro PA et al () . Bone Marrow Transplantation
Grants
  • NIHR Efficacy & Mechanistic Evaluation (EME), Health technology Assessment (HTA), Research for Patient Benefit (RfPB)and Biomedical Research Centre (BRC)
  • Accelerating Clinical Trials (ACT)/DIDACT Foundation, to support Sheffield Teaching Hospitals NHS Foundation Trust within the IMPACT and TAP Clinical Trials Networks.
  • Sheffield Hospitals Charity (SHC).
  • Blood Cancer UK (BCUK, formerly called Bloodwise/Leukaemia and Lymphoma Research/Leukaemia Research Fund).
  • Cancer Research UK (CRUK).
  • Myeloma UK Research Grant Programme.
  • Macmillan Cancer Support.
  • Health Foundation SHINE Award.
  • Healthcare Quality Improvement Partnership.
  • Kay Kendall Leukaemia Fund (KKLF).
  • Weston Park Hospital Cancer Appeal.
  • Arthritis Research Campaign (ARC).
  • National Institutes of Health (NIH)/National Cancer Institute (NCI) of USA.
  • National Health & Medical Research Council (NHMRC) of Australia.

Postgraduate awards 

  • Health Service Journal/Nursing Times winner Best Cancer Care Team Award 2014 (with Prof Diana Greenfield for Late Effects Service).
  • Anthony Nolan Clinical Supporter of the Year Award 2016.
  • , winner of ‘The Future NHS Award’ to Professor Basil Sharrack and Professor John Snowden.
  • , with Richard Burt.
  • 2023, British Society for Haematology (BSH) and NIHR Clinical Research Network Award to recognise research by NHS consultants .
  • 2023, British Society of Blood and Marrow Transplantation & Cellular Therapy (BSBMTCT) Award for Outstanding Services to BMT Patients and the Transplant Community
Teaching activities
  • Throughout my career, I have been actively involved in teaching, lecturing, supervising and examining undergraduate and postgraduate degrees locally and nationally.
  • Supervisor and examiner for MBChB and BMedSci students, University of Sheffield.
  • Clinical co-supervisor and personal tutor for doctorate (PhD and MD) students at University of Sheffield and UCL.
  • Module Co-Lead for MSc(Res) in Translational Oncology (Cancer Diagnosis and Treatment), University of Sheffield.
  • Examiner for MD/PhDs at The University of Sheffield, and external at University of Birmingham, Newcastle University, and University of Oxford.
  • Educational supervision of postgraduate specialist training of numerous specialist trainees through the Membership of Royal College of Physicians and Pathologists examinations.
  • Examiner for the Royal College of Pathologists.
Professional activities and memberships

The University of Sheffield (TUoS) 

  • Professor of Haematology, Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield (from February 2025)
  • Honorary Professor, Department of Oncology & Metabolism, now Division of Medicine, TUoS (November 2013 - January 2025).
  • Honorary Reader, Department of Oncology, TUoS (2010-2013).

Sheffield Teaching Hospitals NHS Foundation Trust (STHFT)

  • Director of Blood and Marrow Transplant & Cellular Therapy Programme (2002-25).
  • Lead Clinician for Haemato-Oncology, STHFT Cancer Services Steering Group (2005-07) and Cancer Executive (2002-05).
  • Lead Clinician in Haematology Late Effects Service (2008-25).

University College London (UCL)

  • Honorary Clinical Professor, Department of Haematology, The Cancer Institute, UCL (2016-25).

Regional NHS Cancer Roles

  • Lead Clinician, Network Site Specific Group (NSSG) for Haemato-Oncology (2007-10), and acting chair/vice-chair of NSSG (2014-15).
  • Chair, NSSG Working Party for the Haemato-Oncology Diagnostic Service (2005-07).
  • Co-Lead Clinician for Haematology-Oncology in the NHS England Genomic Laboratory Hub (GLH) for North-East & Yorkshire (NEY) region (2019-2025). 

National roles and responsibilities 

  • National Cancer Research Institute (NCRI) Clinical Studies Group (CSG) in Haematological Oncology: Member by appointment (2008-17) and Chair of the Supportive Care, Transfusion & Late Effects Working Party (2015-17), Member of Aplastic Anaemia Working Group (2017-19).
  • National Confidential Enquiry into Patient Outcomes and Death (NCEPOD), Member of Expert Working Group for Systemic Anti-Cancer Chemotherapy, from 2006 until publication of report ‘Systemic Anti-Cancer Therapy: For better, for worse?’ in 2008.
  • UK Myeloma Forum Executive, Elected Member, 2009-15.
  • Chair (2016-20), and Member of NHS England Clinical Reference Group (CRG) for National Specialised Commissioning of BMT Services (2011-2024).
  • Chair of the National Clinical CAR-T Panel (NCCP) for acute lymphoblastic leukaemia (2018-19).
  • BSBMTCT Executive Committee Member (elected) 2012-2015, Secretary (elected) 2015-18, President-elect (elected) 2019-20, and then President, 2021-22, Past President, 2023-24.
  • Member, UKNEQAS Leucocyte Immunophenotyping Steering Committee 2014-present.
  • Co-Lead Clinician for Haemato-Oncology of the North East & Yorkshire region Genomic Laboratory Hub (GLH) 2019-25.
  • NICE and other NHS related organisations
    • Expert clinical member of NICE Guideline Development Group in Myeloma (NG35), 2014-15. 
    • Clinical Lead, NICE IOG for Haematological Cancers NG47, 2015-16. 
    • Clinical Co-Lead for COVID-19 rapid NICE Guidance in HSCT (NG164), 2020-21. 
    • Healthcare Improvement Scotland: Scottish Health Technology Guidance (SHTG) Autologous haematopoietic stem cell transplant for patients with highly active relapsing remitting multiple sclerosis not responding to high efficacy disease modifying therapies (as expert advisor) Published date: October 2019 
    • Health Technology Wales: Expert Consultation: Autologous haematopoietic stem cell transplantation to treat people with previously treated relapsing remitting multiple sclerosis (EAR019) (as expert advisor). Publication date July 2020 
    • UK Stem Cell Strategic Forum ‘A ten-year vision for stem cell transplantation’. Publication date July 2022. As President of BSBMTCT, I was an integral member of the UK Stem Cell Strategic Forum report, sponsored by NHSBT and supported by Anthony Nolan. 

International roles and responsibilities

  • Secretary to the European Society for Blood and Marrow Transplantation EBMT (2020-24)
  • Chair of the EBMT Autoimmune Diseases Working Party (2016-20), having been Secretary (2010-16).
  • EBMT JACIE Committee, as Chair (2015-20) and Medical Director (2012-16).
  • JACIE Committee Chair (from April 2015-July 2020) & JACIE Medical Director (2012-16).
  • Worldwide Network for Blood and Marrow Transplantation (WBMT) Executive Member (2015-24).

Other Working Parties and Guidelines Groups 

  • EBMT Transplant Complications Working Party (TCWP) and Severe Aplastic Anaemia Working Party (SAAWP).
  • BSH/UKMF Myeloma Guidelines Group (Lead in Supportive Care and Long Term Monitoring Guidelines).
  • BSH Aplastic Anaemia Guidelines Group 2014-present.

Scientific Organising Committees, Scientific Journal Editorship and Peer Review Work

  • Scientific/organising committee membership e.g. many Annual EBMT Congresses and Educational òݸ & and BSBMTCT educational and scientific days.
  • Associate Editor, Current Research in Translational Medicine (2013-present), Associate Editor Frontiers in Immunology specialty section ‘Alloimmunity and Transplantation’ (2021-).
  • Editorial Board Member, Blood Advances (2021-present), International Journal of Laboratory Haematology (2006-2021).
  • Guest Editorships, Frontiers in Immunology Special Edition on ‘Biomarkers in Graft versus Host Disease’ 2019-20, Clinical Medicine (Journal of the Royal College of Physicians of London) for Haematology CME 2018, Current Opinion in Supportive and Palliative Care 2017 special edition on Haematology.
  • Peer reviewer for scientific journals, conference abstracts and international, national and local grant applications.
  • Peer reviewer for University Professorship promotions.

Clinical Trials Networks and Committees

  • Principal Investigator for Clinical Trials Networks (CTNs):
    • Cure Leukaemia Therapy Acceleration Programme (TAP, funded 2020-22).
    • DIDACT Foundation IMPACT BMT CTN (funded 2023-26).
  • Membership of Trial Management Groups (TMG, Data Monitoring and Ethics Committee (DMEC) and Trial Steering Groups (TSG) for many clinical trials. 

Media and related work

  • Radio and TV as an expert opinion on haemato-oncology and stem cell transplantation, including collaborative work on Haematopoietic Stem Cell Transplantation in Multiple Sclerosis was featured increasingly in media leading to a BBC Panorama documentary ‘Can You Stop My MS?’&Բ;aired in 2016 to estimated 2.4 million live, with subsequent broadcast interview coverage and other on-line coverage reaching an estimated 180 million worldwide.
  • Also featured in many national newspapers and their on-line versions.
Examples of invited lectures, chairing and organising committees for last 10 years

2016

  • Organiser, Invited speaker, EBMT ‘Educational Meeting of Autoimmune Diseases Working Party’, Berlin, January 2016.
  • Invited Speaker, Autoimmune Diseases Meeting, Porto, Portugal, January 2016.
  • Organiser, Invited Speaker, Abstract Reviewer, Sessional Chair, Annual EBMT Meeting, Valencia, April 2016.
  • Invited Speaker, XXXVI World Congress of the International Society of Hematology hosted by the British Society for Haematology, Glasgow, April 2016.
  • Invited Speaker, EBMT Highlights, Jeddah, Saudi Arabia, May 2016.
  • Invited Speaker, Uppsala University, Sweden, May 2016.
  • Invited Speaker, Department of Neurology, Oxford University, June 2016.
  • Invited Speaker, Myeloma UK Symposium, Birmingham, September 2016.
  • Organiser, Invited speaker, BSBMT Annual Educational Meeting, London, November 2016.
  • Organiser, Invited speaker, EBMT ‘Educational Meeting of Autoimmune Diseases and Severe Aplastic Anaemia Working Parties’, Paris, November 2016.
  • Organiser, Invited speaker, ‘Late Effects in Cancer Survivors’, Royal College of Physicians of London, November 2016.
  • Invited Speaker, Autoimmunity and Immunodeficiency Diseases Conference, Moscow, Russia, December 2016.

2017

  • Invited speaker and session chair, Tandem Meeting of the American Society for Blood and Marrow Transplantation (ASBMT) and Centre for International Bone Marrow Transplant Research (CIBMTR), Orlando, FL, USA, February 2017.
  • Organiser, Invited Speaker, Abstract Reviewer, Sessional Chair, Annual EBMT Congress, Marseille, March 2017.
  • Organiser, Invited Speaker, NCRI Haemato-oncology Annual Trials Day, May 2017.
  • Invited Speaker, ‘Inflammation, breaking down Silos’, Oxford University, June 2017.
  • Invited Speaker, University of Jordan, October 2017.
  • Organiser, Invited speaker, BSBMT Annual Educational Meeting, London, November 2017.
  • Organiser, Invited speaker, EBMT ‘Educational Meeting of Autoimmune Diseases and Inborn Errors Working Parties’, Newcastle, November 2017.

2018

  • Invited Speaker, Annual ECCO Congress, Vienna, February 2018.
  • Organiser, Invited Speaker, Abstract Reviewer, Sessional Chair, Annual EBMT Congress, Lisbon, March 2018.
  • Invited speaker, BSBMT Annual Scientific Meeting, London, May 2018.
  • Invited Speaker, EBMT Highlights, Riyadh, Saudi Arabia, May 2018.
  • Invited Speaker, EBMT Highlights, Delhi, India, May 2018.
  • Organiser, Invited speaker, EBMT International Training Course in BMT, September, 2018.
  • Organiser, Invited speaker/chair, BSBMT Annual Educational Meeting, London, October 2018.
  • Invited Speaker, UKE Hamburg-Eppendorf, Germany, October 2018.
  • Invited Speaker, Myelin Meeting, Leipzig, Germany, October 2018.
  • Invited speaker, Royal College of Physicians, London, October 2018.
  • Organiser, Invited speaker, EBMT ‘Educational Meeting of Autoimmune Diseases and Severe Aplastic Anaemia Working Parties’, Florence, November 2018.

2019

  • Invited speaker, Royal Society of Medicine, London, March 2019.
  • Organiser, Invited Speaker, Abstract Reviewer, Sessional Chair, Annual EBMT Congress, Frankfurt, March 2019.
  • Invited speaker, British Society for Cell and Gene Therapy (BSCGT) Annual Meeting, Sheffield, UK, June 2019.
  • Invited speaker, 61st National Congress of the Spanish Hematology and Hemotherapy Society and 35th National Congress of the Spanish Society of Thrombosis and Hemostasis, Valencia, Spain, October 2019.
  • Invited speaker, COSTEM (Controversies in Stem Cell Transplantation) Meeting, Berlin, Germany, October 19-21, 2019.
  • Organiser, Invited speaker, EBMT ‘Educational Meeting of Autoimmune Diseases Working Party’, Berlin, Germany, October 31-November 1, 2019.
  • Invited speaker, international conference “Stem cell transplantation for treatment of autoimmune diseases: sharing the experience”, Moscow, November, 2019.
  • Invited speaker, organiser, national conference of the Intercollegiate Committee on Haematology “Updates, Controversies, Uncertainties”, Royal College of Pathologists, London, December 17, 2019.

2020

  • Invited speaker 4th French International Symposium on CAR T Cells, Faculty of Medicine and Lille University Hospital, Lille, France, January 2020.
  • Organiser, invited Speaker, Abstract Reviewer, Sessional Chair, Annual EBMT Congress, Madrid, re-scheduled as virtual meeting to August 31-September 2, 2020.
  • Organiser, session chair, EBMT ‘Educational Meeting of Autoimmune Diseases Working Party’, Virtual Conference, September 24-25, 2020.

2021

  • Organiser, invited Speaker, Abstract Reviewer, Sessional Chair, Annual EBMT ‘Virtual’ Congress, March 14-17 2021.
  • Organiser, session chair, EBMT ‘Educational Meeting of Autoimmune Diseases Working Party’, Virtual Conference, September 23-24, 2021.
  • Invited speaker and session chair, ‘EBMT Covid-19 Summit’, Virtual Conference, June 29 – July 1, 2021.
  • Invited speaker (virtual), Departments of Haematology and Neurology, Leeds Teaching Hospitals, September 21, 2021.
  • Organiser, session chair, EBMT ‘Educational Meeting of Autoimmune Diseases Working Party’, Virtual Conference, September 23-24, 2021.
  • Invited speaker, UK Primary Immunodeficiency Network (UKPIN) Meeting, Sheffield, November 2, 2021.

2022

  • Invited speaker MS Academy - Live Webinar (with Prof Basil Sharrack) ‘UK stem cell transplantation in MS (the StarMS trial), January 27, 2022.
  • Invited online lecture to Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, Chao Family Comprehensive Cancer Center, University of California, Irvine, February 9, 2022.
  • Invited speaker (online) University College Dublin Centre for Arthritis Research Seminar, February 18, 2022.
  • Organiser, Invited Speaker, Sessional Chair (online), 9th Annual ECTRIMS Focused Workshop on Autologous haematopoietic stem cell transplantation for treatment of MS and related diseases, March 10-11, 2022.
  • Organiser, invited Speaker, Abstract Reviewer, Sessional Chair, Annual EBMT ‘Virtual’ Congress, March 19-23, 2022.
  • Invited Speaker, Northern Connections MS Meeting, Edinburgh, The Royal College of Physicians of Edinburgh, June 10, 2022.
  • Invited speaker, 30th Congress of the Polish Society of Haematology and Transfusion Medicine, September 8-10, 2022.
  • Invited speaker, MS At the Limits Meeting, Royal College of Physicians of London, September 19, 2022.
  • Organiser, session chair, EBMT ‘Educational Meeting of Autoimmune Diseases Working Party’, Royal College of Pathologists, London, September 24-25, 2022.
  • Organiser, North East & Yorkshire Genomic Medicine Service Haemato-Oncology Symposium, October 10, 2022.
  • Organiser, Chair, BSBMTCT Annual Educational Meeting, London, November 1, 2022

2023

  • Organiser, Invited Speaker, Sessional Chair, The 3rd International Symposium on Stem Cell Treatment in Multiple Sclerosis – SITraN, Sheffield, 20 January 2023
  • Organiser, Invited Speaker, Sessional Chair, Annual EBMT Congress, Paris, April 23-26, 2023.
  • Invited virtual lecture to New York Medical College, Westchester Medical Center, Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, April 10, 2023.
  • Invited virtual lecture at the Florey Institute Symposium, The University of Sheffield, 27 April, 2023.
  • Invited online lecture to 1st Jordanian International Convention of Transfusion Medicine and Hematopoietic Stem Cells, May 6, 2023.
  • Invited Speaker, EBMT Midterm Meeting on Immunedysregulatory, Autoinflammatory and Autoimmune Diseases, Brescia, Italy, June 22-24, 2023.

2024

  • Sessional Chair, Annual EBMT CAR-T Meeting, Valencia, Spain, February 15-17, 2024.
  • Organiser, Invited Speaker, Sessional Chair, Annual EBMT Congress, Glasgow, UK, April 14-17, 2024.
  • Invited Speaker, British Society for Haematology (BSH) Annual Scientific Meeting, Liverpool, UK, April 27-30, 2024.
  • Invited speaker and session chair, EBMT Joint Educational Meeting of Cellular Therapy & Immunobiology Working Party and Autoimmune Diseases Working Party, Milan, Italy, October 9-11, 2024.